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ABSTRACT 
 
Some studies on autologous chondrocyte implantation (ACI) have demonstrated little benefit 
over other techniques and few have demonstrated a lasting benefit. A number of factors can 
contribute to failure and a scientific approach to elucidate these variables has not been 
reported. 
 
This thesis reports on the use of a statistical approach - the Generalised Linear Model (GLM) 
to quantify the effect each factor has whilst considering the interplay of other variables. Data 
from a randomised controlled trial and several case-controlled studies will assess the efficacy 
of 2 different types of ACI, the influence of smoking, BMI, and physical activity. Non-
modifiable risk factors that were assessed include the aetiology, site and size of the lesion, the 
duration of symptoms and number of previous operations prior to the index procedure and the 
presence of early osteoarthritis. 
 
Site had a significant effect on outcome but size did not. The GLM predicted a point increase 
in the Modified Cincinnati Score (MCS) before surgery (MCS 0) would lead to a further 0.5 
point increase in MCS 2 years postoperatively (MCS 24) (p=0.001). Other significant non-
modifiable risk factors include age and sex of the patient. When treating lesions in the patella, 
duration of symptoms was a significant factor, but age was not. 
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The GLM predicted that smokers’ MCS 24 (the Modified Cincinnati Score 2 years after 
surgery) was likely to be 15 less than non-smokers (p=0.002). Patients playing no sports 
experienced an 11.4 point decrease. For each increase in BMI, the MCS 24 was 2.4 less 
(p=0.001).  
Factors that optimise outcome following surgery are; avoidance of numerous procedures 
prior to ACI and delay of more than one year before undergoing ACI. Current NICE 
guidelines prohibit the use of ACI as the first-line surgical procedure and prevent addressing 
the above 2 issues. 
Poorer results were observed in obese patients. Weight loss and active lifestyle are essential 
pre-operatively.  Furthermore, we recommend that pre-operative counselling for smokers is 
essential and that all smokers be offered a cessation programme.  
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Chapter 1:  
The Biology of Cartilage 
Introduction 
 
Articular cartilage has a unique structure and function. It forms the articulating surface of 
diarthrodial joints and provides friction-free load-bearing on joint surfaces, hence allowing 
smooth movement without pain. This is accomplished by the production of a special matrix 
(by chondrocytes) which binds and contains water. In most synovial joints, articular cartilage 
provides these essential biomechanical functions for 8 decades or more. No synthetic material 
performs this well as a joint surface. 
Composition 
 
Articular cartilage consists of cells, matrix water, and matrix macromolecular framework. Its 
mechanical properties are derived primarily from its matrix. Cells contribute little to the 
volume of the tissue (approximately 1% in adult humans). 
Chondrocytes 
Chondrocytes are the only type of cell within normal articular cartilage and are responsible 
for synthesizing all the constituents of the extracellular matrix (ECM). They are derived from 
mesenchymal cells, which differentiate during skeletal development to form chondrocytes. 
The size, shape and metabolic activity differ according to zone they reside in (Aydelotte et al. 
1996). All chondrocytes contain the organelles necessary for matrix synthesis (e.g. 
endoplasmic reticulum and Golgi membranes). 20 
 
Chondrocytes are metabolically active and derive their nutrients from the synovial fluid. The 
nutrients must first pass through synovial tissue and fluid and then into cartilage matrix. This 
places a restriction on not only the size of materials but also the charge and molecular 
configuration (Fischer et al. 1995). The configuration of this system means that chondrocytes 
are exposed to low levels of oxygen relative to other tissues and hence depend primarily on 
anaerobic metabolism. 
In growing individuals, chondrocytes produce new tissue to expand and remodel the articular 
surface. In the skeletally mature, they do not substantially change the volume of tissue, but 
replace degraded matrix macromolecules as well as remodelling the articular surface to a 
limited extent (Buckwalter 1995). During the formation and growth of articular cartilage, the 
cell density is high and the cells reach their highest level of metabolic activity as the 
chondrocytes proliferate rapidly and synthesize large volumes of matrix. After completion of 
growth, most chondrocytes probably never divide but rather continue to synthesize collagens, 
proteoglycans and non-collagenous proteins. The maintenance of articular cartilage requires 
on going remodelling of the matrix framework with an establishment of equilibrium between 
synthetic and degradative activity. Several mechanisms influence this balance. For example, 
immobilization of a joint has been shown to exceed the degradative process when compared 
to synthetic activity (Buckwalter 1995). Furthermore, with ageing, the capacity of the cells to 
synthesize some types of proteoglycans and their response to growth factors decrease 
(Guerne et al. 1995 and Martin et al. 1996). In the osteoarthritic patient, there is evidence to 
suggest that chondrocytes are able to synthesize new matrix but many of these molecules are 
degraded by proteolysis (Hollander et al. 1991). 
As well as mechanical loads and hydrostatic pressures changes, chondrocytes also respond to 
soluble mediators, such as growth factors, interleukins and pharmaceutical agents. Although 21 
 
chondrocytes maintain a stable matrix, their response to some factors (e.g. IL-1) may lead to 
degradation of ECM. The response to other types of messages used to commonly regulate 
body processes is limited. Cartilage has no nerve supply; hence neural impulses can not 
provide information. Immune responses (both cellular and humoral) are not likely to occur in 
cartilage (due to exclusion of monocytes and immunoglobulins from tissue by steric 
exclusion). 
Extracellular matrix 
The matrix of articular cartilage consists of two components: tissue fluid and the framework 
of structural macromolecules that give the tissue its form and stability. The interaction of the 
tissue fluid with the macromolecular framework gives the tissue its mechanical properties of 
stiffness and resilience (Arokoski et al.1999). 
Tissue fluid 
Water contributes 65% to 80% of the wet weight of articular cartilage and the interaction of 
water with macromolecules within the matrix influences the mechanical properties of the 
tissue significantly (Linn et al. 1965, Maroudas et al 1987). In order to balance the 
negatively-charged proteoglycans, the tissue fluid contains high concentrations of cations as 
well as gases, small proteins and metabolites. The interaction of water with the large 
aggregating proteoglycans help maintain the fluid within the matrix and the concentrations of 
electrolytes in the fluid. The concentration of positive ions (e.g. sodium) is increased due to 
the presence of large numbers of negatively-charged sulphate and carboxylate groups on 
macromolecules attracting positive charged ions and repelling negatively charged particles. 
Consequently the concentration of negative ions such as chloride decreases. The increase in 
the total concentration of inorganic ions causes an increase in osmolality of the tissue (i.e. it 
creates a Donnan effect) (Buckwalter and Mankin Part 1, 1997). The collagen network resists 22 
 
the Donnan osmotic pressure caused by the inorganic ions associated with proteoteglycans 
thus maintaining the turgor of the tissue (Buckwalter and Mankin Part 2, 1997). 
Structural macromolecules 
Macromolecules contribute 20 to 40% of the wet weight of the tissue (Buckwalter and 
Rosenberg 1990). The three classes of macromolecules in articular cartilage are collagens, 
proteoglycans, and non-collagenous proteins. Collagens contribute 60% of the dry weight of 
cartilage; proteoglycans 25-35%; and non-collagenous proteins and glycoproteins 15-20%. 
Collagens 
Collagens are distributed fairly evenly throughout the depth of the cartilage except for the 
collagen-rich superficial zone (figure 1.1). The collagen fibrillar meshwork gives cartilage its 
form and tensile strength (Buckwater and Mow 1992).  
Figure 1.1: Immunochemical localization of type II collagen in an intact articular cartilage 
region from the knee joint. 
(From biology-online.org with kind permission from editors) 23 
 
Articular cartilage consists of multiple distinct collagen types of which type II collagen 
accounts for 90-95%. Others include Type VI, IX, X and XI. Types II, IX and XI form the 
cross-branded fibrils seen with electron microscopy. These fibrils are organized into a tight 
meshwork that extends throughout the tissue and provides the tensile stiffness and strength of 
articular cartilage. Type II collagen is the primary component of the cross-banded fibrils. 
Type IX collagen molecules bind covalently to the superficial layers of the cross-banded 
fibrils and project into the matrix, where they can also bind covalently to other type IX 
collagen molecules (Eyre 1995). Type XI collagen molecules bind covalently to type II 
molecules and form part of the interior structure of the cross-banded fibrils. The functions of 
type IX and XI collagens remain unclear but it is presumed that they help form and stabilise 
the collagen fibrils assembled primarily from type II collagen. The projecting portions of type 
IX collagen may also help to bind together the collagen-fibril meshwork (Bruckner 1988). 
Type VI collagen appears to form an important part of the matrix surrounding the 
chondrocytes and helps chondrocytes attach to the matrix (Hagiwara et al.1993). Type-X 
collagen is only present near the cells of the calcified cartilage zone of the articular cartilage 
and the hypertrophic zone of the growth plate (where the longitudinal cartilage septa begin to 
mineralize). This suggests that it has a role in mineralization of the cartilage (Eyre et al. 
1992). 
Proteoglycans 
Proteoglycans consist of a protein core and one or more glycosaminoglycan chains (long 
unbranched polysaccharide chains consisting of repeating disaccharides that contain an amino 
sugar (Hardingham 1992). Each unit of disaccharide has at least one negatively charged 
carboxylate or sulphate group. Hence these glycosaminoglycans form long strings of negative 
charges, attracting cations. Glycosaminoglycans found in cartilage include hyaluronic acid, 24 
 
chondroitin sulphate, keratin sulphate and dermatan sulphate. The concentration of these 
molecules varies amongst sites within articular cartilage and also with age, injury to the 
cartilage and disease. 
Figure 1. 2: The micrograph on the cover shows a portion of an aggregate isolated from 
cartilage that consists of a central filament of hyaluronan and a large number of attached 
monomer (aggrecan) proteoglycans 
 
 
 
The major classes of proteoglycans are aggrecans (large aggregating monomers) and small 
proteoglycans such as decorin, biglycan and fibromodulin (Poole et al. 1996). Aggrecans 
have large numbers of chondroitin sulphate and keratin sulphate chains attached to a protein 
core filament. Cartilage also contains large non-aggregating proteoglycans that resemble 
aggrecans in structure and composition and may represent degraded aggrecans (Buckwalter 
and Roughly 1994). Aggrecan molecules fill most of the interfibrillar space of the cartilage 
matrix, contributing 90% of the total matrix proteoglycan mass; large non-aggregating 
proteoglycans contribute 10% and small non-aggregating proteoglycans contribute 3%. The 
latter, due to their small size, may be present in equal or higher molar amounts even though 
they add relatively little to the total mass. 
Most aggrecans non-covalently associate with hyaluronic acid and link proteins (small non-
collagenous proteins) to form proteoglycan aggregates (see figure 1.2).  
"This research was originally 
published in Journal of Biology 
Chemistry. Saul Roseman. 
Reflections in Glycobiology. J Bio 
Chem. 2001; 276(45): . © the 
American Society for Biochemistry 
and Molecular Biology." 
 25 
 
These large molecules have a central backbone of hyaluronan that can range in length from 
several hundred to more than 300 associated aggrecan molecules (Buckwalter and Kuettner 
1985). Link proteins stabilise the association between monomers and hyaluronic acid and 
appear to have a role in directing the assembly of aggregates (Tang et al. 1996). 
Biochemical and electron microscopy studies show two populations of proteoglycan 
aggregates within articular cartilage (Pita et al. 1990): 
1)  slow sedimenting population of aggregates with low chondroitin sulphate-to-
hyaluronate ratio and few monomers per aggregate 
2)  faster sedimenting population of aggregates with higher chondroitin sulphate-to-
hyaluronate ratio and more monomers per aggregate. 
The superficial regions of cartilage contain primarily smaller aggregates whereas the deeper 
regions contain both types. Loss of larger aggregates appears to be one of the earliest changes 
associated with osteoarthritis and immobilization of the joint (Buckwalter and Roughly et al 
1994). The smaller aggregates are thought to influence cell function by binding to other 
macromolecules. 
Non-collagenous proteins and glycoproteins 
There are a wide of variety of these molecules in articular cartilage but thus far only a few of 
them have been studied, hence their role is not as well-understood. In general, they consist of 
a protein core attached to which are monosaccharides and oligosaccharides (Heinegard et al 
1995). Some of these molecules appear to help to organise and maintain the macromolecular 
structure of the matrix. For example, Anchorin CII, a collagen-binding chondrocyte surface 
protein, may help to anchor chondrocytes to the collagen fibrils of the matrix (Pfaffle et al. 
1990). 26 
 
Cartilage oligomeric protein, an acidic protein, is concentrated primarily within territorial 
matrix of the chondrocyte and appears to be present only within cartilage and to have 
capacity to bond to chondrocytes. This molecule may have value as a marker of cartilage 
turnover and of progression of cartilage degeneration in patients who have osteoarthritis 
(Sharif et al. 1995). 
 
Figure 1.3: Diagrammatic representation of the macrofibrillar collagen network and 
aggrecan with hyaluronic acid 
 
(Modified from Poole AR: Cartilage in Health and Disease. In Koopman W [ed]. Arthritis and Allied Conditions. A  
Textbook of Rheumatology. Ed 14. Vol 1. NewYork, Lippincott Williams & Wilkins 2260–2284, 2001.) 27 
 
Structure 
From the articular surface to the subchondral bone, the structure and composition varies 
throughout its’ depth (figure 1.4.).  
Figure  1.4 The zones of articular cartilage 
 
Articular cartilage histology. (a) Van Gieson staining for collagen demonstrating superficial 
(S1), middle (M1) deep (D1) and calcified (C1) layers. (b) Haematoxylin and eosin staining 
illustrating the radial alignment and matrix organisation in the deep layers. (c) Detail showing 
differentiation of the pericellular microenvironment (Pm), territorial matrix (Tm) and the 
interterritorial matrix (Im). Bars: (a) 100 lm, (b) 50 lm, (c) 10 lm. 
Figure taken from CA Poole  J Anat. 1997 
These differences include cell shape and volume, collagen fibril diameter and orientation, 
proteoglycan concentration and water content. The cartilage can be divided into 4 zones: 
1.  Superficial zone 
2.  Middle or transitional zone 
3.  Deep zone 
4.  Zone of calcified cartilage 
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Figure 1.5: Diagrammatic representation of articular cartilage 
D
iagrammatic representation of the general structure of human articular cartilage from an adult to show the zones, 
regions, and relationship with subchondral bone. The insets show the relative diameters and organizations of 
collagen macrofibrils in the different zones. Some special features of molecular content or properties also are 
indicated. (Modified from Poole AR: Cartilage in Health and Disease. In Koopman W [ed]. Arthritis and Allied 
Conditions. A Textbook of Rheumatology. Ed 14. Vol 1. New York, Lippincott Williams & Wilkins 2260–2284, 
2001.) 
 
 
The superficial zone consists of thin collagen fibrils arranged parallel to the surface. The 
chondrocytes in this layer are elongated and the long axis is also parallel to the surface 
thereby providing the tensile and shear strength (Akizuki et al 1986). The chondrocytes are 
covered by a thin film of synovial fluid, called ‘lamina splendens’ or ‘lubricin’ (Buckwalter 29 
 
& Mankin 1997). This protein is responsible for providing an ultimate gliding surface to the 
articular cartilage. Preservation of this superficial layer is critical to protect the deeper zones 
and damage to the superficial zone alters the mechanical properties of cartilage thus 
contributing to the development of osteoarthritis. Type IX collagen is found in this layer 
between type II bundles that provide resistance to shear.  It is thought that this layer limits 
passage of large molecules between synovial fluid and cartilage (Alford and Cole 2005). The 
water content is at its highest level and the proteoglycan content at its lowest. 
The chondrocytes in the middle zone are more spherical and the cell density in this zone is 
lower. The collagen fibres have a larger diameter, are obliquely arranged  though have less 
apparent organization (Buckwalter and Mankin 1997). The proteoglycan aggrecan 
concentration is higher in this zone. This layer resists compressive forces but also serve as a 
transition between the shearing forces on the surface and the compressive forces placed on 
the deeper layers 
The deep zone contains the highest concentration of proteoglycans and the lowest 
concentration of water. Cell density is at its lowest in this zone. The collagen fibres have a 
large diameter and are organized perpendicular to the joint surface. The chondroytes are also 
arranged in columns. This arrangement serves to resist compressive loads. 
The deepest layer, the zone of calcified cartilage separates the hyaline cartilage from 
subchondral bone. It is characterised by small cells distributed in cartilaginous matrix 
encrusted with apatitic salts. The chondrocytes in this zone express hypertrophic phenotype. 
These cells are unique in the way that they synthesise Type X collagen, responsible for 
providing structural integrity and provide a ‘shock absorbing’ capacity along with the 
subchondral bone.  30 
 
Histological staining with haematoxylin and eosin shows a wavy bluish line, called the 
tidemark, which separates the deep zone from the calcified zone. The number of tidemarks 
increases with age as the tissue is remodelled (Buckwalter et al. 1985). This zone was 
considered inactive until Hunziker noticed that chondrocytes in this zone were able to 
incorporate sulphate into pericellular and territorial matrix (Hunziker 1992). It was also 
speculated that following injury, the metabolic activity in this zone becomes temporarily 
impaired. 
Matrix is organized in three different zones in the cartilage: 
1.  Peri-cellular 
2.  Territorial 
3.  Inter-territorial 
Pericellular matrix is a thin rim of matrix organized tissue in close contact with the cell 
membrane (2μm wide). This region is rich in proteoglycans and non-collagenous proteins, 
like cell membrane-associated molecule anchorin CII and decorin (Buckwalter and Mankin 
1997). It also contains non-fibrillar collagen, made of type IV collagen. 
Territorial matrix surrounds the pericellular region and is present throughout the cartilage. It 
surrounds individual chondrocytes or a cluster of chondrocytes including their pericellular 
matrix. In the middle zone, it surrounds each column of chondrocytes. The collagen fibrils in 
this region are organised in a criss-cross manner thus forming a fibrillar basket surrounding 
clustered bunch of chondrocytes, protecting them from mechanical impacts. 
Inter-territorial matrix forms the most of the volume of all types of matrices, made up of the 
largest diameter of collagen fibrils. Fibres are oriented differently in different zones, 31 
 
depending on the requirement, viz. parallel in the superficial zone and perpendicular in the 
radial zone. This region is distinguishable from others, by formation of aggregates 
of proteoglycan molecules. 
Collectively, these highly specialized layers produce the superior loading and minimal 
friction characteristics of hyaline cartilage that makes it particularly difficult to restore or 
duplicate once it is damaged or lost. Damage to any part of this complex system can disrupt 
normal biomechanical properties of articular cartilage leading to further degeneration (see 
box 1). 
Figure 1.6: Functions of Hyaline cartilage and matrix 
 
 
Functions of articular cartilage: 
1. Provides a low-friction gliding surface. 
2. Acts as a shock absorber. 
3. Minimizes peak pressures on the 
subchondral bone. 
 
Functions of the matrix: 
1. Protects the chondrocytes from mechanical 
loading, thus helping to maintain 
their phenotype. 
2. Storage of some cytokines and growth 
factors, required for chondrocytes. 
3. Determines the type, concentration and 
rate of diffusion of the nutrients 
to chondrocytes. 
4. Acts as a signal transducer for the cells. 
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Influence of mechanical factors on structure 
The functional and structural properties of articular cartilage appear to be conditioned to 
stresses to which it is most regularly subjected (Seedhom et al. 1979). Thus, cartilage which 
is regularly subjected to high levels of stress shows a higher content of PGs (Slowman & 
Brandt 1986), higher cell volume (Eggli et al. 1988), and is stiffer (Swann & Seedhom 1993) 
than a cartilage exposed to low stress levels. Both the organization pattern of collagen and 
content of PGs of the articular cartilage appear to be intimately related to local functional 
requirements. Areas which are regularly subjected to high levels of shear stress, i.e. patellar 
surface of femur and femoral condyles, show a higher degree of collagen orientation and a 
thicker superficial zone than an area which is preferentially subjected to weightbearing, e.g., 
the tibial plateaus rich in PGs (Arokoski et al. 1999). Thus, the mechanical forces work up 
and shape the biological properties of articular cartilage. Mechanical forces also seem to be 
more important than motion in supporting the properties of cartilage, since movement of the 
joint in the absence of normal loading causes and maintains atrophic changes in cartilage 
(Palmoski & Brandt 1981). 33 
 
Injury and Repair 
 
The aetiology of cartilage defects can be classified into traumatic, those due to 
chondromalacia patellae and osteochondritis dissecans. This thesis will investigate all 3 
aetiologies but the majority of patients have injury induced defects.  
Acute traumatic joint injury is known to increase the risk for subsequent development of 
osteoarthritis (Davis et al 1989), but the mechanisms responsible for this process are unclear. 
Post traumatic osteoarthritis may account for substantial morbidity in a relatively young and 
active population with many patients showing radiographic signs of osteoarthritis by 10 years 
after anterior cruciate ligament or meniscal injury (Roos et al. 1995). 
Chondral lesions involving the knee are common. Aroen et al. (2004) demonstrated articular 
cartilage pathology in 66% of patients in a study of 993 consecutive arthroscopies. In a more 
substantial paper, articular cartilage lesions were discovered in 63% of 31000 arthroscopies 
(Curl et al. 1997).  
Injuries to joints are common in humans, particularly during sporting activities. Knee trauma 
is common in athletes such as soccer players, reportedly accounting for 20% of all their 
injuries (Levy et al. 1996). The high incidence can be attributed to the high velocities and 
repetitive high impact twisting movements that occur when kicking a ball. This places 
unusual and high stresses on the articular cartilage (Levy et al. 1996).  
Chondral lesions secondary to injury are thought to occur through two distinct mechanisms: 
1)  The largest group arise through abrasive wear, which results in superficial fibrillation. 
Often at this stage the lesion is asymptomatic until erosion progresses to the 
subchondral bone. 34 
 
2)  The second type arises due to disruption to the deep cartilage ultra-structure by shear 
forces. 
Ateshian et al. (1994) demonstrated that shear stress is concentrated at the junction of the 
uncalcified and calcified cartilage, which may produce damage to the cartilage above the 
tidemark but also the subchondral bone. Levy et al confirmed this when they performed 
biopsies of the base of the osteochondral defects (OCD)s in soccer players at the 
delamination border revealing that the calcified cartilage remained with the subchondral 
bone. 
 
Repair mechanisms 
In response to injury, the body reacts in a uniform fashion. Although there are certain 
characteristics specific to individual tissues and organs, the general pattern requires two 
essential ingredients. The presence of specific cells is essential not only to clean up necrotic 
material, but also to synthesize new tissue. These cells are either derived from the replication 
of cells in situ, or from cells that have migrated from the wound margin or enter the area by 
blood vessels. The second requirement is a vascular supply. The vascular system supplies 
many of the cells mentioned and also is a source of many bioactive molecules (such as 
growth factors, chemotactic, mitogenic, and cytotactic factors, and others) that are needed to 
create the proper biochemical environment for healing. With these basic ingredients, the 
classic response to injury is usually described as consisting of three phases. 
 
Classic healing 
The phase of necrosis is first, and it begins at the time of injury. There is a variable amount of 
cellular death, depending on the amount of trauma and devascularisation that takes place. The 35 
 
cell death that occurs subsequent to the original event increases the overall amount of tissue 
damage. Coincident with injury, blood escapes from damaged blood vessels, forming a 
haematoma, and subsequently a clot is produced. Platelets trapped within the clot release 
various growth factors and cytokines, inducing the migration of pluripotential stem cells into 
the area, their subsequent proliferation and differentiation, as well as stimulating a vascular 
invasion. The inflammatory phase is next, and depends almost wholly on the vascular system. 
Vasodilatation and increased vessel wall permeability give rise to transudation of fluid and 
proteins, as well as cellular exudation into the damaged area. This results in the formation of 
a dense fibrinous network, which ultimately contains inflammatory cells, as well as the 
pluripotential cells that will (in some locations) eventually differentiate into cells capable of 
replacing the damaged tissue. The remodelling phase is the last, and the longest, of the 
healing phases. It begins when the fibrinous network is invaded by vascular buds, creating a 
vascular granulation tissue. In some organs, this tissue matures and contracts, creating a scar. 
In  others, the cells undergo a metaplasia into cells capable of replicating the function and 
structure of the original tissue. 
 
Limitations of cartilage 
The response of cartilage to injury differs from this classic response because of two important 
features of the structure of cartilage, of which the most important is its avascular status 
(Mankin 1982). The second and third phases of healing are almost entirely mediated by the 
vascular system, and thus all the inflammatory and reparative aspects that the vascular system 
provides are not available to cartilage. In addition, the migration of new phagocytic and 
pluripotential cells by means of the vascular system is denied to cartilage. Indeed, articular 
cartilage matrix may contain natural inhibitors of vascular and macrophage invasion, as 36 
 
well as inhibitors of clot formation. The second difference is that the chondrocytes are 
literally imprisoned in a mesh of collagen and proteoglycan, unable to migrate to the injury 
site from adjacent healthy cartilage. Even if they were able to turn their synthetic engines on 
in an effort to replace damaged matrix, they cannot get to where they are needed. These 
conditions will be different if the cartilage injury penetrates through the subchondral plate, 
providing a pathway to the highly vascular bone. In this injury, because of the participation of 
the vascular system, the repair response is much more similar to that seen elsewhere in the 
body. Descriptions of the attempt of articular cartilage to heal itself after injury have typically 
followed two pathways, one detailing the events after a superficial injury to articular 
cartilage, and the other involving a deep, full-thickness injury through the subchondral bony 
plate (Buckwalter and Mankin 1997). 
 
Partial thickness injury 
The reaction to a partial-thickness injury is the same whether it is tangential or perpendicular 
to the surface (Ghadially et al. 1977). Immediately adjacent to the margins of the wound there 
is a zone of necrosis, with ghost cells seen in the chondrocyte lacunae. There is a brief period 
of mitotic activity and matrix synthesis among the chondrocytes near the injury, but this 
activity rapidly ceases, with no significant healing (DePalma et al. 1966, Fuller t al. 1972). 
Cellular proliferation results in small clusters of chondrocytes, seen only in injury and 
osteoarthritis (Mankin 1974). Studies have demonstrated no progression of healing over time, 
but importantly, they have also demonstrated that these lesions remain stable and tend to 
progress only rarely to osteoarthritis (Meachim et al. 1971, Thompson 1975). 
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Full thickness injury 
When injury to a joint surface violates the subchondral plate of bone, the healing process is 
stimulated by tapping into the potential of the vascular system (Convery et al. 1991, Meachim 
et al. 1971, Mitchell et al. 1976). The defect is filled with a fibrin clot, trapping cells from 
blood and marrow. Shapiro et al. (1993) have shown that the source of the repair cells for the 
entire sequence is from the undifferentiated mesenchymal cells of the marrow. The 
inflammatory and reparative phases as previously described then produce a maturing, cellular 
mass. The deeper portions form bone, reconstituting the subchondral plate. The reparative 
tissue in the cartilage defect undergoes a metaplasia to a hyaline-like chondroid tissue 
(Shapiro et al. 1993). By 2 weeks, rounded chondrocytes appear and produce substantial 
amounts of Type II collagen. However, later in the process, there is still significant (20% to 
35%) Type I collagen present (Furukawa et al.1980), the proteoglycan content decreases 
significantly, and the tangential collagen layers of the superficial zone fail to appear. 
Furukawa et al.(1980) speculate that this altered composition would almost certainly 
influence the mechanical properties. An important observation by Shapiro et al. (1993) 
consistent with other experimental studies (Brittberg et al. 1996, Desjardins et al. 1991, 
Wakitani et al. 1994) of cartilage healing, is that the collagen fibrils of the repair tissue were 
not well integrated with those of the residual cartilage, rather in some specimens they were 
separated by a gap. This might lead to vertical shear stresses between the repair and residual 
cartilage, precipitating micromotion and degenerative changes. Additionally, the chondrocyte 
lacunae immediately adjacent to the injury site remained empty. Shapiro et al. (1993) noted 
the appearance of some degenerative changes as early as 10 weeks, and these were more 
advanced by 24 weeks. Between 6 and 12 months, matrix and cells become more typical of 
fibrocartilage, and over longer periods of time, surface fibrillation and a cellular areas are 
present, with subsequent degeneration (Furukawa et al. 1980, Mankin 1982). 38 
 
Clinical consequences of cartilage injury 
The natural history of cartilage injuries is not well understood, but a knowledge of it may 
help to identify which patients are suitable for treatment. Chondral injuries noted at the time 
of anterior cruciate ligament reconstruction do not appear to affect clinical outcome at a mean 
of 8.7 years (Shelbourne et al 2003). Although these defects were small and, in a young 
population, it may be difficult to extrapolate these findings to patients presenting with 
symptomatic lesions. In a long-term follow-up of a small group of young patients noted to 
have chondral defects at arthroscopy, there was a high rate of radiological evidence of 
osteoarthritis (57%), although most patients had few symptoms (Messner et al. 1996). 
 
Linden published a long-term follow up study on osteochondritis dissecans of the femoral  
condyles and evaluated 76 knee joints (58 patients) at a mean of 33 years after diagnosis 
(Linden 1977). Of the 23 patients who were children at the time of diagnosis, only two (9%) 
had mild osteoarthritis at follow-up. In contrast, osteoarthritis affected 81% of those with 
adult-onset osteochondritis dissecans, approximately ten years earlier than for primary 
osteoarthritis. 
From this limited information, it is perhaps reasonable to suggest that only symptomatic, 
chondral defects should be treated as there is no evidence to suggest that patients with 
asymptomatic lesions will become symptomatic in the future. Osteochondral defects in 
adults may warrant more aggressive attention because of the high incidence of early-onset 
osteoarthritis.  39 
 
Treatment of cartilage injuries 
 
Debate still persists about the best treatment for symptomatic chondral defects. The focus of 
this thesis is Autologous Chondrocyte Implantation (ACI) but the next section will discuss 
the efficacy of the different surgical techniques that may be used to address these lesions. 
Debridement 
Cartilage in and around a symptomatic chondral defect is abnormal. Mechanical overloading 
results in increased matrix metalloproteinase production (Blain et al. 2001, Honda et al. 2000) 
which has a damaging effect on the opposing surfaces and surrounding cartilage. Simple 
excision of this damaged  cartilage has been shown to improve symptoms for five years or 
more (Hubbard  1996).  In this study, it was recommended that patients should be selected on 
the basis of a chondral defect combined with local tenderness. His aim at surgery was 
meticulous removal of all unstable cartilage and to debride the calcified layer sufficiently for 
new tissue to form in the base. In this prospective randomised trial, only isolated medial 
femoral condylar defects were selected and arthroscopic lavage was used as the control. The 
debridement group had significant improvement when compared with lavage as measured by 
the Lysholm score. Results gradually deteriorated over the five year period. Studies of 
debridement in osteoarthritis, as opposed to discrete chondral defects, reach conflicting 
conclusions (Moseley et al. 2002, Jackson et al. 2003). Opinion is divided 
as to whether arthroscopic debridement has any place in the treatment of established 
osteoarthritis although this debate does not apply to the treatment of localised, symptomatic 
chondral defects. 
 40 
 
Microfracture 
This procedure was introduced by Steadman et al (Steadman et al 1997, 2001, 2003, 2003, 
Miller et al 2004) over 20 years ago and is a technique in which accurate debridement of all 
unstable and damaged articular cartilage is performed, down to the subchondral bone plate 
while maintaining a stable perpendicular edge of healthy cartilage. An arthroscopic awl is 
used to make multiple holes in the defect 3 to 4 mm apart, and ensuring the subchondral plate 
is kept intact. After this microfracture, the defect is filled with so-called super clot, said to be 
the optimal environment for pluripotential marrow cells to differentiate into stable tissue 
(Steadman 2001). The rehabilitation protocol is an important part of the microfracture 
procedure. Early mobility of the joint with continuous passive motion is advocated in 
conjunction with reduced weight-bearing for an extended period. Microfracture is a 
modification of the Pridie drilling technique (Pridie 1959). Microfracture, drilling and 
debridement (abrasion) may all be considered as marrow stimulation techniques, where the 
chondral lesion is exposed to material moving from the bone cavity through the subchondral 
plate. This layer is unsealed by removing the lower, calcified layer of articular cartilage and 
by making holes which penetrate the subchondral plate. Advantages of microfracture over 
drilling might include reduced thermal damage to subchondral bone and the creation of a 
rougher surface to which repair tissue might adhere more easily. It is also easier to penetrate a 
defect perpendicularly with a curved awl during an arthroscopic procedure as compared with 
a drill. There are currently no published studies which compare microfracture with drilling. 
According to Hunziker, marrow-stimulation techniques have acceptable clinical results up to 
five years and decline thereafter (Hunziker 2002), although Steadman et al published 
outcomes of microfracture to show that at seven years 80% of patients rated themselves as 
improved (Steadman 2003). They also found that patients aged less than 35 years improved 
more than those aged between 35 and 45 years. The patients in this study were retrospectively 41 
 
selected from a larger  group and had relatively small chondral defects, with a mean size of 
2.8 cm
2, although no histological results were presented. However, Knutsen et al described 
20 biopsies after microfracture and noted that 11.4% had predominantly hyaline cartilage and 
17.1% a mixture of fibrocartilage and hyaline cartilage within them (Knutsen et al. 2004). 
There is much interest in microfracture as a treatment of chondral injuries in professional 
sports players. In a series of 25 National Football League American football players, 
Steadman et al reported that 76% of players returned to their sport by the next season 
although this reduced to 36% at a mean follow-up of 4.5 years (Steadman et al. 2003). 
 
Mosaicplasty 
Mosaicplasty, or osteochondral cylinder transplantation, was first described in 1993 and is a 
technique that has been widely advocated (Matsusue et al. 1993, Bobic 1996, Hangody et 
al.1997, 2003, Morelli et al. 2002). In this procedure, osteochondral plugs are taken with a 
cylindrical cutting device and used to fill an articular cartilage defect. Plugs are usually taken 
from the peripheries of both femoral condyles at the level of the patellofemoral joint and 
introduced as a mosaic to fill the defect. Different sizes of plug can be used in order 
to maximise filling of the defect. The technique is usually undertaken as an open procedure, 
although it is possible to perform it arthroscopically. Advantages of this technique are that 
defects can be filled immediately with mature, hyaline articular cartilage and that both 
chondral and osteochondral defects can be treated in the same way (Hangody et al 2004). 
However, donor site morbidity is a concern and Hangody and Fules recommend that the area 
to be treated is limited to between 1 and 4 cm
2. There are also technical difficulties in 
restoring the surfaces of both cartilage and bone to produce a smooth, convex joint surface. 
The thickness of the donor cartilage may differ from that of the area to be treated and 
reconstitution of the important subchondral layer may not occur. In addition, lateral 42 
 
integration rarely occurs raising the concern that synovial fluid may penetrate through the 
subchondral layer and cause cyst formation. Perpendicular access to the cartilage surface by 
cylinder cutters is required for this technique and this makes treatment of defects of the tibial 
plateau difficult. Bentley et al advised against using mosaicplasty (especially on the patella) 
(Bentley et al. 2003). The largest single series of mosaicplasty to date is that of Hangody and 
Fules (2003) who reported the results of operations on 597 femoral condyles, 76 tibial 
plateaux and 118 patellofemoral joints at up to ten years post-operatively. Good or excellent 
results were reported in 92%, 87% and 79% of patients who underwent mosaicplasty of the 
femoral condyle, tibial plateau and patellofemoral joint respectively. This paper does not give 
the mean time to follow-up and did not discuss the survival of osteochondral grafts in those 
patients with the longest follow-up. The long term durability of this technique has been 
questioned and a recent randomised controlled trial comparing mosaicplasty with ACI has 
found ACI to be significantly better at a minimum of 10 years follow-up (Bentley et al 2012). 
 
Perichondrial grafts 
This technique, which was described by Homminga et al, uses autologous strips of  
perichondrium fixed to the subchondral bone with fibrin glue (Homminga et al 1990). The 
long-term results for 88 patients with a mean follow-up of 52 months showed good results in 
only 38% using the Hospital for Special Surgery score (Bouwmeester et al. 1999). In a 
histological analysis of 22 biopsies taken after perichondrial grafting, tissue with a hyaline 
morphology of over 50% was found in only six biopsies (27%). 
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Carbon fibre 
Fine spaces between the fibres of carbon-fibre rods direct the regeneration of tissues on to the  
surface of a joint. Carbon-fibre matrix is more commonly used in the patella but was reported 
by Meister et al. to give good results in only 41% (Meister et al. 1998). No systematic 
histological study has been reported but, in failed implants, poor quality fibrous tissue with 
carbon fibre fragmentation is seen over the pads. The main disadvantage of carbon rods is the 
introduction of a nonabsorbable material deep to the subchondral bone. In early osteoarthritis, 
Brittberg, Faxen and Peterson had 83% success in 37 patients who were studied prospectively 
(Brittberg et al. 1994). This may, therefore, be the best indication for the use of carbon fibre, 
where there are degenerative changes present and when knee replacement would be the next 
form of treatment. 
 
Osteotomy 
Osteotomy is usually reserved for early unicompartmental osteoarthritis. Three studies are of 
relevance when studying articular cartilage healing. Wakabayashi et al observed that cartilage 
healing principally occurred only when cartilage loss was down to bone (Wakabayashi et al. 
2002). In this study, osteotomies were performed and the knees were arthroscopically 
reassessed a year later. A better Outerbridge score was found in those joints where there was 
full-thickness cartilage loss before osteotomy (Wakabayashi et al. 2002). This might appear 
strange but is consistent with the effect of debridement where bone can heal but cartilage 
does not. Schultz and Gobel looked at four groups of patients who underwent a Coventry-
style tibial osteotomy (Schultz et al. 1999). All had a follow-up arthroscopy and biopsy which 
demonstrated thicker tissue and improved histology when Pridie drilling or abrasion 
arthroplasty was combined with the osteotomy. An improved  walking distance and knee 
extension in these groups was also claimed. Wakitani et al cultured autologous bone marrow 44 
 
stem cells to add to the tibial plateau after osteotomy in 12 patients and compared these with 
a control group of 12 patients who received an osteotomy  alone (Wakitani et al. 2002). 
Cultured stem cells were suspended in a collagen gel and covered with a patch of periosteum. 
Better histology was obtained at a year but there was no significant clinical benefit in the 
short term compared with the control group. Evidence from Peterson et al in Gothenberg, 
using autologous chondrocyte cell implantation in isolated chondral defects, predicted good 
long-term results at seven years for those who had good results at two years after surgery 
(Peterson et al. 2002). Combined cell therapy with osteotomy may be a logical way to 
develop better long-term results in unicompartmental arthritis. 
Periosteal grafts 
Periosteum has the potential for both chondrogenesis and osteogenesis (Ritsila et al. 1994) 
and its use has  been described in a number of publications (Alfredson et al. 1999,  
Angermann et al. 1998, Hoikka et al. 1990, Korkala 1988). Lorentzon et al reported 
promising results in treating patellar lesions in a study of 26 patients with a mean follow-up 
of 42 months (Lorentzon et al. 1998). They showed that 17 patients had excellent and eight 
had good results. Only one patient had a poor outcome. Interestingly, they combined grafting 
with drilling of the defect bed and thus allowed marrow elements to contribute to the repair. 
To date, these clinical results are comparable with other techniques for patellofemoral 
lesions. Alfredson and Lorentzon (1999) reported on the post-operative benefits of 
continuous passive motion in a study of 57 patients with patellar defects who were treated 
with periosteal grafts. Of the 38 patients who used continuous passive motion post-
operatively, 76% had an excellent or good result at a mean follow-up of 51 months. Of the 19 
patients who did not have continuous passive motion post-operatively, 53% had an excellent 
or good result at a mean follow-up of 21 months. One study from Finland reported good 
clinical results with periosteum after four years (Hoikka et al. 1990). However, by 12 years 45 
 
after treatment all the patients had a poor clinical result. Calcification of the grafts has been 
mentioned as a problem in the long term. In the Chinese literature, periosteal grafting in 
association with a silicon membrane, which was removed at six months, was described as a 
treatment for large cartilaginous defects in 37 patients (Yang et al. 2004). The follow-up was 
a mean of 10.5 years (7 to 15). In this heterogeneous group of patients with significant 
pathology, the clinical results at follow-up were described as excellent in 11 patients, good in 
18 and poor in eight. 
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Autologous chondrocyte implantation 
The technique of autologous chondrocyte implantation (ACI) was first performed by Peterson 
et al. in Gothenburg in 1987 and was the first application of cell engineering in orthopaedic 
surgery. Brittberg et al presented the results of 23 patients with a mean follow-up of 39 
months. Good or excellent clinical results were reported in 70% of cases (88% of femoral 
condylar defects). Of the biopsies from treated femoral condylar lesions, 11 of 15 had a 
hyaline-like appearance (Brittberg et al. 1994). A more recent publication from the same 
group showed durable results up to 11 years following the treatment of osteochondral lesions 
(Peterson et al 2002). Encouraging results of ACI have also been reported by other authors 
(Kon et al 2009, Bartlett et al 2005, Saris et al 2009). In studies where histological analysis 
has been performed, it is apparent that ACI is capable of producing tissue which is hyaline-
like in some specimens (Roberts et al 2003). However, the best repair tissue is not 
morphologically or histochemically identical to normal hyaline cartilage, and fibrocartilage 
may be found in a proportion of samples. A variation of the ACI technique using culture-
expanded bone marrow stem cells has the advantage of not requiring an additional 
arthroscopic procedure in order to harvest articular cartilage. This technique has been used in 
conjunction with high tibial osteotomy (Wakitani et al. 2002). 
Determinants of outcome after ACI 
Krishnan et al investigated the prognostic indicators in a 199 patients who had underwent 
collagen covered ACI in a 4 year period (Krishnan et al 2005). They discovered that older 
patients (above 40) had significantly worse outcome than those younger than 40. The 
improvement in Modified Cincinnati Score (MCS) was greater for those patients with a 
higher pre-operative score as opposed to those with a low score. Other poor prognostic 
indicators include knee symptoms for greater than 2 years, patients with 3 or more previous 47 
 
operations, or multiple defects. The site of the defect also influenced results, with lesions in 
the patella and the medial femoral condyle doing significantly worse than lesions in the 
lateral femoral condyles. Interestingly, the size of lesion was not shown to have an effect on 
the MCS. 
In a study of 55 patients, De Windt et al determined the prognostic value of patient age, 
defect size and age, and location on the clinical outcome 3 years after treatment of OCDs 
treated with either ACI or microfracture (De Windt et al 2009). Medial femoral condyle 
lesions had better clinical scores when compared with defects on the lateral femoral condyle. 
Logistic regression analysis determined that clinical outcome was better in patients younger 
than 30 years old or defects less than 24 months old. This study also discovered that defect 
size did not predict outcome, a finding mirrored by other studies (Krishnan et al 2005, 
Niemeyer et al 2008, Zaslav et al 2009). However, in another study of 17 patients, the clinical 
results were significantly better in lesions greater than 3cm
2 (Selmi et al 2008). 
The above findings are not exclusively related to the technique of ACI. Mithoefer has shown 
that patients in a younger cohort, with defects less than 2cm
2 and shorter duration of 
symptoms (less than 12 months) were associated with higher clinical scores and return to 
sports (Mithoefer et al 2006). Age of the patient was also found to influence outcome after 
microfracture (Knutsen et al 2007). 
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Goals of this thesis 
The general consensus in the literature is that certain patient and defect characteristics have 
an influence on outcome after ACI in the treatment of OCD in the knee; 
  Older patients are said to have worse outcome. 
  Patients who have undergone multiple operations prior to ACI also do not experience 
good results.  
  Lesions in the patella tend to have worse results following surgery than lesions in the 
femoral condyles.  
The results when investigating other factors have yet to be elucidated; 
  Whether medial or lateral femoral condyles lesions do better is a contentious issue. 
  The  size of the defect does have an effect in some studies but not in others 
  Multiple lesions in the same knee compared with single defects have mixed results 
  The significance of a longer duration of symptoms prior to definitive surgery in the 
form of ACI/MACI is unclear as is the question ‘when is it too long to wait for 
ACI/MACI’ 
This thesis will add to the body of evidence already present regarding the influence of patient 
demographics and defect characteristics on outcome following ACI. I also aim to definitively 
answer the above unanswered questions.  Perhaps more importantly, the studies in this thesis 
will investigate factors that can be manipulated before or after surgery (e.g. body mass index 
(BMI), the smoking status and physical activity) to optimise results following surgery and 
increase the health status of the patients. This aspect of studying prognostic indicators has not 49 
 
been previously reported. An attempt will also be made to ascertain why failures occur in 
certain cohort of patients.  
When assessing prognostic factors in any non-randomised study, there is inevitably interplay 
of these factors affecting the measured outcome. If these factors are not taken into account 
then conclusions made on the basis of univariate analysis are invalid. This thesis will also 
assess the methodology and data analysis of studies on autologous chondrocytes implantation 
and with the use of a statistical model devise an approach to correctly identify prognostic 
factors affecting outcome. 50 
 
Chapter 2: Methods  
Introduction 
In this chapter, the analyses performed on the different cohort of patients will be outlined. 
The properties of the Modified Cincinnati Score (MCS) will also be discussed and why it was 
used as a tool to assess efficacy of surgery. Finally, details of the statistical approach will be 
discussed, the key points in performing a randomised controlled trial, and the use of multiple 
linear regression and the generalised linear model when a RCT cannot be performed. 
 
Outline of Patients 
This thesis is comprised of a number of different types of studies. The patients in each study 
will be outlined below. There is a certain amount of overlap of patients in each of the 
chapters. This was deemed necessary in order to increase the number of patients for data 
analysis to answer the relevant question in each chapter in an attempt to reduce the 
probability of a type I statistical error. 
 
Chapter 3 
The first study is a randomised controlled trial (Chapter 3). 247 consecutive patients that 
were enrolled into the trial formed the basis of the data analysis. The operations were 
performed between July 2002 and July 2005. Prior to the start of this thesis, a multicentre 
randomised controlled trial (RCT) was in effect. The null hypothesis stated that there was no 
difference in outcome following autologous chondrocyte implantation using a synthetic type 51 
 
I/III collagen porcine membrane (ACI-C) and ACI using a collagen bilayer with 
chondrocytes implanted in the middle; matrix-carried autologous chondrocyte implantation  
(MACI). The RCT involved over 55 surgeons in 36 centres across the entire of England and 
Wales. It became apparent that a large number of surgeons were not filling the data capture 
forms adequately and there were large amounts of missing data. Therefore, these patients 
were excluded from the analysis. Chapter 3 includes all patients that were operated between 
July 2002 and July 2005 in the Joint Reconstruction Unit at the Royal National Orthopaedic 
hospital, Stanmore. The first 91 patients’ 1 year results were published in 2005 (Bartlett et al. 
2005) and from this cohort 56 patients were included in this chapter.    
                                  
Chapter 4 
Chapter 4 analysed the results of both ACI and MACI in the treatment of osteochondral 
lesions in the patella-femoral joint. The results of all patients (215) treated from November 
2001 to January 2006 were included in this study. However, 35 patients had concomitant 
procedures such as patellar realignment and so they were excluded from the data analysis (as 
we could not conclude whether any improvement in function was the result of chondrocyte 
implantation or the realignment procedure. In this cohort, there were a large number of 
patients that were not randomised; hence this was a prospective cohort study. Of the 180 
patients that were included in this chapter, 80 patients were also analysed in chapter 3.  
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Chapter 5 
This case-control study reviewed the radiographs of 200 patients and correlated findings with 
the Modified Cincinnati Score (MCS). All the procedures were performed between July 1998 
and July 2008.  Thirty four patients from this chapter were also part of the cohort from 
chapter 3. 
 
Chapter 6  
A telephone and postal questionnaire was sent to 150 patients who had their operation 
performed between January 2001 and 2006 to retrieve missing data regarding smoking status, 
weight, height and physical activity. One hundred and twenty two patients responded and of 
these 48 were part of the cohort of patients in chapter 3. 
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The Modified Cincinnati Score 
The Cincinnati Knee Rating System is one of the more commonly used specific instruments 
for assessing knee injuries. It was developed in 1983 (Noyes & Matthews et al. 1983, Noyes 
& Mooar et al. 1983) and consists of multiple parts; symptoms, sports activity and activities 
of daily living, along with clinical parameters. This system has been modified over the years 
(by utilising the subjective components) to the Modified Cincinnati Score (MCS). The MCS 
only requires patient input to provide a score ranging from 6 to 100 (best function) as well as 
a functional subscores on pain, swelling, giving way, walking, stairs, running and overall 
activity levels (see table 2.1). Following surgery, if scores fall within certain ranges, the result 
could be deemed: 
Excellent (MCS > 80) 
Good (MCS = 55-80) 
Fair (MCS = 30-54) 
Poor (MCS < 30) 
Though the origin of this modification is unclear, the MCS in recent times is the version most 
often used in presentations and in the literature (Agel et al 2009, Greco et al 2010). 54 
 
Table 2.1: The  Modified Cincinnati Score 
CATEGORY  SCORE 
PAIN   
No pain, normal knee, performs 100%  20 
Occasional pain with strenuous sports or heavy work, knee not entirely normal, some limitations but minor 
and tolerable 
16 
Occasional pain with light recreational sports or moderate work activities, running, heavy labour, strenuous 
sports 
12 
Pain usually brought on by sports, light recreational activities or moderate work. Occasionally occurs with 
walking, standing or light work 
8 
Pain is a significant problem with simple activity such as walking, relieved by rest, unable to do sports  4 
Pain present all the time. Not relieved by rest  0 
SWELLING   
No swelling  10 
Occasional swelling with strenuous sports or heavy work. Some limitations but minor and tolerable  8 
Occasional swelling with light recreational sports or moderate work activities. Frequently brought on by 
vigorous activities, running, heavy labour and strenuous sport 
6 
Swelling limits sports and moderate work. Occurs infrequently with simple walking activities or light work 
(approx 3 times a year) 
4 
Swelling brought on by simple walking activities and light work. Relieved by rest  2 
Severe problem all the time, with simple walking activities  0 
GIVING WAY   
No giving way   20 
Occasional giving way with strenuous sports or heavy work. Can participate in all sports but some guarding 
or limitations present  
16 
Occasional giving way with light sports or moderate work. Able to compensate but limits vigorous activities, 
sports, or heavy work not able to cut or twist suddenly 
12 
Giving way limits sports and moderate work, occurs infrequently with walking or light work  8 
Giving way with simple walking activities and light work. Occurs once per month, requires guarding  4 
Severe problem with simple walking activities, cannot turn or twist while walking without giving way  0 
OVERALL ACTIVITY LEVEL   
No limitation, normal knee, able to do everything including strenuous sports or heavy labour   20 
Perform sports including vigorous activities but at a lower performance level: involves guarding or some  16 55 
 
limits to heavy labour 
Light recreational activities possible with rare symptoms, more strenuous activities cause problems. Active 
but in different sports; limited to moderate work  
12 
No sports or recreational activities possible. Walking with rare symptoms; limited to light work  8 
Walking, ADL cause moderate symptoms, frequent limitations  4 
Walking, ADL cause severe problems, persistent symptoms  0 
WALKING   
Walking unlimited  10 
Slight/mild problem  8 
Moderate problem: smooth surface possible up to approx 800m  6 
Severe problem, only 2-3 blocks possible  4 
Severe problem; requires stick or crutches  2 
STAIRS   
Normal, unlimited  10 
Slight/mild problem  8 
Moderate problems only 10-15 steps possible  6 
Severe problem; requires banister support  4 
Severe problem; only 1-5 steps possible  2 
RUNNING ACTIVITY   
Normal, unlimited; fully competitive, strenuous  5 
Slight mild problem; run half speed  4 
Moderate problem 2-4 km  3 
Severe problem only 1-2 blocks possible  2 
Severe problem only a few steps  1 
JUMPING OR TWISTING ACTIVITY   
Normal, unlimited, fully competitive, strenuous  5 
Slight to mild problem; some guarding but sport possible  4 
Moderate problem; gave up strenuous sports, recreational sports possible  3 
Severe problem; affects all sports; must constantly guard  2 
Severe problem; only light activity possible (golf, swimming)  1 56 
 
The subjective components of the Cincinnati Knee Rating System and the MCS have been 
shown to be reliable, valid and responsive (Barber-Westin et al. 1999, Marx et al. 2001, Agel 
et al. 2009, Greco et al. 2010). As a measure of responsiveness, the standardized response 
means (SRMs) are often calculated by dividing the change in score by the standard deviation 
of the change in score. Pearson product correlations can then be calculated to compare 
different questionnaires as a measure of construct validity. Agel et al calculated SRM of the 
MCS to be 0.9 and this compared favourable to the longer version of the Cincinnati System 
of 0.8 (Kirkley et al. 1998). The responsiveness was much lower for the generic instrument 
Short Form-12 Questionnaire, where the SRM was 0.37 (Hurst et al. 1998). 
The original Cincinnati Knee Rating System was developed to be observer-administered and 
has a format that requires significant skills to be completed by patients. The MCS however, is 
self administered and patient-related aspects are taken into account. This is important as it has 
been shown that observer-based assessments score significantly better than patients’ self-
administered questionnaires due to observer bias (Hoher et al. 1997). Furthermore, patient-
relevant outcome measures are now promoted in general health care, orthopaedics, and sports 
medicine, and they should be considered the primary outcome measure in clinical trials 
(Altman et al. 1996, Clancy et al 1998, Roos 2000).   
The International Cartilage Repair Society (ICRS) have recommended the use of the 
Modified Cincinnati Score as the main tool for assessment of knee function in patients 
involved in cartilage repair clinical research. The committee members of this society include 
prominent Orthopaedic surgeons and basic scientists who are leaders in cartilage repair 
research and include the likes of Lars Peterson and Matt Brittberg. More recently, the ICRS 
has recommended the use of the SF-36 questionnaire, and patients being recruited into the 57 
 
RCT from 2009 have to complete this questionnaire pre-operatively and annually after their 
surgery (personal communication Prof G Bentley). 
 
Statistical Approach  
A well designed randomised controlled trial (RCT) remains the gold standard for hypothesis 
testing, as systematic bias due to unknown confounding variables is avoided. However, RCTs 
are difficult and expensive to set up and run and that is why there are comparatively few in 
the orthopaedic literature. The enrolment of patients and the allocation process in RCTs can 
be modified if certain prognostic variables are known before the initiation of the study, such 
that there are equal numbers of patients with the known factor in each treatment group. This 
is termed blocking or stratification but cannot be performed when the study has a small 
number of patients (Altman and Bland 1999). The most effective way to ensure there are 
equal number of patients in subgroups when randomising in small trials is minimisation 
which was first described in 1975 and has now become the most accepted way of allocation 
(Pocock and Simon 1975, Altman and Bland 2005). In the minimisation process, after 
randomisation of the first few patients each subsequent allocation will be determined by 
which of the treatment arms would provide a better equilibrium of the explanatory variables 
in question. This form of randomisation is best performed with the aid of computer software 
due to its complexity (Altman and Bland 2005) but is certainly useful in making the 
researcher think about confounding variables from the outset and ensuring adherence to the 
study.  
There are several features that are pertinent to the design and conduct of a good randomised 
trial. From the very beginning, it is important to have a scientific question in mind, i.e. a 58 
 
hypothesis-driven study. This will allow a clear focus on how to go about answering the 
question and a study protocol to be developed. 
Choosing the right patient population is the next stage in the planning of a RCT. If this not 
planned properly, the generalisability of the study may be undermined and worse still the 
results may be invalid if there is sampling bias. Hence it is important to have clear inclusion 
and exclusion criteria so that the sample population is appropriate for the research question in 
mind. In chapter 2 the allocation was simply random without any stratification or 
minimisation all patients fulfilling the inclusion and exclusion criteria. Once the target 
population has been decided, the next question that needs to be answered is how many 
patients need to be recruited into the study. Sample size calculations are important to ensure 
that the chances of type II statistical errors are minimised. It also important not to recruit too 
many patients in a RCT as this will lead to waste of valuable resources. 
Appropriate outcome measures need to be selected to assess the efficacy of the treatment. 
Following surgery, these are usually in the form of questionnaires and functional scores. A 
variety exist in the orthopaedic literature, and it is important to choose one that is appropriate 
to the research question (i.e. is reliable and valid with no ceiling or floor effects).  
Randomisation and concealment is the cornerstone of a RCT. The randomisation procedure 
can be performed in a variety of ways, but probably the most common is using a computer 
random number generator (Petrie 2006). Once patients have been truly randomised, it is 
important for the treatment allocation to be concealed from the investigator in order to 
prevent bias. A widely accepted way of randomising is to produce computer generated set of 
random allocation in advance of the study which are then sealed in consecutively numbered 
opaque envelops (Kendall 2003), which was performed in this RCT. The chief investigator in 59 
 
the study was blinded to the treatment allocation. When functional scores were collected, the 
research fellow was also blinded to the treatment received. 
 
A critical aspect of clinical research is quality control. This is most often overlooked during 
data collection, which then leads to errors because of missing or inaccurate data. This has 
been an issue in all of the studies in this thesis. Ideally, quality control should begin in the 
design phase of the study when the protocol is drafted and re-evaluated in a pilot study. The 
appraisal of the pilot study will allow a thorough assessment of all the key features of the 
RCT; the sampling strategy, method and tools for data collection and subsequent data 
handling. Any adjustments to the methodology can then be finalised. An operations manual 
and also formalised training is very useful when there are several investigators (especially in 
a multi-centre study). It would also be very useful for the chief investigator to have regular 
meetings with other investigators to ensure quality data management and appropriate 
delegation of responsibility and supervision of tasks. Other investigators should be motivated 
to collect all the relevant data, as time goes by this occurs less and less. This can be avoided 
by using research nurses to perform and manage these tasks and by regular team meetings. 
 
In conclusion, a well-designed RCT when assessing two different forms of treatment 
probably represents the most powerful way of assessing new innovations and certainly has 
the capacity to change surgeons’ practice. However, poorly designed and conducted RCTs 
can be dangerous because of their potential to influence practice based on inaccurate data. 
Early involvement of a Clinical Trials Unit is advisable to ensure sound methodology when 
writing the study protocol and their continued involvement will ensure quality control 60 
 
throughout the whole process. A pilot study if recommended and if successfully implemented 
will confirm whether the research goals are practical and achievable. Finally, the 
dissemination of findings is critical and the publication in a peer review journal should follow 
the CONSORT guidelines. 
 
When assessing prognostic factors in any other type of study, there is inevitably interplay of 
these factors affecting the measured outcome. If these factors are not taken into account then 
conclusions made on the basis of univariate analysis may be invalid. If we want to push 
forward the boundaries of orthopaedic research in non-randomised trials, the data analysis 
has to be performed efficiently and appropriately so as to utilise the maximum amount of the 
data obtained from clinical scores (for example) and obtain an answer to the research 
question, even if the study is retrospective and provides a lower level of evidence. Some 
studies in the literature on ACI have failed to demonstrate any benefit over other techniques 
and few have demonstrated a lasting benefit so far. Theoretically, a number of factors can 
contribute to failure and a scientific approach to elucidate these variables has not been 
reported.  After critically appraising the literature, it has become apparent that due to lack of 
appropriate statistical methods, the validity of conclusions in many studies is questionable. 
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The Generalised Linear Model  
Multiple linear regression and multiple logistic regression are methods of statistical analysis 
that account for and quantify the relative contribution of each confounding variable on 
outcome.  Multiple linear regression is used when the dependent variable is continuous (e.g. a 
scoring system) and multiple logistic regression is used when the outcome is binary (e.g. 
success or failure) (Petrie 2006). Both methods of analysis can be used to identify 
explanatory variables associated with the dependent variable and hence promote an 
understanding of the underlying process and both are types of Generalised Linear Model. 
Generalised linear models are a general class of mathematical models which extend the usual 
regression framework to cater for responses which do not have Normal distributions. In a 
Generalised linear model the response or dependent variable (y) is assumed to be a member 
of the exponential family (be this either normal, binomial, Poisson etc) and some function 
(the link function) of the mean response is predicted by a linear response equation of the 
predictors.  The link function is incorporated to define the transformation required for fitting 
a linear model for non-normal data. Multiple linear regression is a particular type of 
Generalised Linear Model (GLM) where it is assumed that the response is normal, and that 
the mean response can be predicted by a linear function with the identity link function (no 
transformation function needed). Therefore, the GLM is a step forward from multiple 
regression as it allows the analysis of data in a mathematical model when the distribution of 
the data is not normal via the link function and transformation of x or y (Petrie and Sabin 
2006). 
With the formulation of a complex equation, the model allows us to predict the dependent 
variable taking into account all the explanatory variables. As with any mathematical model, 
certain assumptions have to be satisfied in order for the analysis to be accurate which usually 62 
 
involves the residuals. The residual is the difference between observed dependent variable (y) 
and the corresponding fitted dependent variable or predicted variable (Y) for each 
explanatory variable (x). The assumptions underlying the multiple linear regression model are 
(with the first two being the most important)  
A linear relation between x and y exists 
The observations are independent 
The residuals should be normally distributed and the mean should be zero 
The residuals should have a constant variance 
The x variable can be measured without error (Ananth and Kleinbaum 1997) 
 
GLM can be used when the factors being assessed are not linear and this is a key advantage. 
In multiple regression, it is assumed that age and health status has a linear relationship but 
that is not the case. For example, the difference in health status in an adult aged 30 and an 
adult aged 40 is likely to be less than the difference in adults aged 60 and 70. 
A more detailed description of the statistical tests will be given in the methods section of 
each chapter. However, broadly speaking, the dataset contains the MCS before surgery 
and at 6, 12 and 24 months after surgery. In chapter 3, there is also MCS latest which is 
the latest available MCS.  The paired t-test was used to confirm whether there was 
statistically significant improvement in knee function following surgery. This was done 
to compare results from this thesis with other published data. The independent t-test was 
used to determine if there was a statistically significant difference between ACI and 
MACI in improving knee function. Where there were more than 2 groups being analysed, 63 
 
analysis of variance (ANOVA) was used. Kaplan-Meier survival analysis was performed 
for time to event variables, for example the time to the joint replacement or osteotomy 
surgery. Finally the chi-squared test was used to compare categorical data.  To assess 
prognostic factors, the generalised linear model was used and these will be discussed in 
more detail in each chapter. 64 
 
Chapter 3:  
Autologous Chondrocyte Implantation 
using Type I/III Collagen Membrane 
(ACI-C) vs Matrix-Carried Autologous 
Chondrocyte Implantation (MACI) 
Introduction 
 
As discussed earlier, a variety of surgical treatment options exist for the treatment of 
osteochondral defects (OCDs) in the knee. A number of techniques endeavour to replace the 
defect with hyaline cartilage (such as osteochondral allografts and autologous osteochondral 
grafts or mosaicplasty). To date, none have been proven to provide a long term and 
reproducible improvement from pre-operative function and concerns such as disease 
transmission and donor site morbidity remain.  
The origins of ACI can be tracked back to 1965, following the isolation of adult articular 
chondrocytes in suspension (Smith 1965). Three years later Laurence and Smith 
demonstrated that isolated epiphyseal articular chondrocytes survived when implanted into 
fractures in rabbits (Laurence and Smith 1968). Further advancement in chondrocyte 
implantation occurred when Bentley and Greer repaired chondral defects in an animal model 
using autologous epiphyseal and articular chondrocytes (Bentley et al 1971). Chondrocytes 
were taken from immature rabbits as it was previously shown that chondrocytes from 
immature rabbits had the potential to divide but chondrocytes from mature rabbits did not 
(Mankin 1962). 65 
 
The next logical progression in the development of ACI was to be able to expand the number 
of chondrocytes without losing their ability to produce Type II Collagen. Green described a 
technique of culturing chondrocytes after they had been isolated from the extracellular matrix 
by enzymatic digestion (Green 1977). However, during the expansion, the cells gradually 
dedifferentiated and lost their ability to manufacture type II collagen. Chondrocytes regained 
this ability once they were exposed to agarose gels (Benya and Shaffer 1982). Aston and 
Bentley showed that by growing the chondrocytes at high density the phenotype was 
preserved and the cells produced type II collagen (Ashton & Bentley,1986). The ability to 
expand the numbers of adult chondrocytes in a monolayer culture proved a significant 
advance in the treatment of osteochondral defects using autologous cells. Peterson et al. 
(1984) reported on the repair of defects in skeletally mature rabbits with autologous or 
homologous cultured chondrocytes. Cartilage plugs were removed from the mid patellae and 
enzymatically digested and grown in a monolayer culture for 2 weeks. Following this, the 
pellets of chondrocytes were implanted into artificially created defects and covered with 
either a layer of fascia, synovium, blood clot, tendon, or periosteum. Results were 
encouraging with a total reconstitution of full thickness 3mm defects with hyaline cartilage. 
Using autoradiography, Grande et al proved that autologous chondrocytes grown in vitro 
were responsible for the repair tissue in artificially created defects in rabbits (Grande et al 
1989). 
Brittberg’s original technique for ACI involved covering the chondral defect with periosteum 
harvested from the proximal tibia during the 2
nd stage procedure (see operative technique 
below). Once the defect is covered and the periosteum sutured, the chondrocytes are injected, 
and the repair process is completed by sealing the periosteum with fibrin glue to ensure there 
is a watertight seal (Brittberg et al. 1994). Minas and Nehrer (1997) speculated that growth 66 
 
factors secreted by the periosteum stimulate cultured chondrocytes to divide. Another 
possible mechanism speculated was that the periosteum and cultured chondrocytes stimulate 
adjacent cartilage, in the subchondral bone or in the periosteum itself to enter the defect and 
repair it (O’Driscoll & Fitzsimmons 2001). The latter can probably be disregarded since the 
results of treatment of chondral defects in both animal models and human subjects have been 
poor with the use of a periosteal patch alone (Brittberg et al. 1996 and Angermann et al. 
1998). Evidence for the dual action of periosteum with cultured chondrocytes was confirmed 
when dead periosteum was sutured to the rim of the chondral defect in rabbits and 
chondrocyte suspension was injected into this sealed defect (Lindahl et al 2002). Only 1 out 
of 8 rabbits developed good repair tissue, thus suggesting that periosteum and chondrocytes 
work together to repair the defect. 
Several concerns were raised with the use of the periosteal flap technique (ACI-P). This so-
called first generation technique required a second surgical procedure at the proximal tibia 
causing additional pain and risks to the patient. In addition, the periosteal flap had to be fixed 
by sutures 3mm apart thereby damaging healthy cartilage. Further disadvantages are low 
mechanical stability as well as the unequal distribution of the cultured chondrocytes 
(especially due to gravity). Furthermore, hypertrophy, delamination, and even graft failure 
may occur.(Gooding et al 2006) 
Second generation techniques involved using a synthetic type I/III collagen porcine 
membrane (ACI-C). This avoided the removal of the periosteum from the tibia. Though the 
synthetic membrane still requires suturing to adjacent cartilage, it has been shown that ACI-C 
has significantly lower rates of graft hypertrophy requiring secondary surgery than ACI-P 
(Gooding et al 2006 and Wood et al. 2006). A prospective study of 63 patients treated with 
ACI-C found significant improvements in ICRS and Modified Cincinnati Scores that were 67 
 
maintained at 3 years with no incidence of graft hypertrophy (Steinwachs et al 2007). The 
favourable results with ACI-C suggest that the implanted chondrocytes repopulate the defect 
and synthesize a new cartilage matrix. The periosteal patch acts simply as seal, ensuring the 
cells stay within the defect.  
Concerns regarding unequal distribution of cells, suturing of membrane to adjacent healthy 
cartilage and also the possibility of cell leakage beyond the periosteal flap or collagen 
membrane led to the development of Matrix-carried Autologous Chondrocyte Implantation 
(MACI; Verigen, Leverkusen, Germany). MACI has a similar porcine derived type I/III 
collagen membrane. One surface has a roughened appearance because of widely spaced 
collagen fibres, between which chondrocytes are seeded. The other side has a smooth surface 
due to the high density of collagen fibres (Zheng et al 2003). The MACI membrane can be 
secured to the defect directly with fibrin glue and therefore does not require additional cover. 
There is no need for additional sutures or harvesting of periosteum. The procedure can be 
performed faster and with less extensive exposure (Bentley, BOA 2007). 
A concern regarding the MACI technique is the number of chondrocytes present in the 
collagen bilayer. It is estimated that there are 1 million cultured chondrocytes per mm
2. In the 
ACI-C technique there are approximately 5 million cells per ml of suspension. Le Baron and 
Atahnasiou performed a study seeding a manufactured scaffold with chondrocytes. They 
reported that scaffolds with less than 10 million cells/ml resulted in poor cartilage formation 
(Le Baron et al 2000). Puelacher et al. noted that scaffolds seeded with 20-100 million 
cells/ml resulted in cartilage formation when implanted subcutaneously into nude mice 
(Puelacher et al. 1994). However, normal articular cartilage contains only 10,000 cells/mm
2. 
Possible reasons for the need for such high concentrations of implanted chondrocytes may be 
because a proportion of implanted cells undergo apoptosis once they are implanted into the 68 
 
defect or perhaps it is the physical crowding of cells that is needed for them to redifferentiate 
into type II secreting chondrocytes. In their recent review, the Swedish group have advocated 
using 30 X 10
6 cells/ml in the clinical setting. Despite these reservations several studies have 
shown that MACI is as efficacious as the 1
st and 2
nd generation techniques (Bartlett et al. 
2005, Cherubino et al. 2003, Brittberg 2003, Zeifang et al. 2010). 69 
 
Operative Technique 
Both ACI-C and MACI are two-stage procedures and have been previously described 
(Bentley et al. 2003). In the first stage, an arthroscopy is performed to assess the site, size and 
containment of the chondral lesion, together with the competence of the menisci and cruciate 
ligaments. If suitable, approximately 300mg of cartilage is harvested from the non-weight 
bearing areas of the medial or lateral trochlea together with 100mls of venous blood (figure 
3.1). The chondrocytes are sent for culture in the patient’s serum and several passages of the 
cells are expected to increase the number of chondrocytes by 20 to 30 fold. After 3 to 5 
weeks, the patient is re-admitted for the second (implantation) stage. An open arthrotomy is 
performed and the lesion is exposed. The lesion is debrided to a healthy and stable edge and 
care is taken to avoid subchondral bone bleeding (this is supplemented with the use of topical 
adrenaline). 
Figure 3.1: Harvesting of cartilage graft 
 Arthroscopic photo courtesy of Prof Bentley 70 
 
ACI-C 
The collagen membrane is cut to the size and shape of the defect and sutured to the rim of the 
defect with 6/0 Vicryl sutures approximately 3mm apart (see figures below). Fibrin glue is 
used to ensure a water-tight seal. A fine catheter is use to inject normal saline to confirm the 
suture line is water-tight. The suspension of the cultured chondrocytes is then injected to fill 
the defect. The catheter is removed and the final suture is placed. 
 
Figure 3.2: Overview of ACI-C (Second Stage) 
 Courtesy of Verigen Corporation 
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Figure 3.3: Debrided cartilage defect seen intra-operatively 
 
 
Figure 3.4 The collagen type I/III membrane is sutured to the defect and the cultured 
chondrocytes are injected 
 
Figures Courtesy of G. Bentley 72 
 
MACI 
The lesion is templated using a sterile foil from a suture pack (figure 3.5). The MACI matrix 
is cut to size. Fibrin glue is injected onto the base of the debrided defect and the cut MACI 
membrane is placed over the defect whilst maintaining firm digital pressure for 2 minutes 
(figure 3.6). Graft stability is assessed by putting the knee through a full range of motion. If 
necessary, additional vicryl sutures can be placed to provide further stability. 
 
Figure 3.5: Template cut to size and syringe containing fibrin glue  
  
Courtesy of G. Bentley 
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Figure 3.6: Final appearance of MACI graft 
            
Courtesy of Mr. John Skinner 
 
Following both procedures the knee is closed and dressed with a sterile dry dressing. The 
knee is held in full extension with a plaster-of-Paris backslab. From the first post-operative 
day patients are encouraged to weight-bear with the aid of crutches. After 2-3 days, the 
backslab is converted to a lightweight cylinder cast and this removed after another 10 days. 
Upon cast removal, active physiotherapy is commenced. The standardised regime also 
consists of, gym-rowing, swimming and cycling after 6 weeks. Patients are advised to avoid  
pivoting or impact loading. Light jogging is permitted after 6 months and return to contact 
sports after 1 year. 
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Figure 3.7: Overview of MACI 
 
Courtesy of Verigen Corporation 75 
 
Aims and Objectives 
 
A small, prospective randomised study compared ACI-C (44 patients) with MACI (47 
patients). It concluded that there was no difference in clinical, arthroscopic and histological 
outcome one year following implantation (Bartlett et al. 2005). This study was underpowered 
and hence the inconclusive findings may not be accurate. Another study attempted to identify 
factors that may affect outcome following ACI-C (Krishnan et al 2006). It concluded that 
younger patients with higher pre-operative Modified Cincinnati Scores (MCS) and shorter 
duration of length of symptoms had better outcomes. Single defects located in the trochlea or 
lateral femoral condyles also tended to do better. The statistical analysis may not be entirely 
accurate and will be discussed later. 
The aim of this chapter is to compare the efficacy of ACI-C with MACI two years after 
surgery in a prospective randomised controlled study. A power analysis has been performed 
to minimise type II statistical errors. A secondary aim will be to identify patient and defect 
characteristics that could have an adverse effect following surgery.  
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Patients and methods 
 
The South East Multi-Centre Research Ethics Committee and the Joint Research and Ethical 
Committee of the Royal National Orthopaedic Hospital Trust gave its approval before 
commencing this study (study number MREC 02/01/73). This is a parallel group randomised 
controlled trial assessing two different forms of autologous chondrocyte implantation; ACI-C 
versus MACI. The inclusion criteria for surgery included: 
  Persistent knee pain/swelling/giving way attributable to a lesion of the articular 
cartilage in the knee 
  Patients aged between 15 and 50 years 
  An osteochondral defect larger than 1cm
2  
  Patient able to comply with rehabilitation programme following surgery. 
Absolute contra-indications included: 
  Defects smaller than 1cm
2 
  The presence of osteoarthritis 
  The presence of rheumatoid arthritis 
In addition patients also suffering from joint instability (secondary to Anterior Cruciate 
Ligament rupture) and joint mal-alignment could still have ACI but these problems had to be 
addressed simultaneously during the second stage procedure. The patients were assessed 
clinically in the outpatients department and if eligible were listed for an arthroscopy 
procedure. At the time of the arthroscopy, if the lesion was suitable for ACI or MACI a 77 
 
sealed envelope would be opened to determine what kind of intervention the patient would 
undergo and the first stage procedure would be performed, hence enrolling the patient into 
the trial. 
 
Outcomes 
The primary outcome measure in this study was The Modified Cincinnati Score (MCS). The 
scores were taken pre-operatively at the time of the clinical consultation when the decision 
was made to perform the first arthroscopy. The functional assessments were repeated six and 
twelve months following surgery and yearly thereafter. One year following surgery, an 
arthroscopy was performed and The International Cartilage Repair Society (ICRS) score was 
used to gauge the macroscopic appearance of the repair tissue. If possible a biopsy of the 
graft was undertaken to determine the quantity of hyaline cartilage in the repair tissue. The 
ICRS scores and the biopsy results formed the secondary outcome measures. 
 
Randomisation 
An independent observer used a random number generator from the website 
www.randomgenerator.com  to perform block random allocation. This produced a reference 
number with an assignment of either ACI or MACI, and these tags were placed in an opaque 
sealed envelope which were sequentially numbered. The random number generator produced 
blocks of 10 ACI and 10 MACI tags. The envelopes were kept in theatres in a specified 
drawer and were opened by the operating surgeon at the time of the first stage procedure to 
determine which treatment arm the patient would be enrolled into. The patient was blinded to 
the treatment received. Following the 2
nd stage procedure, the patients were assessed by an 
independent observer who was also blinded to the treatment allocation. 78 
 
 
CONSORT Statement 
Between July 2002 and July 2005, 247 patients underwent ACI for isolated symptomatic 
osteochondral defects of the knee. They were all treated at the Royal National Orthopaedic 
Hospital in one department (The Joint Reconstruction Unit) by three different surgeons. 126 
patients had ACI-C and 121 patients had MACI (see figure 3.8). There are fewer patients at 
the 2 year interval compared to the MCS at latest follow-up. This is because an effort was 
made to contact patients who were failing to attend their regular annual review to obtain their 
latest MCS. As a result there, the number of patients increased by 28 in the ACI group and 41 
in the MACI group. 
 
Statistical analysis 
With α = 0.05 and β = 0.2 (hence a power of 80%) and a standard deviation of 16.9 (taken 
from previous small study), a total of 200 patients would be required to detect a difference of 
10 points in the modified Cincinnati scale. Statistical analyses were performed using SPSS 
version 18.0. The independent t-test was used to compare the improvement in knee scores 
between patients who had ACI and MACI. The Fisher’s exact test was used to compare the 
proportion of excellent and good results achieved in both groups. The level of significance 
was set at p=0.05. 79 
 
Figure 3.8: CONSORT Statement 80 
 
A generalised linear model was used to assess which factors had the greatest effect on 
outcome. The residuals were tested for normality and this was found to be the case (personal 
communication Tim Morris, Statistician in the Clinical Trials Unit, Medical Research 
Council). 
 
The dependent variable was the latest MCS (MCS latest). The predictive factors in this model 
were  
  the type of surgery (i.e ACI or MACI) 
  the aetiology of the OCD 
  the anatomical site of the defect 
  the number of previous operations prior to the first stage procedure 
  the sex of the patient  
 
The predictive covariates were  
  the MCS pre-operatively (MCS 0) 
  the duration of symptoms, 
  the age of the patient at the time of the second stage surgery  
  the size of the lesion (in mm
2) 
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Results 
The patient and lesion characteristics in the two treatment groups are summarised in table 3.1. 
The age distribution of the patients is displayed in figure 3.9. Tables 3.2 displays the 
anatomical distribution of the chondral lesions and table 3.3 shows the reason for the cause of 
the OCD. 
 
 
Table 3.1: Patient and lesion characteristics 
  ACI                          
n=126 
MACI                      
n=121 
Age  33.4 +/- 0.8           
n=126 
33 +/- 0.8               
n=120 
Percentage males  53.2%  57% 
Length of symptoms 
(months) 
101.2 +/- 7.6        
n=122 
101 +/- 8.7            
n=115 
Number of previous 
operations 
2.16 +/- 0.13        
n=124 
2.4 +/- 1.98            
n=120 
Size of lesion (mm
2)  522 +/- 28.5           
n=122 
520 +/- 24.9           
n=116 
Modified Cincinnati 
Score pre-operatively 
(MCS 0) 
46.3 +/- 1.5            
n=123 
47 +/- 1.64            
n=116 
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Figure 3.9: Age distribution of patients  
 
 
 
 
Table 3.2: Anatomical site of chondral lesions according to treatment groups 
Anatomical site  ACI  MACI 
Femur (trochlea, MFC, LFC)  76 (61.8%)  78 (65%) 
Patella single defect  28 (22.8%)  25 (20.8%) 
Patella multiple defects  19 (15.4%)  17 (14.2%) 
TOTAL  123  120 
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Table 3.3: Aetiology of lesions according to treatment groups 
Anatomical site  ACI  MACI 
Trauma   53 (48%)  64 (60.4%) 
Other  32 (29%)  30 (28.3%) 
Failed previous procedures  26 (23%)  12 (11.3%) 
TOTAL  111   106 
 
The Modified Cincinnati Scores (MCS) before and after surgery are shown in figure 3.10 for 
descriptive purposes. The reason for displaying this graph is to compare the absolute 
functional scores with other published work. The ACI group were followed up for slightly 
longer compared to the MACI group (39.4 months compared with 43.8 months) but this was 
not statistically significant (p=0.12). 
 
Figure 3.10: The Modified Cincinnati Scores 
 
The numbers displayed are the mean MCS with standard error bars 
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Figure 3.11 Change in Modified Cincinnati Scores (MCS) from baseline 
 
Numbers represent mean change from pre-operative status at 6, 12, and 24 months and latest 
follow-up with standard error bars 
 
The graph above demonstrates similar improvements in MCS when comparing ACI and 
MACI groups at all time intervals. The independent t-test revealed no statistical significance 
between the two groups with respect to their latest MCS (p= 0.3) which was the score of 
interest.  
Patients were grouped according to whether they had an excellent or good result according to 
the MCS one and two years following surgery and at the latest follow up. This form of 
analysis was executed to enable comparison of results from this study with other studies 
which do not use the same outcome measures but report good or excellent results. An 
excellent result is a MCS of 80 or more, a good result is a score between 55 and 79 inclusive, 
a fair result is a score between 30 and 54 and a poor result is score below 30 (Bentley et al 
2003). 85 
 
The proportion of excellent and good results did not differ according to the treatment they 
had (see table 3.4). One year following surgery, 64 patients (59.2%) had achieved good or 
excellent results in the ACI group compared to 61 patients (62.3%) in the MACI group. At 
two years, the proportion of good/excellent results had deteriorated, with 52.6% (41 patients) 
in the ACI group and 55.9% (33 patients) in the MACI group. At the time of latest clinical 
review (mean of 41.8 months), the results had deteriorated further; the proportion of 
good/excellent results were only 47% in the ACI group and 53% in the MACI group. 
Table 3.5 shows that at the time of the 2 year review, a large number of patients failed to 
attend their clinical appointments. The two year results were only available for 55.5% of 
patients (137 patients had 2 year results from a total of 247 patients). An attempt was made to 
contact patients who had not attended their appointments to ascertain their clinical status and 
how well their knee is functioning. Therefore, at the latest follow up (at a mean of 41.8 
months) results were available for 206 (83.4%) patients. This is why there are a greater 
number of patients in the final time interval in the CONSORT statement than the previous 
time interval (MCS 2 years after surgery) 
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Figure 3.12: Timelines for patients undergoing ACI and MACI 
 
 
The figure above demonstrates the trend in MCS at each time interval for every single patient 
segregated according to the type of surgical procedure they received. The general trend is that 
patients tend to get better after surgery but it appears to take at least 1 year. If patients have 
improved then they tend to maintain that level of function and have a slow steady decline 
after 3-4 years. 87 
 
Table 3.4 – Proportion of Excellent and Good Results in ACI and MACI patients 
Time  Outcome  ACI  MACI  p value 
 
 
1 year 
Excellent  21 (19%)  28 (29%)   
 
0.67 
Good  43 (40%)  33 (34%) 
Fair   24 (22%)  23 (24%) 
Poor  20 (19%  13 (13%) 
Total  108  97 
 
 
2 years 
Excellent  20 (26%)  15 (25%)   
 
0.73 
 
Good  21 (27%)  18 (31%) 
Fair   22 (28%)  19 (32%) 
Poor  15 (19%)  7 (12%) 
Total  78  59 
 
 
Latest 
Follow Up 
Excellent  27 (25.5%)  28   
 
0.41 
 
Good  23 (22%)  25 
Fair   29 (27%)  33 
Poor  27 (25.5%)  14 
Total  106  100 
The p values are derived from performing the Fisher’s exact test to compare proportion of good and 
excellent results according to the Modified Cincinnati Score (MCS). 88 
 
An analysis of patients who attended their two year clinical outpatient visit and those patients 
who did not was performed (table 3.5). There were no significant differences in age, length of 
symptoms, number of previous operations or the size of the lesions between patients who 
attended their two year clinical visit and those that did not. However, there was a significant 
difference in the MCS before surgery in the two groups (patients who attended their follow 
up had significantly lower score). This an important observation as a lower MCS pre-
operatively suggests that the post-operative MCS is going to be lower (see section on 
generalised linear model). 
 
Table 3.5 – A comparison of results in patients with 24 month follow up data and those 
without 
  No Follow up 
N=117 
Follow up 
N=122 
p value 
Age 
 
32.6 +/- 0.76 
 
33.7 +/- 6.8  0.3 
Length of symptoms 
(months)  
109.4 +/- 9.6  93.5 +/- 6.6  0.1 
No. of previous ops 
 
2.2 +/- 0.16  2.3 +/- 0.16  0.5 
Size of lesion 
 
528.7 +/- 28.2  512.6 +/- 25.9  0.68 
MCS 0  49.1 +/- 1.56 
 
44.3 +/- 1.58 
 
0.03 
p values are derived by comparing the means in the two groups using the independent t-test 
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Further procedures 
Sixteen patients required further procedures (Table 3.6) at a mean of 40.3 months. 
 
Table 3.6 – Major re-operations 
Procedure  ACI  MACI 
Revision ACI/MACI  2  3 
Patellectomy  1  1 
High Tibial Osteotomy  1  2 
Unicompartmental or 
Patellofemoral Replacement 
4  0 
Total Knee Replacement  2  0 
Total  10  6 
 
 
Kaplan-Meier survivorship analysis was performed from the date of the 2
nd stage operation to 
the end-point of re-operation for the above indications (therefore the analysis is on the time to 
revision surgery). The log-rank test was used to compare whether there was a significant 
difference in re-operation rates between ACI or MACI groups (figure 3.13). The mean 
survival times (according to the above end-points) were 89.7 months in the ACI group and 
68.7 months in the MACI group. This was not statistically significant (p=0.5). The 5 to 8 year 
survival figures are displayed in the table 3.7. 
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Table 3.7 – Survivorship figures according to Kaplan-Meier Analysis
 
Time   ACI  MACI 
5 years   94% +/- 2.5  95% +/- 2.9 
6 years  90% +/- 3.6  91.1% +/- 4.8 
7 years  90% +/- 3.6  *75.9% +/- 10.6 
8 years  83.8% +/- 5.4  Not available 
Mean survival time(with 95% 
Confidence Intervals) 
89.7 months                  (95% 
CI 84.8% to 94.6%) 
68.7 months                 (95% 
CI 66.3% to 71.1%) 
Overall (combining ACI & 
MACI groups together) 
90.3 months (95% CI 86.5 to 94.1%) 
The probability of survivorship (i.e. not requiring revision surgery) is shown as a percentage 
with the standard error of mean. *only 83 month survivorship figure available for the MACI 
group 
 
Figure 3.13: Kaplan-Meier Survivorship Analysis of ACI and MACI 
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Predictors of Outcome 
 
Since there were no differences in outcome when comparing ACI-C with MACI, the patients 
were grouped together when analysing predictors of outcome. This enabled greater number of 
predictive factors to be taken into consideration in the statistical analysis. 
 
Site  
The graph below displays the change in the Modified Cincinnati Score (MCS) from baseline 
(pre-operatively) to the various time frames after surgery listed below.  .  
Figure 3.14: Improvement in MCS from baseline according to site of defect 
 Graph displays mean values with standard error bars. LFC = lateral femoral condyle, MFC = medial 
femoral condyle, Pat single = single patella lesion, Pat. Multiple = multiple patella lesions 
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The standard error of the means for the all the groups were quite high (especially at 12 and 24 
months after surgery). Therefore statistical analysis was only performed at the final time 
point which represents the greatest number of patients (change in MCS at the latest follow-
up). Analysis of variance (ANOVA) revealed a statistically significant difference between the 
groups in terms of improvement of the MCS from baseline to mean follow-up of 41.8 months 
(p=0.038). 93 
 
Aetiology 
The graph below displays the change in MCS from the pre-operative score to 6, 12, 24 
months after surgery and at the time of latest follow-up (mean 41.8 months) according to the 
aetiology of the osteochondral defects.  Patients who had a previous mosaicplasty, carbon 
fibre rods, or an ACI-P were grouped together and termed ‘Failed’. The other three groups 
(Trauma, Chondromalacia Patellae (CP) and Osteochondritis Dissecans (OD)) had had 
previous arthroscopies and debridement procedures. 
 
Figure 3.15 – Change in Modified Cincinnati Scores According to Aetiology 
 
Graph displays mean values with standard error bars 
 
There are quite large standard error bars (especially at the 12 and 24 month time intervals). 
Therefore, very little conclusions can be made regarding efficacy of surgery at 12 and 24 
months after surgery according to aetiology. This is because there was a lot missing data as 
mentioned earlier in the chapter and some of the data was recovered. Hence, the error bars in 94 
 
‘Latest MCS Change is smaller. ANOVA revealed no statistically significant difference in 
improvement in MCS between the groups at the time of latest follow-up (p=0.5).  
All patients experienced similar improvements from baseline to the time of final follow-up 
expect patients with chondromalacia patellae (the mean increase in MCS was approximately 
half that of the others) but was not statistically significant (analysis of variance test 
(ANOVA) revealed p=0.5). 
It is important to realise that by separating the group of patients into this sort of cohort means 
that the patients are no longer randomised. Therefore, there may be other variables that may 
be contributing to the differences in outcome. Table 3.8 shows the results of ANOVA 
analysis on patient and lesion characteristics that may also have an effect on outcome. 
The number of previous operations varies significantly in this cohort of patients. It is 
reasonable to assume that in the group termed ‘Failed previous operations’ they are going to 
have had a greater number of previous operations. It was also interesting to note that in this 
cohort of patients the size of the lesion was greater.  
As one would expect the OD group was younger and when compared directly to the ‘Failed 
group’ was statistically significantly younger (though ANOVA analysis revealed p > 0.05 
when taking into account all four groups). 
In order to address these compounding variables a generalised linear model was utilised. 
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Table 3.8– Descriptive statistics of patient and lesion characteristics according to Aetiology 
 
N  Mean  Std. Error 
95% Confidence 
Interval for Mean 
p value 
(derived 
from  
ANOVA) 
Lower 
Bound 
Upper 
Bound 
Age  Trauma  116  32.9  0.8  31.26  34.60   
OD  24  28.6  1.9  24.70  32.55   
CP  38  32.8  1.4  29.95  35.63  0.07 
Failed  38  34.7  1.2  32.20  37.22   
Total  216  32.7  0.6  31.55  33.93   
Length of symptom  Trauma  113  91.6  7.8  76.10  107.00   
OD  23  115.8  24  66.02  165.54   
CP  37  96.8  11.4  73.75  119.82  0.15 
Failed  36  127.2  15.4  95.96  158.38   
Total  209  101.3  6  89.43  113.13   
No. of previous ops  Trauma  116  2.2  0.1  1.94  2.51   
OD  24  2  0.4  1.08  2.92   
CP  38  2.1  0.2  1.66  2.60  0.002 
Failed  37  3.4  0.4  2.65  4.17   
Total  215  2.4  0.1  2.14  2.63   
Size (mm
2
)  Trauma  114  499.6  26.7  446.6  552.5   
OD  23  548  60.3  422.9  673.1   
CP  38  489.3  39  410.4  568.3  0.05 
Failed  36  646.3  59.8  524.9  767.8   
Total  211  528.1  20.3  487.9  568.2   
CP = Chondromalacia Patellae, Osteochondritis Dissecans = OD, Failed = patients with 
failed previous mosaicplasty, microfracture or previous ACI 
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Number of previous operations 
The graph below displays the change in Modified Cincinnati Scores (MCS) from baseline 
according to the number of previous operations the patients had received prior to their first 
stage procedure. 
Figure 3.16:   Change in Modified Cincinnati Score according to number of previous  
    operations 
 
All three groups of patients experienced significant improvement in symptoms and ANOVA 
revealed no difference in outcome between the three groups at the time of latest follow-up. 97 
 
Sex 
The graph below displays the change in MCS from baseline at 6, 12, 24 months and the time 
of latest follow-up (mean 41.8 months) in males and females. 
Figure 3.17: Change in MCS from baseline in males and females 
 
The independent t-test revealed no statistically significant difference in efficacy of surgery 
according to the change in the latest MCS between men and women. 98 
 
Generalised Linear Model (GLM) 
In this section there will be 2 models performed. The first model will contain the latest MCS 
as the dependent variable. The covariate will be the MCS before surgery (MCS 0). The type 
of surgery (ACI vs MACI) will be the co-factor. The table below displays the results. The 
second GLM will analyse all the other possible predictors of surgery. 
The residuals for this GLM and the following GLM which incorporates all other confounders 
were plotted and tested for normality. This was found to be the case; hence multiple linear 
regression testing was performed (Personal communication from Tim Morris, statistician at 
the Clinical Trials Unit, MRC). 
Table 3.9: Results of the GLM to determine efficacy of surgery 
Parameter  Magnitude 
of Effect 
Std. Error  95% Confidence Interval 
Lower  Upper  Significance 
ACI  -2.95  3.2  -9.25  3.34  0.36 
MACI  0
a  .  .  .  . 
           
MCS 0  0.6  0.094  0.41  0.78  <0.01 
          
0
a  represents the reference category for comparison of other categorical data within the group. 
 
The GLM shows that the MCS before surgery has a significant effect on the MCS after 
surgery, whereas the type of surgery (i.e. ACI or MACI) does not. The ‘Magnitude of Effect’ 
column displays the data for continuous and categorical factors differently. For continuous 
data (MCS 0), a one point increase in MCS 0 is likely to increase the latest MCS by 0.6 
points. When comparing categorical data there must be a reference category and in this case it 
is MACI. The model predicts that ACI patients are likely to have a MCS at the latest follow-99 
 
up that is 3 points inferior to MACI patients independent of the MCS before surgery (though 
this is not statistically significant). 
As there were no statistically significant differences in outcome between ACI-C and MACI, 
the patients were grouped together in order to increase the number of patients in which 
prognostic factors could be analysed. In total there were 169 patients that had all of the 
previously mentioned factors listed in the database. Tables 3.10a shows the breakdown of the 
number of patients for each of the categorical variables. Table 3.10b displays the mean for 
each of the continuous variable. In an effort to increase the efficiency of statistical analysis 
and in order to analyse more confounding variables the site of the lesion was grouped in to 
four categories where patella single and multiple lesions were one category. Furthermore, in 
the aetiology section chondromalacia patella and osteochondritis dissecans were grouped 
together and termed ‘other’. 
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Table 3.10a:  Categorical Variable Information 
 
Factor   N  Percent 
 
Type of surgery 
ACI  90  53.3% 
MACI  79  46.7% 
Total  169  100.0% 
Sex 
Male  89  52.7% 
Female  80  47.3% 
Total  169  100.0% 
Previous operations 
>4  29  17.2% 
2-3  60  35.5% 
0-1  80  47.3% 
Total  169  100.0% 
Sites 
LFC  26  15.4% 
Trochlea  22  13.0% 
Patella  37  21.9% 
MFC  84  49.7% 
Total  169  100.0% 
Aetiology 
Trauma  85  50.3% 
OD  18  10.7% 
CP  34  20.1% 
Failed  32  18.9% 
Total  169  100.0% 
LFC = lateral femoral condyle, MFC = medial femoral condyle, Pat single = single patella lesion, Pat. 
Multiple = multiple patella lesions, CP = Chondromalacia Patellae,  and OD= Osteochondritis 
Dissecans 
 
  
Table 3.10b: Continuous Variable Information 
  N  Minimum  Maximum  Mean  Std. 
Deviation 
Dependent Variable  Last MCS  169  8  100  56.6  25.1 
Covariates  MCS 0  169  10  88  45.8  16.4 
Age (years)  169  15  52  33  8.8 
Length of Symptoms (months)  169  11  504  100  87.6 
Size (mm
2)  169  96  1575  535  302 101 
 
Table 3.11 - Results of Generalised Linear Model 
 
Parameter 
Magnitude 
of effect  Std. Error 
95% Confidence Interval 
Hypothesis 
Test 
Lower  Upper  Sig. (p-value) 
 Covariates 
 Type of surgery 
         
ACI  -2.8  3.5  -9.6  4  0.4 
MACI  0
a  .  .  .  . 
           
 Aetiology           
Failed   -2.8  5.1  -12.8  7.1  0.6 
 Other  -1.4  3.8  -8.8  6  0.7 
Trauma  0
a  .  .  .  . 
  
Site  
         
LFC  -0.8  5.3  -11  9.6  0.9 
Trochlea  13.3  5.3  3  23.7  0.01 
Patella   0.4  4.4  -8.2  9.1  0.9 
MFC   0
a  .  .  .  . 
 
Sex of patient 
         
Male  9.8  3.78  2.43  17.2  0.01 
Female  0
a  .  .  .  . 
           
No. Previous Ops           
4 or more  3.91  4.9  5.7  13.5  0.4 
2-3  -1.4  3.8  8.8  6  0.7 
0-1  0
a  .  .  .  . 
           
Co-factors           
MCS 0  0.5  0.1  0.25  0.7  <0.001 
Age  -0.5  0.2  -0.9  -0.1  0.01 
Size   -0.006  0.001  -0.02  0.005  0.3 
Length of symptoms  -0.002  0.02  -0.04  0.04  0.9 
Other aetiologies included  osteochondritis dissecans and Chondromalacia Patellae,  
LFC – Lateral Femoral Condyle, MFC – Medial Femoral Condyle,  
MCS 0 is the pre-operative  Modified Cincinnati Score 
0
a  represents the reference category for comparison of other categorical data within the group. 
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Table 3.11 shows that the only statistically significant factors affecting outcome were the  
pre-operative MCS, age and sex of patients and site of the lesions. The latest MCS  was on 
average 13 points greater in patients with lesions in the trochlea compared to patients with 
lesions in the medial femoral condyle (p=0.01).  
Male patients did significantly better compared to female patients when all other confounding 
variables were taken into consideration. 
The size of the lesion or length of symptoms did not affect outcome when taking into account 
all the other variables. The strongest predictor of the latest MCS was the MCS before 
surgery. From the model above, it can be concluded that a single point increase in MCS 0 is 
likely to increase the MCS 24 by 0.5 points. Therefore if the starting MCS was 10 points 
higher, then the MCS 24 is likely to be 5 points higher. This relationship is statistically 
significant (p<0.001). There is also an inversely proportional relationship between age and 
the latest MCS. An increase in age by 1 year is likely to decrease the MCS 24 by 0.5 points 
(p=0.01).  
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Discussion 
Treatment by both ACI and MACI resulted in significant improvements to the Modified 
Cincinnati Score (MCS) a year following surgery and this improvement was maintained at 
the latest follow up of 41.8 months. There was no significant difference between the two 
techniques in terms of the final MCS or the improvement in MCS from the pre-operative 
status. Furthermore, there was also no difference in the two groups in terms of achieving 
excellent or good results. This is in keeping with an earlier study which compared ACI vs 
MACI at 1 year (Bartlett et al. 2005). The mean MCS in the ACI-C group (n=44) was 59 
(mean increase 17.5 points) and in the MACI group (n=47) was 64.1 (mean increase 19.6 
points). However, this difference was not statistically significant. Analysed another way, 
72.3% of patients reported a good or excellent outcome in the MACI group compared with 
59.1% in the ACI-C group. These results are similar to the results presented in this study at 
one year (64% in the ACI group and 61% in the MACI group). In this study, the overall 
increase in the MCS was 10.6 and 13.2 in the ACI and MACI groups respectively at 1 year. 
Similar increases in the MCS were experienced by the patients at 2 years and at the last 
follow up. The increase in MCS from pre-operative status was much higher in the cohort of 
patients reported by Bartlett et al (2005). The starting MCS was lower in the study by Bartlett 
et al. compared to this study and this may explain the difference. 
There are few randomised trials comparing two different techniques of cartilage transplant. 
Gooding et al (2006) compared ACI using a periosteal flap (33 patients) with ACI using a 
synthetic collagen membrane (ACI-C) such as the one used this in this study (35 patients). 
The clinical results were similar in the two groups, though a significant number of patients in 
the ACI-P required a re-operation for graft hypertrophy. This difference in the re-operation 
rates resulted in the trial being stopped prematurely. 104 
 
More recently, 21 patients were randomised to have either ACI-P or MACI using a 
resorbable scaffold of polyglactin 910 and poly-p-dioxanon (Zeifang et al 2010). Knee 
function was assessed according to the International Knee Documentation Committee 
(IKDC) score at 24 months. Secondary outcome parameters used were the SF-36, Lysholm 
and Gillquist and Tegner Activity scores. The mean IKDC score changed from 51.1 to 72 in 
the ACI-P group and from 52 to 76.6 in the MACI group at 12 months and this improvement 
was maintained at 2 years. There was no significant difference in the IKDC with respect to 
the treatment received. The only scoring system that demonstrated a significant difference 
between the two treatment groups was the Lysholm and Gillquist scores which favoured the 
ACI-P group. Comparison with our results is difficult due to the use of different scoring 
systems. MRI scoring to evaluate cartilage repair had shown that there was a significant 
difference in favour of MACI at 6 months but not at 12 and 24 months. This is confirmed by 
another study which showed complete attachment of MACI grafts in 14 out of 16 patients at a 
mean of 34.7 days (range 22 to 47 days) (Marlovits et al 2004). For a randomised study it was 
interesting to read that the ACI-P group contained 10 males and the MACI group consisted of 
6 men and 5 women. The number of patients in this study is questionable even though they 
had performed sample size calculations and stated that their study had 80% power. In their 
discussion they have admitted that the standard deviation of 3.5 for IKDC scores used to 
calculate the sample size required was grossly underestimated and hence their sample size 
calculations were incorrect. There are two other weaknesses of the study; firstly, there were 
no women in the MACI group and secondly there were no lateral femoral condyle lesions in 
the ACI-P group. As this is a randomised study with few patients these discrepancies are 
likely to have occurred by chance, but results from this study have to be interpreted with 
caution. 105 
 
In a prospective cohort study, 20 patients received two different types of MACI; 10 patients 
had a MACI graft with a synthetic collagen membrane (similar to the one used in this study) 
and 10 patients had a MACI graft based on hyaluronic acid (Welsch et al 2010). They 
reported that the collagen MACI had higher quality superficial repair tissue according to an 
MRI scoring system though this did not translate clinically as there were equal proportion of 
good or excellent outcome (80%) in both treatment groups according to the Brittberg Score.  
Once again, due to the use of different scoring systems, a comparison between this study and 
ours is difficult. Feruzzi et al (2008) had demonstrated superior results with the use of MACI 
on a hyaluronic acid scaffold implanted arthroscopically (50 patients) compared with ACI-P 
(48 patients) implanted in the traditional manner (open arthrotomy). In both groups, there was 
statistically significant increase in IKDC scores at 6, 12, 18, 24, 36, 48 and 60 months 
following surgery. Between the two groups, the arthroscopic MACI group had significantly 
better scores than ACI-P until 18 months. At 24 months the scores were slightly higher in the 
arthroscopy group but was not statistically significant. However, complication and re-
operation rates were significantly lower in the arthroscopy group (9 complications in the open 
series versus 2 in the arthroscopy group, p=0.008). The authors’ speculated that the use of 
hyaluronic acid as a scaffold and its adhesive properties could explain no graft delamination 
or loose-body formation. The design of this study has a fundamental flaw. It can not conclude 
that arthroscopic implantation is better than the open technique since there were two different 
types of ACI used. It would have been more appropriate to have used MACI in the open 
series. 
MACI was shown to be efficacious in two other studies assessing traditional versus 
accelerated approaches to post-operative rehabilitation. Sixteen patients were randomised to 
have an accelerated weight-bearing compared whereas 15 patients had delayed weight-106 
 
bearing following surgery (Wondrasch et al 2009). Clinical assessment was performed using 
the IKDC, the Knee Osteoarthritis and Outcome Score (KOOS) and the Tegner score. 
Compared to the pre-operative status, all clinical scores showed an improvement in both 
treatment groups with no statistically significant differences. These were supported by a 
larger randomised controlled trial of 62 patients randomised to have traditional versus 
accelerated weight-bearing following MACI (Ebert et al 2008). In their study it was shown 
that accelerated weight bearing resulted in significantly lower knee pain (according to 
KOOS). 
 The rehabilitation following surgery at our Institute is early weight-bearing with the support 
of crutches. This is based on the theory that long periods of unloading lead to degeneration of 
articular cartilage, possibly having an adverse effect on the transplanted cells,. Non-weight-
bearing and could lead to joint structures (such as menisci, capsular structures and ligaments) 
adapting to a non-physiological situation which could compromise healing cartilage. The 
MACI technique allows the grafted cells to be directly held on the defect and minimizes the 
risk of cell leakage thereby allowing earlier weight-bearing.  
The ultimate goal of ACI is to restore function in relatively young, fit and active patient 
population. The secondary more long-term goal is to avoid the development of secondary 
degenerative changes in the affected knee that may require a more radical surgical procedure 
such as tibial osteotomy or partial/total joint arthroplasty. This is the first study to analyse the 
effectiveness of ACI in avoiding the need for the above procedures. The 7-year survivorship 
following ACI-C was 90% and following MACI was 75.5% (this difference was not 
statistically significant). Zaslav et al (2009) demonstrated 75% survivorship of ACI grafts at 
48 months (though they used different end-points). The 10-year survivorship in 72 patients 
was 83.3% with end-point being any operation to remove the implanted ACI graft (Moseley 107 
 
et al 2010). The criticism of this study could be the lack of a negative control and also the 
end-point used. It would be ethically incorrect for symptomatic chondral defects of the knee 
not to have any treatment and hence the lack of negative control. Most joint registries use 
revision surgery as an end-point when performing survivorship analysis, and so our study 
adds a useful comparison to joint arthroplasty. 
More recently, Filardo et al. (2014) have reported a 10.4% failure rate with the use of a 
hyaluronan-based MACI at a mean of 77.4 months follow-up. In their review of 142 patients 
with lesions in the trochlea and femoral condyles, they reported more favourable outcomes in 
male patients and younger patients which agrees with our results. They also observed better 
results in patients with shorter duration of symptoms in patients with traumatic lesions, small 
lesion size (for OCD) and no previous surgery. Perhaps the difference in their results and ours 
is that they specifically analysed results in a separate cohort of  patients i.e. size of lesion in 
patients with OCD or duration of symptoms in traumatic lesions. The advantage of analysing 
results in a GLM is that it takes into consideration other variables, hence, is a more accurate 
form of analysis. 
The literature suggests that both ACI and MACI are equally effective in treating full 
thickness chondral defects in the knee and seem to be better than other techniques for larger 
defects (Bentley et al 2003, 2012, Visna et al 2004, Saris et al 2008, Saris et al 2009). The 
results from our Institute do not seem to be as good as those reported from other studies 
(Brittberg et al 1994, Peterson et al 2000, 2002, Ferruzzi et al 2008, Zeifang et al 2010, Ebert 
et al 2008, Wondrash et al 2009, Welsch et al 2010, Behrens et al 2006, Moseley et al 2010). 
The use of different scoring systems makes direct comparison of results extremely difficult. 
Nevertheless, the proportion of good and excellent results does seem to be lower at our 
Institution compared to others. This may be because patients are made to wait longer for 108 
 
cartilage transplant procedure and have had many other procedures prior to ACI/MACI as a 
result National Institute for Health and Care Excellence (NICE) guidelines which prohibits 
the use of cartilage transplantation as first line treatment for chondral lesions. 
The initial attrition rates in this study were among the highest in the literature for randomised 
studies assessing ACI. Horas et al. (2003) reported a 5% attrition rate in his study on ACI vs 
mosaicplasty, while Knutsen reported 0% loss to follow up in his studies on ACI vs 
Microfracture (Knutsen et al. 2004, 2007). In other studies rates varied from 0 to 28% (Dozin 
et al 2005, Behrens et al 2006, Visna et al 2004, Saris et al 2009). In total 205 patients (out of 
247) had returned for their 1 year visit representing an attrition rate of 17%. However, 2 years 
following surgery, only 137 patients had returned for their clinical visit, representing an 
attrition rate of 44.5%.  
The general consensus is that in studies with high attrition rates, there is a differential drop 
out with those lost to follow-up not doing as well as those attending clinical visits (Sprague et 
al 2003, Kristman 2004, Dumville et al 2006, Fewtrell et al 2008). Schulz and Grimes (2002) 
argue that loss to follow-up of 5% or lower is usually of little concern, whereas a loss of 20% 
or greater means that readers should be concerned about the possibility of bias; losses 
between 5% and 20% may still be a source of bias (Ferguson et al 2002). In a simulation 
study using 1000 computer replications of a cohort of 500 observations, the authors found 
seriously biased estimates of the odds ratios with high levels of loss to follow-up (Kristman et 
al 2004).  Murray et al. demonstrated that patients who had total hip or knee replacements 
and were lost to follow-up had a worse outcome than those who continue to be assessed 
(Murray et al 1997). The results from this study suggest otherwise. Patients who did not 
attend their 2 year clinical visit had significantly higher starting MCS than those who did 
attend (Table 3.5).  109 
 
 
There are two possible explanations for this trend. Firstly, the patients being treated are a 
much younger cohort than those needing joint replacement, hence they are more mobile and 
are more likely to change residence during the rehabilitation period. The second and probably 
more likely explanation is that in this Institute we treat many tertiary referrals, so patients 
may have to travel quite far. If patients have experienced a significant improvement in their 
symptoms then they may not want to attend a clinical visit 2 or 3 years later just to be asked 
some questions and be examined, even though they consented to do so at the beginning of the 
trial. 
 
A large proportion of patients refused to undergo repeat arthroscopy at 1 year to assess the 
quality of graft and fewer still had a biopsy of the graft performed. It was therefore decided 
not to include the ICRS grade of the graft or the biopsy results in the analysis as fewer than 
20% patients had these and this may not represent the true patient population. Briggs et al had 
demonstrated that 8 out 14 ACI grafts had hyaline-like cartilage repair, but all 14 grafts 
contained chondrocytes which had the potential to express type II collagen (Briggs et al 
2003). Furthermore, the same group analysed the maturity of graft (according to the timing of 
the biopsy) to determine if this affected the histological as well as clinical and functional 
scores. They had suggested that biopsies taken at 1 year may not be a true representation of 
the amount of hyaline cartilage formation in the long-term as grafts are continuing to mature 
even at 36 months (Gikas et al 2009). However, it was difficult enough to persuade patients 
to undergo an arthroscopy and biopsy a year after surgery let alone 3 years! Nevertheless, a 
statistical model such as the GLM has not been reported in the literature, and it would have 
been very interesting to establish if hyaline cartilage formation following surgery was a 
significant prognostic factor independent of the other aforementioned variables. 110 
 
 
Conclusion 
The results from this randomised trial show that there is no statistically significant difference 
between ACI and MACI when treating OCD defects of the knee. In this cohort of patients, 
the pre-operative MCS was the strongest predictor of outcome at 2 years. If patients had 
previous treatment in the form of mosaicplasty or previous ACI/MACI (i.e. failed aetiology) 
then they are predicted to have inferior results following revision surgery. Patients with 
lesions in the patella are also predicted to have significantly worse results. The question 
therefore has to be asked whether we should be performing such expensive surgery if the 
lesions are located in the patella or if it is revision surgery. Only cost-utility studies over the 
long term can answer these questions. 111 
 
Chapter 4:   
The Treatment of Patellofemoral 
Osteochondral Defects 
Introduction 
 
The patellofemoral joint consists of the patella, the femoral condyles and the trochlea groove. 
The patella is a sesamoid bone which re-directs the forces of the quadriceps to the distal part 
of femur. Hence, it functions  as a lever arm, thereby increasing the efficiency of the extensor 
mechanism (Hungerford et al. 1979). The patella has a medial and lateral facet which 
articulates with both of the femoral condyles. In addition, approximately three-quarters of 
individuals have a third articulating facet on the medial ridge of the patella that articulates 
with the medial femoral condyle at 120
0 of flexion-the so-called “odd”facet (Goodfellow et al 
1976). 
The flexion-extension pathway of the patello-femoral joint is complex. There is no contact 
between the patella and the trochlear groove in full extension. At initiation of flexion the 
inferior pole of patella comes into contact with the trochlea. As the knee continues to flex to 
90
0 the patello-femoral contact point moves more proximally. Flexion beyond 120
0 results in 
only the medial and lateral aspects of the patella making contact with the femoral condyles 
(Mihalko et al 2007). As a result of the great pressures throughout the patello-femoral joint, 
the human body has adapted so that the articular cartilage of the patella is the thickest of any 
in the body (Grelsamer & Weinstein 2001). 112 
 
In early flexion, there is a small compressive force across the patellofemoral joint (PFJ). 
However, the compressive forces increase as flexion increases. On the patella there are 
therefore three main forces:  
1.  The pull of the quadriceps 
2.  The tension of the patella tendon 
3.  Joint reactive force of the patello-femoral joint. 
The estimated force through the patello-femoral joint varies from 1.5 times the body weight 
at 30
0 of flexion to 6 times the body weight at 90
0 of flexion (Grelsamer & Weinstein 2001, 
Scuderi 1995). After 90
0 of flexion the quadriceps tendon comes into contact with the distal 
femur and this is thought to dissipate the contact forces (Huberti and Hayes 1984). 
Disorders of the patello-femoral joint represent a considerable therapeutic challenge due to 
the unique anatomy and biomechanics. The organisation of static forces (ligamentous and 
osseous elements) and dynamic factors (neuromuscular) contribute equally to its functional 
capacity (Saleh et al 2005). The medial and lateral patello-femoral and patello-tibial 
complexes form the main soft tissue static stabilisers of the joint (Arendt et al 2002). Patello-
femoral function is also dependent on limb alignment, which includes varus or valgus tibio-
femoral alignment as well as femoral anteversion. An imbalance of forces is likely to result in 
malalignment of the patellofemoral joint, and the question then rises as to the role of 
malalignment in chondral defects in the PFJ and subsequent osteoarthritis (OA) (Post et la 
2002). With respect to the patella, the most prevalent area of chondral disease is on the lateral 
facet (Fulkerson & Hungerford 1990). The fact that the lateral facet becomes overloaded 
more commonly than the medial side suggests some degree of patella tilt or malalignment is 
more common than we realise. Certainly, when the literature regarding knee arthroplasty is 113 
 
reviewed this is the case. In a series of 72 knees managed with patellofemoral arthroplasty 
85% required a re-alignment procedure at the time of arthroplasty (Cartier et al 1990). A 
similar principle should be applied to the treatment of osteochondral lesions in the patella so 
that if a malalignment problem exists, this should be corrected simultaneously whilst 
addressing the chondral lesion. 
Fulkerson first described the correlation of the site of patella defects with outcome following 
re-alignment (distal) osteotomy (see figure below). 
 
Figure 4.1 Fulkerson’s classification of chondral defects in the patella 
 
Fig 1A–D. This schematic diagram (which is looking at the under-surface of the patella) represents 
the four chondral defect locations of the patella  according to Fulkerson’s classification.16 (A) Type I 
is articular injury to the inferior pole of the patella. (B) Type II is articular injury to the lateral facet of 
the patella. (C) Type III is articular injury to the medial facet of the patella (frequently associated with a 
trochlear defect). (D) type IV is articular injury to the proximal pole (Type IVa) or a panpatellar injury 
(Type IVb). When associated with maltracking, 
Type I and Type II injuries have a predictably good outcome with anteromedialization tibial tubercle 
osteotomy whereas Type III and Type IV injuries have poor outcomes, especially when associated 
with a trochlea defect. 
(With kind permission from T. Minas) 
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Osteochondral defects in the Patellofemoral Joint 
 
The aetiology of defects in this compartment of the knee is similar to the other compartments 
with one key difference. Chondromalacia patellae (CP) is a distinct clinical entity in which 
there is anterior knee pain and softening or breakdown of articular cartilage on the “odd” and  
medial facet of the patella though changes can occur in the lateral facet especially if there is 
tightness of the lateral patellar retinaculum as described by Ficat (Ficat and Hungerford 
1977). CP was initially thought to result from malalignment of the unstable patella as it 
articulates with the distal femur (Wiberg 1941). This notion has largely been superseded by 
the concept that CP is secondary to trauma to the superficial chondrocytes resulting in release 
of proteolytic enzymes and enzymatic breakdown of articular cartilage and occurs frequently 
with no evidence of malalignment (Hinricsson 1939, Bentley and Dowd 1983). Two thirds of 
patients affected by symptomatic chondromalacia patellae are female (Bentley 1970) and 
symptoms affect two distinct groups. Some are inactive teenage girls and the second group 
are highly active teenagers of both sexes (Bentley & Dowd 1983). The first group experience 
symptoms after long periods of knee flexion e.g. when driving or sitting at a desk which is 
commonly relieved by mobilising the knee joint. The second group are usually active whose 
symptoms are aggravated by sport and relieved by rest. Outerbridge (1961) characterised 
cartilage damage in CP into four grades:  
Grade I  Softening and swelling or fibrillation/fissuring in an area < 0.5cm 
Grade II  Fissuring or fibrillation/fissuring in an area of 0.5-1cm 
Grade III  Fibrillation (“crabmeat appearance”) or fibrillation/fissuring in an area 1-2cm 
(figure 4.2) 
Grade IV  Erosive changes and exposure of subchondral bone or fibrillation in an area > 
2cm (figure 4.3) 115 
 
 
 
 
Figure 4.2: Retropatellar fibrillation 
 
 
  
Figure 4.3: Full thickness retro-patellar chondral defect (Figures courtesy of G. Bentley) 
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Non-operative management 
 
This mainly consists of physiotherapy to improve quadriceps strength. Specific focus on the 
vastus medialis muscle is also undertaken particularly if there is patella maltracking. It is 
important to improve function with physiotherapy but at the same time ensuring that the 
damaged patello-femoral articulation is not overloaded. Recently, more emphasis has been 
placed on overall body balance and stability. Such core strengthening focuses on abdominal 
muscle control, trunk balance and limb control. The expectation is that with improved 
alignment and balance there will be decreased pressure on the PFJ.  
The patellar (McConnell) taping technique may be useful in cases of severe lateral patella 
translation and tilt. This depends on the integrity of the patient’s skin to withstand repeated 
applications. Several braces have also been designed to shift the patella medially and off- 
load the lateral facet. This form of therapy largely depends on patients’ co-operation and 
determination to put on the brace daily. Finally water-based exercises are useful, particularly 
in obese patients as joint forces are reduced during these exercise programs. 
 
Surgical procedures to correct re-alignment 
Arthroscopic lateral retinacular release 
This procedure is frequently utilised in combination with chondroplasty to address lateral 
alignment and  patellar tilt problems with lateral facet chondral damage. Release of the lateral 
retinacular structures will decrease the pressures on the lateral facet, whilst chondroplasty 
may provide temporary pain relief. 117 
 
Proximal soft tissue re-alignment 
This procedure is performed when the aim is to unload the lateral facet and improve patellar 
tracking. A midline incision is performed from the superior pole of patella to medial aspect of 
tibial tubercle. The lateral patellofemoral ligament and retinaculum is released. The vastus 
lateralis lower fibres are also released and the release is continued to the tubercle. The vastus 
medialis is elevated from underlying capsule approximately 10cm from its insertion. It is then 
advanced to the free edge of the vastus lateralis creating a sleeve around the patella. 
Four years following surgery, a 91% patient satisfaction rate was reported by Insall et al 
(Insall et al. 1979). The outcome following this procedure is not predictable and when there 
are widespread arthritic changes the failure rate can be high as 62% (Fulkerson 2005). The 
focus is purely on the relieving pressure off the lateral facet. Therefore, any disease of the 
trochlea or medial facet may result in increased pain. Soft tissue alignment procedures in 
combination with other procedures to address chondral damage is indicated in skeletally 
immature patients (Mihalko et al 2007). In mature patients, success following this procedure 
has been reported when there is minimal arthritic changes and a Q angle of < 10 (Hughston & 
Walsh 1979). 
 
Distal Re-alignment 
Tibial tubercle transfer is mainly indicated in patients with discrete chondral damage in the 
patella or trochlea which can be unloaded. An absolute pre-requisite for this procedure is 
healthy cartilage onto which patella loading can be transferred. Several osteotomies can be 
performed: 
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Anterior/Elevation Osteotomy of Tibial Tubercle 
This is also known as the Maquet procedure and is indicated in distally based disease in the 
patella. Although effective in younger patients with disease confined to the distal pole, it does 
not address maltracking (Maquet 1963) and has been abandoned.  
Antero-medial Tibial Tubercle Transfer 
This is also known as Elmslie-Trillat procedure. This mainly indicated in patients with large 
Q angles, lateral tracking of the patella with or without instability and grade 1/II patella 
lesions (Brown et al. 1984). 
More recently a modification of the Roux-Goldthwaite distal re-alignment has been 
employed successfully, in which a lateral release, medial quadriceps reefing and medial 
transfer of the lateral two thirds of the patellar tendon is performed (Bentley 1989).  
Anteromedial Tibial Tubercle Osteotomy 
This is known as Fulkerson procedure. It involves the transfer of the tubercle to a more 
anterior and medial location. It is effective in diminishing or eliminating load on the distal 
and lateral aspects of the patella (Fulkerson & Becker 1990). 
 
Treatment of pure chondral lesions 
 
The general consensus in the literature is that the clinical results from treating cartilage 
lesions in the medial and lateral femoral condyles are considerably better than treating 
patellar defects. Microfracture has been shown to lead to inferior results when utilised in the 
patella (Kreuz & Steinwachs et al 2006, Kreuz & Erggelet et al 2006). Similarly, there are a 
number of studies reporting on the use of mosaicplasty but there are only a few that have 119 
 
reported on the results of the patella (Bentley et al 2003, Hangody et al. 2003, Karataglis et al 
2006). These studies have indicated that osteochondral plugs transferred to the patella are not 
as successful as transfer to the femoral condyles. Bentley et al. had shown the arthroscopic 
appearance was fair to poor in all patients treated with mosaicplasty in the patella (Bentley et 
al 2003). Hangody’s group reported 79% good to excellent results when treating patella and 
trochlea lesions though this is still lower than 92% success rate when treating femoral 
condyle defects. The primary reason for this discrepancy has been postulated to be due to 
difference in articular cartilage thickness between trochlea (donor) and patella (host). The 
structural organization of the cartilage in the trochlea may not be suited for the biomechanical 
environment in the patellofemoral joint where shearing forces are more prevalent (Bentley et 
al 2003). 
Both ACI and MACI have been compared in a small randomised trial of 91 patients. Of the 
44 patients that had received ACI, fourteen lesions were located in the patellofemoral joint. 
Seventeen out of 47 patients that had received MACI had lesions in the PFJ. The proportion 
of good and excellent results were similar 54.5% versus 52.5% (p=0.72) (Bartlett et al. 2005). 
In another study, the frequency of good/excellent results were significantly higher when 
treating trochlea and lateral femoral condyle lesions compared with single facet patella and 
multiple patella lesions (84% versus 66% and 54.2%, p=0.05) (Krishnan et al. 2006). 
Several other studies have reported satisfying results with different forms of autologous 
chondrocytes implantation in treating cartilage lesions in the trochlea, medial and lateral 
femoral condyles, whilst patella lesions are less predictable (Pascal-Garrido et al 2009, 
Niemeyer et al 2008, Minas et al 2005, Peterson et al 2002, Brittberg et al 1994). The 
possible explanation for the inferior results associated with treating patella lesions is the 
greater shearing forces in the PFJ compared to the lateral and medial compartments. This is a 120 
 
less favourable environment for the differentiation of transplanted cells than the hydrostatic 
forces that is more prevalent in the region of the femoral condyles (Fitzgerald et al 2006, 
Torzilli et al 2006, Grodzinsky et al 2000). 
 
 
Aims & Objectives 
 
In most of the reported literature, patients with patella defects account for only a small 
proportion of the total patient population. Hence, it has been very difficult to analyse any 
prognostic factors that may have an effect on the outcome of treating this difficult cohort of 
patients. The purpose of this chapter is to identify such factors.  
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Patients and Methods 
The study was approved by the Joint Research and Ethics Committee of the Royal National 
Orthopaedic Hospital (RNOH) Trust. The primary indication for surgery was persistent pain 
which was attributable to an articular cartilage lesion of the knee. The inclusion and 
exclusion criteria was the same as that outlined in Chapter 3 (ACI vs MACI, page 76). All the 
patients were operated in the Joint Reconstruction Unit at the RNOH between 2001 and 2004. 
As not all patients were randomised, this was a prospective cohort study.  The study group 
comprised 215 patients. Thirty-five patients had other procedures at the time of the cartilage 
transplant such as patella re-alignment or anterior cruciate ligament (ACL) reconstruction. 
Hence, they were excluded from analysis. Of the remaining 180 patients, 84 had an ACI 
procedure and 94 had a MACI procedure. The primary outcome measure was the Modified 
Cincinnati Score (MCS). The patients were scored pre-operatively (MCS 0) and at 6 months 
(MCS 6), 12 months (MCS 12) and 24 months (MCS 24) after surgery.  122 
 
Statistical Analyses 
Statistical analyses were performed using SPSS version 18.0. Paired t-tests were used to 
compare knee scores before and after surgery. The independent t-test was used to compare 
outcome between two different groups of patients. Analysis of variance (ANOVA) was used 
to assess difference in outcome between 3 or more groups. Fisher’s Exact Test was used to 
compare the proportion of excellent and good results achieved in each group and also to 
compare re-operation rates. The level of significance was set at p=0.05. 
A  generalised  linear  model  was  used  to  assess  which  factors  had  the  greatest  effect  on 
outcome. The highest number of patients available for post-operative scores were in the MCS 
12 group, hence in the model the dependent variable was MCS 12. The predictive factors in 
the model were type of operation (ACI versus  MACI),  aetiology, site  of defect,  and the 
number of previous operations. The predictive covariates were age of the patient, length of 
symptoms and MCS 0. 123 
 
Results 
The length of symptoms prior to the index procedure was longer in the ACI group and though 
this was not statistically significant the p-value was quite low (p=0.06) (table 4.1). On 
average ACI patients had to wait 2 years longer than MACI patients and this may well be a 
confounding variable. There were no other significant differences between ACI and MACI 
groups in terms of patient or lesion characteristics (see Table 1). 
Table 4.1: Patient and lesion characteristics 
  ACI                           
n=84 
MACI                       
n=92 
p value 
Age  35.2 +/- 1  33 +/- 0.9  0.97 
Percentage males   58  60  >0.05  
Duration of 
symptoms (months) 
104 +/- 11   80 +/- 7.3  0.06 
Number of previous 
operations 
2.1 +/- 0.2   2 +/- 0.2  0.7 
Size of lesion (cm
2)  5.1 +/- 0.3  4.5 +/- 0.3  0.15 
Modified Cincinnati 
Score pre-
operatively (MCS 0) 
 43.8 +/- 1.7  43.8 +/- 1.8  0.99 
 
Bivariate correlation showed that there was no significant relationship between length of 
symptoms and the change in MCS following surgery (Table 4.2). Interestingly, there was no  
a significant negative correlation between the number of previous operations and the change 
in functional score 12 and 24 months after surgery. As expected, MCS 0 correlated 
significantly with the change in MCS 12 months following surgery. 124 
 
 
 
 
 
 
 
 
 
Table 4.3 shows that the distribution of lesions in the patello-femoral joint were similar in 
each group (p>0.05 for each anatomical site according to Fisher’s exact test). There were a 
higher proportion of trauma patients in the MACI group (refer to table 4.4)) (p=0.1) and 
consequently a lower proportion of ‘failed previous procedures’ in the MACI group which 
was statistically significant (p=0.02). This group of patients had undergone a previous 
mosaicplasty or chondrocyte implantation (table 4.4).  
 
Table 4.3: Anatomical site of chondral lesions according to treatment groups 
Anatomical site  ACI  MACI 
Trochlea  21 (24%)  21 (21.6%) 
Multiple lesions (in PFJ)  20 (23%)  20 (20.6%) 
Single facet patella   45 (53%)  57 (58.8%) 
TOTAL  86  97  
 
 
 
   
 
Length of 
symptoms 
MCS 
change 12 
MCS 
change 24 
No. of ops 
previously 
Length of  
Symptoms 
 Pearson Correlation  1  -0.08  -0.1  0.2
* 
Sig. (2-tailed)    0.4  0.4  0.04 
N  154  93  53  151 
No. of ops  
Previously 
Pearson Correlation  0.2
*  -0.09  -0.2  1 
Sig. (2-tailed)  0.04  0.4  0.1   
N  151  102  58  180 
MCS 0  Pearson Correlation  -0.2
*  -0.4
**  -0.4
*  -0.2
* 
Sig. (2-tailed)  0.02  <0.001  0.01  0.025 
N  143  103  57  169 
   
   
Table 4.2: Correlations between length of symptoms and change in functional scores 
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Table 4.4: Aetiology of lesions according to treatment groups 
Aetiology  ACI  MACI 
Trauma   53 (49%)  64 (61%) 
Osteochondritis dissecans  13 (12%)  11 (10%) 
Chondromalacia patellae  17 (15%)  19 (18%) 
Failed previous procedure  26 (24%)  12 (11%) 
TOTAL  109  106 
 
 
Figure 4.4 shows the knee function between the two groups prior to surgery and at all time 
frames following surgery. It displays functional scores for descriptive purposes and allows 
comparison of absolute scores with other published work. Figure 4.5 shows that MACI was 
three times more effective than ACI at improving MCS, and even with such low numbers in 
the sample the p-value was statistically significant according to the independent t-test 
(p=0.038). 
As with the previous chapter, statistical analysis was performed to ascertain the proportion of 
excellent and good results in order to compare the results from this thesis with other 
published work. There was not a statistically significant difference in the proportion of good 
or excellent results in the two groups (Table 4.5). However, when the improvement in MCS 
from pre-operatively to 2 years following surgery was analysed there was a significant 
difference.   
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Figure 4.4:  Functional results with the modified Cincinnati Score (MCS)  
 
 
 
 
 
Figure 4.5: Change in MCS 
 
 
 
p=0.038 127 
 
Table 4.5: Proportion of excellent and good results in ACI and MACI patients with lesions in 
the patellofemoral joint. 
 
Time  Outcome  ACI  MACI  p value 
 
 
6 months 
Excellent  9 (22.5%)  8 (23%)   
 
0.45 
Good  12 (30%)  9 (26%) 
Fair   16 (40%)  15 (43%) 
Poor  3 (7.5%)  3 (8%) 
Total  40  35 
 
 
12 months 
Excellent  12 (21.5%)  18 (31%)   
 
0.4 
 
Good  26 (46%)  26 (45%) 
Fair   11 (20%)  9 (15.5%) 
Poor  7 (12.5%)  5 (8.5%) 
Total  56  58 
 
 
24 months 
Excellent  8 (25.8%)  5 (17.5%)   
 
0.45 
 
Good  8 (25.8%)  7 (24%) 
Fair   7 (22.6%)  7 (24%) 
Poor  8 (25.8%)  10 (34.5%) 
Total  31  29 
The p values are derived from performing the Fisher’s exact test to compare proportion of good and 
excellent results according to the Modified Cincinnati Score (MCS). 
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Table 4.6: Complications and further procedures 
Procedure  ACI  MACI  p-value 
Manipulation under 
anaesthesia 
9  2  0.03 
Graft hypertrophy  7  3  0.2 
Unplanned arthroscopy  3  3  - 
Further realignment procedure  2  0  - 
Graft delamination  0  1  - 
Total  21/86 
(24.4%) 
9/94 
(9.6%) 
0.009 
 
 
The reoperation rate was higher in the ACI group and this was statistically significant 
according to Fisher’s exact test (p=0.009) (table 4.6). The main reason for the high 
reoperation rates were for knee stiffness which required a manipulation under anaesthesia. 
There were also higher rates of graft hypertrophy in the ACI group but this was not 
significant.129 
 
Predictors of outcome  
The next section will analyse whether the site of the lesion specifically in the patello-femoral 
joint, the aetiology of the defect and the number of previous operations influences outcome 
following surgery. The ACI and MACI patients were grouped together and the mean MCS at 
each time frame was determined for each factor.  
 
Site 
Figure 4.6 illustrates the MCS according to the site of the lesion in all patients (i.e. ACI and 
MACI patients grouped together). Unfortunately, it was not specified whether the single 
lesion was in the medial or lateral facet of the patella in 56/160 patients (35%). It was for this 
reason that single defects in the patella were grouped together (whether they were in the 
medial facet or lateral facet or not specified). Once again the graph displays the absolute 
MCS at all time frames for descriptive purposes.  
Figure 4.7 displays the change in MCS from pre-operative to 6, 12 and 24 months after 
surgery. ANOVA revealed a significant difference in efficacy of surgery when treating 
trochlear lesions compared to single and multiple patella lesions one year following surgery 
(p=0.01).  130 
 
Figure 4.6: Modified Cincinnati Scores (MCS) According to site of lesion in all patients 
 
 
 
Figure 4.7: Change in MCS from baseline according to site of lesion in all patients 
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Aetiology 
 
Figure 4.8 illustrates the MCS according to the aetiology of the lesion in all patients. Patients 
with a failed previous procedure had a much lower MCS 0 than patients being treated for 
traumatic lesions or patients with chondromalacia patellae (CP). Other diagnoses included 
osteochondritis dissecans or early osteoarthritis.  Figure 4.9 shows the change in MCS from 
baseline according to aetiology. There were no significant differences between the groups at 
any of the time frames.  All groups experienced am improvement in the MCS from baseline 
at all time frames, though the improvement in MCS declined after 1 year. One way ANOVA 
was performed to determine if there was a significant difference in the change in MCS from 
baseline to 1 year post-operatively (MCS 12). There was no statistically significant difference 
between the groups (p=0.3). 
 
Figure 4.8: The MCS according to aetiology in all patients 
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Figure 4.9: The change in MCS from baseline in all patients  
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Number of previous operations 
 
Figure 4.10 illustrates the MCS according to the number of previous operations. Patients who 
had 4 or more previous operations had a lower MCS 0. Figure 4.11 demonstrates the change 
in MCS from baseline. What is clearly evident is that  at the time latest follow-up, patients 
who have less than 4 operations prior to their index procedure (1
st stage ACI or MACI) 
experience greater improvement in their knee function (as measured by MCS) than those 
have had 4 or more (ANOVA, p=0.03). 
 
 
Figure 4.10:  The MCS in patients according to the number of previous operations 
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Figure 4.11: The change in MCS from baseline according to number of previous operations 
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Generalised Linear Model (GLM) 
 
92 patients (with documented MCS one year following surgery) had a complete set of records 
which could be utilised in this model (this was the dependent variable). Once again, statistical 
analysis involved the generation of two GLMs. In the first GLM the categorical variables 
included sex of patient and type of surgery and the continuous variables included MCS 0 and 
age of patient (i.e. the significant factors from the previous chapter). This was done to 
ascertain if MACI was truly better than ACI in improving knee function after taking into 
consideration all other significant variables. The second GLM will include other factors such 
as aetiology, number of previous operations, site of lesion and duration of symptoms. 
 
Table 4.7: Results of the limited GLM  
Parameter  Magnitude 
of Effect 
Std. Error  95% Confidence 
Interval 
Lower  Upper  Sig. 
Co-variates           
Male  7.9  3.9  0.2  15.7  0.04 
Female   0
a  .  .  .  . 
ACI  -4  3.9  -11.7  3.6  0.3 
MACI  0
a  .  .  .  . 
Continuous            
Age  .002  .0029  -.004  .007  .536 
MCS 0  .445  .1245  .201  .689  .000 
          
0
a  represents the reference category for comparison of other categorical data within the group. 
 
In this model the only significant factors were being a male patient and the pre-operative 
MCS (MCS 0). 136 
 
 
Table 4.8 displays the categorical data information and table 4.9 the continuous variable 
information in the more comprehensive model. Table 4.10 shows the results of the statistical 
analysis. The number of previous operations were categorised into either less than 4 or more 
than 4 as the results in figure 4.11 showed that the improvement in MCS were similar in 
patients if they had 0-1 previous operations or 2-3. Furthermore, patients with other 
diagnoses were grouped together with patients with chondromalacia patellae as ‘Other’. 
 
Table 4.8: Categorical Variable Information 
 
  N  Percent 
Factor  Type   ACI  50  53.2% 
MACI  42  46.8% 
Total  92  100.0% 
Aetiology    Others  44  48% 
Failed procedure  11  12% 
Trauma  37  40% 
Total  92  100.0% 
Site   Trochlea  13  14.1% 
Multi pat  23  25% 
Single pat  56  60.9% 
Total  94  100.0% 
  Sex  Male  41  44.6% 
  Female  51  55.4% 
  Total  92  100% 
Previous Ops  4 or more  14  15.2% 
Less than 4  78  84.8% 
Total  94  100.0% 
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Table 4.9: Continuous Variable Information 
 
  N  Minimum  Maximum  Mean  Std. Deviation 
Dependent Variable  MCS 12  92  14  100  61.8  22 
Covariate  Age  92  16  52  33.7  9.1 
MCS 0  92  10  74  43.6  15.7 
Duration symptom  92  2  360  92.5  82.2 
 
Table 4.10: Results of the Generalised Linear Model 
 
Parameter  Magnitude 
of Effect  Std. Error 
95% Confidence Interval 
Lower  Upper  Sig. 
Type of surgery 
ACI 
 
-4.2 
 
4 
 
-12.1 
 
3.9 
 
0.3 
MACI  0
a  .  .  .  . 
  
Sex 
 Male 
 Female 
 
Aetiology  
  Other                   
 
 
5.4 
0
a 
 
 
-2 
 
 
4.4 
. 
 
 
4.6 
 
 
-3.3 
. 
 
 
-11 
 
 
14 
. 
 
 
6 
 
 
0.2 
. 
 
 
0.6 
Failed previous operation  -1  7.2  -15  13  0.9 
Trauma  
 
Site 
0
a  .  .  .  . 
Trochlea  14  6  3  25  0.02 
Multiple lesion  -1.1  4.9  -10.6  8.6  0.8 
Single lesion 
 
Previous Operations  
0
a  .  .  .  . 
4 or more  -4  5.5  -14.6  7.2  0.5 
Less than 4  0
a  .  .  .  . 
 
Continuous Variables 
MCS 0 
 
 
0.4 
 
 
0.15 
 
 
-0.06 
 
 
0.6 
 
 
0.02 
Age  -0.4  0.2  -0.8  0.06  0.09 
Duration of symptoms  -0.05  0.03  -0.1  0.001  0.05 
               
0
a  represents the reference category for comparison of other categorical data within the group. 138 
 
When taking all confounding variables into account, there does not appear to be a difference 
between ACI and MACI in improving knee function after cartilage repair. 
Lesions in the trochlea achieve better results than in the patella (single or multiple) and this 
variable has the most significant effect on outcome. Interestingly, the duration of symptoms 
prior to surgery did affect MCS 12, whereas the number of previous operations did not have a 
significant effect on outcome. In the previous statistical analysis (table 4.2), the correlation 
between length of symptoms and MCS 12 (r=-0.3, p=0.001) was greater and more significant 
than the number of previous operations and MCS 12 (r=-0.22, p=0.02). This further 
underlines the importance of the generalised linear model to analyse variables that may affect 
outcome. In the previous chapter duration of symptoms did not have an effect on outcome. 
Perhaps waiting longer for cartilage repair when the lesion is in the patella is more 
detrimental 
There was a negative correlation between age and MCS 12. Although the p value was low it 
failed to reach statistical significance.  In the chapter on ACI vs MACI, age did have an effect 
on outcome. Perhaps fewer patients in this chapter has led to a type II statistical error. 
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Discussion 
 
In this chapter, it has been shown that both ACI and MACI are effective in significantly 
increasing knee function 12 and 24 months following surgery. There were no statistically 
significant differences in the pre- and post-operative scores in the two groups. When the 
paired data was investigated (i.e. analysing the increase in MCS in patients that had both pre- 
and post-operative scores) there was a significant difference in the increase in MCS 24 
months following surgery. The MACI group experienced an increase of 21.6 points whereas 
the ACI group experienced an increase of only 7.1 point. A confounding variable in this 
analysis is that the MACI group had a shorter duration of symptoms. This issue was 
addressed in the Generalised Linear Model (GLM) and will be discussed later. 
Only one study has compared ACI and MACI. In a cohort of 91 patients, 28 patients had 
patellar lesions of which 11 had ACI and 17 had MACI. There were no excellent results in 
the ACI group and 4 in the MACI group, but with such few numbers, it was not statistically 
significant (Bartlett et al. 2005). Taking the whole group together (ACI and MACI) there 
were no differences in outcome when comparing patella lesions with medial femoral condyle 
lesions. However Krishnan et al. (2006) showed that the proportion of excellent and good 
results in the trochlea and medial femoral condyle was 84.2% and 84% respectively and this 
compared favourably to patella single defects (66%) and patella multiple defects (54.2%).  
Several other studies have assessed the efficacy of different types of ACI in the 
patellofemoral joint alone. 32 patients with chondral lesions in the patellofemoral joint (22 in 
the patella and 10 in the trochlea) were treated with a Hyaluronan based scaffold seeded with 
autologous chondrocytes much like MACI (Gobbi et al. 2006). The mean subjective 
International Knee Documentation Committee (IKDC) score increased from 43.2 before 140 
 
surgery to 73.6 two years after surgery (p<0.0001). Once again trochlea lesions obtained 
better results than patella lesions (p=0.001). Although patients with osteochondritis dissecans 
experienced improvement in IKDC scores this was not significant.  
Henderson et al reported on the results of 1
st generation ACI techniques (with a periosteal 
patch) in 44 patients with patella lesions (Henderson et al. 2006). The patients were divided 
into 2 equal groups; group A (n=22) had ACI with patella realignment and group B (n=22) 
had patella ACI and normal patella tracking. Group A experienced greater increase in MCS, 
better SF-36 function and physical component scores and better overall IKDC scores than 
group B. They speculated that the difference in results may be a result of the unloading effect 
of the osteotomy, since patellar tracking is normal in the two groups after realignment. Gross 
suggested that when performing patella ACI an unloading osteotomy should be also be 
performed if the lesion is in a compartment subjected abnormal load, much like a high tibial 
osteotomy for lesions in the medial femoral condyle and varus aligned knee (Gross 2002).  
In the heterogeneous group of 45 patients reported by Minas et al 62% had distal patellar re-
alignment in the form of Fulkerson’s anteromedialization (Minas and Bryant 2005). 
Furthermore, the best functional outcome was in patients with isolated lesions in the patella 
or trochlea rather than multiple lesions (i.e patella lesion + femoral condyle lesion or multiple 
patella lesions). Similar results were reported by Pascual-Garrido et al (2009) in 52 patients. 
The authors’ divided their cohort of 52 patients into three groups; 1) isolated ACI treatment, 
2) ACI with realignment procedure, and 3) ACI with realignment procedure with history of 
failed microfracture procedure. There were no statistical differences between outcomes in 
patients with a history of a previous failed microfracture compared with those with no such 
history. Patients undergoing anteromedialisation tended toward better outcomes than those 141 
 
without realignment. However the re-operation in the whole cohort was high at 44% 
(Pascual-Garrido et al 2009). 
In the initial report of ACI by Brittberg et al., a successful outcome in patella lesions only 
occurred in 2 out of 7 patients (Brittberg et al 1994). Later reports by the same group reported 
good or excellent results in 11/17 patients at 2 years (Peterson et al 2000) and 13/17 patients 
at 10 years (Peterson et al 2002) because they address patella realignment at the time of 
chondrocyte implantation. It is clear from these studies that outcome after ACI in the patella 
is improved with patella realignment procedures if there is patella maltracking. The question 
rises as to whether outcome can be improved following patella ACI with concomitant 
anteromedialisation procedures in pure type II patella lesions or laterally based trochlea 
lesions. The only way to address this question would be to perform a randomised trial with 
one group having patella ACI in the lateral facet, normal tracking, and anteromedialisation 
procedure and another group having patella ACI in the lateral facet, normal tracking and no 
realignment procedure. This is why the conclusions by Henderson et al do not seem accurate 
as they are comparing results in two different groups of patients (Henderson et al. 2006).  
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Predictors of outcome 
 
This study has highlighted differences in outcome according to site of the lesion in the PFJ, 
as well as aetiology and number of previous operations. The GLM also highlighted site of 
lesion as the most significant predictor of outcome, such that both lateral and medial facet 
lesions are predicted to have a MCS 12 which is approximately 20 points inferior to trochlea 
lesions. In this model, patients with failed previous procedures were predicted to have a MCS 
12 that was 14.9 points less than patients with traumatic lesions though this did not reach 
statistical significance. Similarly, patients that had 2-3 operations had a MCS 12 that was 
10.5 points less than patients with 0-1 previous procedures (p=0.02). However, patients that 
had 4 or more procedures had 11.3 points less than the 0-1 group, though this was not 
significant (p=0.07). MCS 0 was the only continuous variable that predicted MCS 12. 
These results are similar to one of the largest case series of purely patellar chondral defects 
treated with ACI (Niemeyer et al. 2008). 70 patients were treated with either ACI or MACI 
(depending on surgeon preference) and the mean follow-up was 38.4 months. They reported 
good or excellent outcome in 67.1% of patients with no difference in outcome between ACI 
and MACI. They discovered defects in the lateral facet had better post-operative scores than 
defects in the medial facet or both facets. This is one of the few studies to utilise multivariate 
analysis to assess prognostic factors; defect location (p=0.02) and age (p=0.048) significantly 
affected outcome whereas defect size (p=0.068) just failed to reach statistical significance. 
Other factors such as number of previous procedures, BMI, pre-operative sports activity and 
length of follow up did not have a statistically significant effect on outcome. Analysing their 
results further, the mean defect size in the lateral facet was 4.4cm
2 whereas lesions involving 
both facets, the mean size was 6.2cm
2 (nearly 50% more). Therefore the observed difference 
in outcome could be explained by location as well as size. This is where the GLM in the 143 
 
analysis would be extremely useful as it would allow quantification of the effect the size and 
location of the lesion on outcome whilst taking into account the interaction of these two 
variables. Another a key flaw in their analysis was that they had not taken into account the 
pre-operative functional scores of the patient when performing multivariate analysis. 
 
Summary 
 
The results from this study are similar to those reported in literature when treating 
osteochondral defects of the patello-femoral joint. The results suggest that MACI is more 
efficacious than ACI when treating chondral lesions in the patella. The overall re-operation 
rate is also significantly lower in MACI patients (p=0.009) and this may reflect the 
technically challenging nature of performing ACI in patella lesions. Once again numerous 
operations prior to chondrocyte implantation should be avoided to obtain the best results. If 
patients have had a failed previous chondrocyte implantation or mosaicplasty on the patella 
then ACI should probably be avoided and MACI should be considered. 144 
 
 Chapter 5: 
Radiographic Evidence of Osteoarthritis 
 
Introduction  
 
The diagnosis of osteoarthritis (OA) is made on the basis of radiographic and clinical 
findings. The radiographic criteria were first proposed by Kellgren and Lawrence (1957) and 
this will be discussed in detail later. The American Rheumatism Association described OA as 
‘a heterogeneous group of conditions that lead to joint symptoms and signs which are 
associated with defective integrity of articular cartilage, in addition to related changes in the 
underlying bone and joint margins’ (Altman et al. 1986). Table 5.1 displays how OA is 
classified and is reproduced from the original paper (Altman et al 1986). The signs and 
symptoms described by patients with OA of the knee are well established. Evidence from 
published literature is divided as to the natural history of cartilage defects in the knee in 
patients without OA (Amin et al 2005, Cicuttini et al 2005, Wang et al 2005, Hunter et al. 
2006). However, generally, it is accepted that in patients with symptomatic cartilage defects 
in the knee, it is likely that patients will develop the full clinical spectrum of knee OA and in 
an effort to avoid performing arthroplasty in relatively young patients cartilage repair surgery 
should be performed initially (Biswal et al 2002). 
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Whilst it has been demonstrated that knee cartilage defects are prevalent in patients with 
radiographic evidence of OA (Link et al 2003), it has not been fully established whether 
asymptomatic cartilage defects are a risk factor for OA or indeed cartilage loss (Squires et al 
2003). Cartilage volume loss in the knee has been shown to be associated with worsening of 
knee symptoms (Wluka et al. 2003). Furthermore, those with knee OA who are in the highest 
tertile of knee cartilage loss have a 7-fold increased risk of requiring knee arthroplasty within 
4 years. Cicuttini et al., further demonstrated that the presence of asymptomatic chondral 
defects in the medial compartment identifies healthy individuals most likely to lose knee 
cartilage and subsequent development of knee OA (Cicuttini et al. 2004, 2005). In their 
longitudinal study, knee cartilage volume was estimated with T1-weighted fat suppressed 
magnetic resonance imaging (MRI) in 86 volunteers at base-line and at a 2-year follow up 
visit. The reduction in total cartilage volume from the tibia and femora were statistically 
significantly higher (19-25% greater) in volunteers with cartilage defects than those without 
(p<0.05). 
Davies-Tuck et al. also reported that cartilage defects in patients with symptomatic OA tends 
to progress over a two year period and factors associated with progression were increasing 
age and baseline tibial bone area (Davies-Tuck et al 2007). Cartilage defects were graded 0-4 
according to MRI and overall, 81% of defect scores increased, 15% remained unchanged and 
4% decreased. It was interesting to note that the cartilage defects scores increased in all 
compartments (p<0.001) except the lateral tibial compartment which remained largely 
unchanged. 
The treatment of patients with mild to moderate arthritic changes in the knee and the presence 
of a symptomatic chondral defect is complicated by the limited treatment options. 
Furthermore, the patients tend to be younger than those with OA requiring arthroplasty and, 147 
 
therefore, the expectations are much higher in terms of return to function and physical 
activity. Non-operative measures such as non-steroidal anti-inflammatory drugs, steroid and 
hyaluronan intra-articular injections may provide symptomatic relief, but do not prevent 
disease progression.  
Arthroscopic debridement of chondral lesions in patients with OA was widely performed  as 
it was relatively quick and minimally invasive with few complications. However, this 
procedure has been proven to be not very effective. In the landmark paper by Moseley et al. 
(2002) 180 patients with OA of the knee were randomised into three treatment groups; 
arthroscopic debridement, arthroscopic lavage or placebo surgery (patients received skin 
incision, simulated debridement without insertion of an arthroscope). Paired t-tests revealed 
no difference in knee pain and functional scores before surgery and at any of the time frames 
after surgery in any of the three groups. Furthermore at no point was there a difference in 
scores post-operatively in the three groups or a difference in the change in scores. 
There are few studies assessing cartilage repair techniques in patients with widespread 
arthritic changes. Bae et al. evaluated the clinical, radiological, histological and second-look 
arthroscopic findings in 49 knees (46 patients) that had undergone microfracture (Bae et al. 
2006). The mean age of the patients was 57 and the mean defect size was 3.9cm
2. At mean 
follow-up of 2.3 years, good to excellent results (as measured by Baumgaertner’s functional 
score) were obtained in 89% patients. Radiographic evaluation had revealed that the joint 
space had widened 1.1mm on an antero-posterior view and1.4mm on the lateral views which 
were statistically significant. Second look arthroscopy had revealed healing rates of 91-99% 
if the defects were less than 3cm
2.  Only 18 cases were evaluated histologically and all had 
appeared to have significant amount of fibrocartilage in the regenerate tissue. According to 
analysis by Western Blotting, the amount of type II collagen varied from 20-70%. There are 148 
 
several problems with this paper which leads me to question the validity of their conclusion 
that microfracture is efficacious in the treatment of full thickness chondral defects in patients 
with OA. Firstly, in the 49 cases of microfracture, 41 cases had simultaneous procedures (30 
medial menisectomies, 7 excisions of suprapatellar plica excisions, and 4 cases of lateral 
meniscal surgery). Therefore, the post-operative improvement in functional scores can not all 
be contributed towards the microfracture performed. Secondly, though there was statistically 
significant increase in joint space as measured by radiographs, I have to question the clinical 
significance of 1mm and finally only a small proportion of patients underwent histological 
(36.7%) and Western Blotting (42.9%) analysis and this may not represent the true patient 
population. 
It is generally accepted that autologous chondrocyte implantation is not efficacious when 
treating lesions in an arthritic joint, hence patients with widespread OA, or an inflammatory 
arthropathy are excluded from this treatment. However, the evidence for this is not so robust. 
One may question the ability of chondrocytes from arthritic joints to expand adequately and 
then function when implanted to the same level as chondrocytes from non-arthritic joints. In 
an ex vivo model, Stoop et al. reported similar levels of type I and II collagen production in 
chondrocytes taken from OA patients and chondrocytes taken from patients who are about to 
undergo ACI (Stoop et al. 2007). However, there was an exponentially higher level of mRNA 
production of IL-1β from OA chondrocytes compared with ‘healthy’ individuals. This 
cytokine is secreted by activated macrophages and is an important mediator of the 
inflammatory response. Furthermore, IL-1β is known to induce chondrocytes-mediated 
cartilage degradation and to reduce type II collage expression (Smith et al 1989). Bearing this 
in mind, the authors then implanted the same cells expanded and seeded on collagen scaffolds 
into immunodeficient mice to assess their ability to generate hyaline-like cartilage. Eight 149 
 
weeks after implantation, no cartilage formation was observed in the empty control scaffolds, 
whereas there was cartilage like tissue formed from cells of OA patients but not healthy 
individuals when the cell concentration was 1 X 10
6 cells/cm
2 in 1/3 donors. When the 
concentration was 3 X 10
6 cells/cm
2 all three donors exhibited cartilage formation. However, 
this concentration is 3 times higher than the current levels used in human ACI. 
In another animal model, where OA-like degenerative process was created in a rodent knee 
by transecting the ACL, a three dimensional ACI was implanted in the ‘trochlea’ region. 
Reverse transcription polymerase chain reaction analysis demonstrated the expression of type 
II collagen in the chondrocytes implanted group, but not in the groups with no chondrocytes 
present. This finding was also confirmed macroscopically and histologically (Kuroda et al. 
2011). 
Tom Minas’s group in Boston are one of the centres in which ACI is performed in the United 
States of America and the procedure is performed even in the presence of mild OA (defined 
as less than 50% joint space loss). In their review of ACI in patients with early OA, they 
reported 93% survivorship rates at 5 years with the end point being arthroplasty. There was 
also a mean improvement of WOMAC pain score of 4.9 points (51% improvement) and 
WOMAC function scores of 15.7 points (53%) (Minas et al 2010). Similar results were 
reported by others on the efficacy of ACI in treating large complex lesions and kissing 
lesions (Ossendorf et al. 2011, Kon et al 2011, Kreuz et al 2009, Osendorf et al. 2007). 
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Aims & Objectives 
 
The aim of this chapter is to investigate whether patients with evidence of early osteoarthritis 
(OA) on their pre-operative radiographs of the knee were associated with worse outcome 
following ACI than those without any evidence of OA. It was also determined whether ACI 
or MACI was effective in reducing the need for arthroplasty which is effectively an 
indication of end stage disease (OA). The rationale for performing cartilage transplant in 
patients with osteochondral defects and early OA is that once the cartilage lesion is treated 
and any unstable flaps of cartilage are removed, the progression of OA should be reduced 
and, knee function improved. 
 
A secondary aim was to assess the reliability and reproducibility of the Kellgren and 
Lawrence and the Stanmore Grading system for evaluating severity of OA in knee 
radiographs (Table 5.2 and figures 5.1 to 5.5). 
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Patients and Methods 
 
This was a retrospective case-control study of patients who had autologous chondrocyte 
implantation (ACI) or matrix-carried autologous chondrocyte implantation (MACI). 
The pre-operative radiographs of 200 patients that had undergone ACI or MACI from July 
1998 to December 2008 were randomly retrieved from archives. They were reviewed by 2 
independent observers who were blinded to the outcome of surgery and what kind of surgery 
the patient had received. The presence of osteoarthritis (OA) radiologically was determined 
and, if present, was graded according to Kellgren and Lawrence and The Stanmore Grading 
System (see table 5.2 below). The unweighted Kappa statistic was used to establish levels of 
agreement when analysing inter-observer variation. The Landis & Koch criteria was used to 
interpret results: 
 
(Landis and Koch 1977) 
–  < 0.2 slight agreement 
–  0.21 – 0.4 fair 
–  0.41 to 0.6 moderate 
–  0.61 to 0.8 substantial 
–  > 0.8 almost perfect 
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Table 5.2: The Grading Systems Used to Assess OA 
Grade  Kellgren & 
Lawrence 
Stanmore Grade 
0   No arthritis   No arthritis  
1   Doubtful   Joint space narrowing  
2   Minimal   Presence of osteophytes  
3   Moderate   2 + subchondral sclerosis  
4   Severe   3 + early bone loss with or without subchondral 
cysts  
5     4 + joint disorganization + destruction  
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Figure 5.1: Radiograph showing Stanmore grade I changes – joint space narrowing 
 
 
Figure 5.2: Stanmore grade II – Osteophyte formation 
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Figure 5.3: Stanmore Grade III – subchondral sclerosis 
 
 
Figure 5.4: Stanmore grade IV – Bone cyst 155 
 
Figure 5.5: Stanmore grade V – joint destruction 
 
Figures courtesy of G. Bentley (personal communication) 
 
Knee function before and after surgery was assessed according to the Modified Cincinnati 
Score (MCS). An attempt was made to contact all patients who had their radiographs 
reviewed by telephone or post so that the most up to date MCS was also available, as 
generally after 2 years patients were failing to attend their clinical appointments. 
An earlier pilot study enabled us to perform sample size calculations. With α = 0.05 and β = 
0.2 (hence a power of 80%), a total of 116 patients would be required (58 in each group) to 
detect a difference of 10 points in the Modified Cincinnati Score. 156 
 
Results 
 
The patient and lesion characteristics in the two treatment groups are summarised in table 5.3. 
The latest MCS was available in 158 patients. Patients with radiographic evidence of OA had 
experienced a statistically significant greater number of operations prior to ACI or MACI. 
The duration of symptoms and size of lesions were greater in this group of patients (though 
the p value was low it was not statistically significant). 
 
Table 5.3: Patient and lesion characteristics 
  No OA   
                   
OA  p value 
Age  33.6 +/- 1             35.1 +/- 0.8                 0.25 
Percentage males  52%  56%  0.9 
Proportion of ACI 
procedures 
54.5%  41%  0.17 
Length of symptoms 
(months) 
81 +/- 12.2  112.6 +/-12.1  0.07 
Number of previous 
operations 
2.13 +/- 0.25         3.18 +/- 0.27  0.006 
Size of lesion (mm
2)  449 +/- 42.3           566 +/- 45.8  0.06 
Modified Cincinnati 
Score pre-operatively 
(MCS 0) 
51.4 +/- 1.8  40.6 +/- 1.7  < 0.001 
Time to follow-up 
(months) 
38 +/-  1  48 +/- 2.9  0.04 
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The distribution of lesions in the two groups anatomically is shown in table 5.4. The majority 
of lesions were on the medial femoral condyle. There were no discrepancies between the two 
groups. 
Table 5.4: Anatomical site of chondral lesions according to treatment groups 
Anatomical site  No OA  OA 
Lateral femoral condyle  8 (16%)  4 (10%) 
Medial Femoral Condyle  28 (56%)  22 (53.5%) 
Trochlea  3 (6%)  1 (2.5%) 
Patella single defect  7 (14%)  9 (22%) 
Patella multiple defects  4 (8%)  5 (12%) 
TOTAL  50  41 
 
The aetiology of the lesions in the two groups is shown in table 5.5. In the OA group a 
greater proportion of patients had a failed previous mosaicplasty or previous ACI and this 
was statistically significant (p=0.01). 
 
Table 5.5: Aetiology of lesions according to treatment groups 
Aetiology  No OA  OA 
Trauma   19 (57.5%)  14 (38%) 
Osteochondritis dissecans  9 (27%)  2 (5.4%) 
Chondromalacia patellae  3 (9%)  3 (8%) 
Failed previous procedure  2 (6%)  18 (49%) 
TOTAL  33  37 
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Figure 5.6: The Modified Cincinnati Scores in patients with and without osteoarthritis 
 
 
The Modified Cincinnati Scores (MCS) before and after surgery are shown in figure 5.6 for 
descriptive purposes. Figure 5.7 shows that two years after surgery, patients with no 
radiographic evidence of OA were likely to increase their MCS by twice as much as those 
with evidence of OA.  However, it was interesting to note that patients with OA still 
experienced a clinically significant 10 point increase in MCS (although this was not 
statistically significant). At the latest follow up (mean 43 months), both groups experienced 
significant increases in MCS from the baseline, though the increase in MCS was greater in 
the No OA group which was significant (independent t-test to compare increase in MCS from 
baseline between two groups, p=0.01). 159 
 
Figure 5.7: The Change in Modified Cincinnati Scores in Paired Groups 
 
 
 
The proportion of good and excellent results according to MCS is displayed in Table 5.6. The 
results were significantly better in the No OA group compared with the OA groups at all time 
frames. Two years following surgery, Good to Excellent results were achieved in 71% 
patients with no OA compared with 30% with OA (no excellent results). At the time of latest 
clinical review (mean 50 months) the results were similar (69% versus 40.5%). Of note, the 
results were better in the OA group at the latest follow-up compared with the 2 year results, 
but this may simply be because of the greater sample size at final follow-up. 
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Table 5.6: Proportion of Good and Excellent results according to MCS 
Time  Outcome  No OA  OA  p value 
 
 
1 year 
Excellent  11 (37%)  2 (6%)   
 
0.01 
Good  7 (23%)  8 (22%) 
Fair   2 (7%)  12 (33%) 
Poor  10 (33%)  14 (39%) 
Total  30  36 
 
 
2 years 
Excellent  10 (42%)  0   
 
0.008 
 
Good  7 (29%)  7 (30%) 
Fair   4 (17%)  8 (35%) 
Poor  3 (12%)  8 (35%) 
Total  24  23 
 
 
Latest 
Follow Up 
Excellent  33 (53%)  16 (16.5%)   
 
0.0004 
 
Good  10 (16%)  23 (24%) 
Fair   11 (18%)  40 (41%) 
Poor  8 (13%)  18 (18.5%) 
Total  62  97 
The p value is generated from performing the Fisher’s exact test to compare the proportion of good 
or excellent clinical outcome according to the MCS in patients with radiographic OA and those 
without OA. 161 
 
Further procedures 
 
Table 5.7: Major Re-operations 
Procedure  No OA 
(n=95) 
OA 
(n=84) 
Revision ACI/MACI  2  7 
Patellectomy  1  0 
High Tibial Osteotomy  3  8 
Unicompartmental or 
Patellofemoral Replacement 
1  15 
Total Knee Replacement  2  3 
Others (including 
microfracture, mosaicplasty) 
0  6 
Total  12  
(13.6%) 
36  
(42.9%) 
 
Kaplan-Meier survivorship analysis was performed from the date of the second stage 
operation to the end-point of re-operation for the above indications. Table 5.8 shows the 3, 5, 
7 and 8 year survivorship figures and figure 5.8 displays the plot. The log-rank test was used 
to compare whether there was a significant difference in re-operation rates between patients 
with radiographic evidence of OA and those without. As predicted, the survivorship was 
significantly better at all time frames in the No OA group. Figure 5.8 shows that the overall 
survivorship was significantly better in the No OA group according to the log rank test 
(p=0.005). However, it is not known whether it is osteoarthritis that is contributing to the 
inferior clinical results of survivorship or other discrepancies within the OA group, such as 162 
 
greater number of previous procedures, larger lesions and longer duration of symptoms. 
Therefore the Generalised Linear Model was used to account for these variables. 
 
Table 5.8: Survivorship figures according to Kaplan-Meier Analysis 
Time   No OA  OA 
3 years   93.8% +/- 3  76.2% +/- 5.1 
5 years  87.1% +/- 4.7  51.6% +/-6.7 
7 years  82.7% +/- 6  49.3% +/-6.7 
8 years  78.2% +/- 7.3  26.6% +/- 8.9 
The probability of survivorship (i.e. not requiring revision surgery or major re-operation) is 
shown as a percentage with the standard error of mean. 
 
Figure 5.8: Kaplan-Meier Survivorship Analysis of Patients with OA and without OA 
p=0.005  p value derived from log rank test. 163 
 
Generalised Linear Model (GLM) 
 
The dependent variable in this model was the latest MCS. Once again 2 GLMs were created. 
In the first GLM, the categorical variables were type of surgery (ACI or MACI) and the 
presence or absence of OA. The continuous variables were MCS 0 and age. The results can 
be seen below. 
 
Table 5.9: Categorical Variable Information 
  N  Percent 
 
Type 
ACI  61  48.0% 
MACI  66  52.0% 
Total  127  100.0% 
OA 
No OA  50  39.4% 
OA  77  60.6% 
Total  127  100.0% 
 
 
 
 
Table 5.10: Continuous Variable Information 
  N  Minimum  Maximum  Mean  Std. 
Deviation 
Dependent Variable  Latest MCS  127  10  100  56  26.3 
Covariate 
MCS      0  127  10  88  44.4  18.1 
Age  127  16  55  34.8  8.8 
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Table 5.11: Results of the Limited Generalised Linear Model (GLM) 
Parameter  Magnitude 
of effect 
Std. Error  95% Confidence Interval 
Lower  Upper  Sig. 
           
ACI  0.8  3.64  -6.4  7.9  0.8 
MACI  0
a  .  .  .  . 
No OA  8.8  3.9  1.2  16.4  0.02 
OA  0
a  .  .  .  . 
Continuous  
MCS0 
 
0.7 
 
0.1 
 
0.5 
 
0.9 
 
<0.001 
Age  -0.7  0.2  -1.1  -0.3  0.001 
          
0
a  represents the reference category for comparison of other categorical data within the group. 
 
Both age and the pre-operative MCS were significant factors. Patients with no OA were 
likely to have a MCS at latest follow-up that is nearly 9 points greater than patients with OA 
independent of the other mentioned variables in the model. 
In the next GLM, there were four main aetiologies; traumatic, osteochondritis dissecans 
(OD), chondromalacia patellae (CP) and failed previous ACI/mosaicplasty. As there were so 
few patients in the OD and CP groups, it was decided to group patients according to whether 
they had failed previous surgery or not. Other categorical prognostic factors in the analysis 
included presence of OA, ACI or MACI procedure, and anatomical site of the lesion. The co-
variates in the analysis included the pre-operative MCS, age, and duration of symptoms. 
Table 5.12 displays a breakdown of the number of patients for each of the categorical 
variables. 
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Table 5.12: Categorical Variable Information 
  N  Percent 
 
Type of surgery 
ACI  38  52.1% 
MACI  35  47.9% 
Total  73  100.0% 
Presence of OA 
No  25  34.2% 
Yes  48  65.8% 
Total  73  100.0% 
Previous Failed  
ACI/Mosaicplasty 
No  42  57.5% 
Yes  31  42.5% 
Total  73  100.0% 
Site 
LFC/Trochlea  12  16.4% 
Patella  24  32.9% 
MFC  37  50.7% 
Total  73  100.0% 
ACI = autologous chondrocytes implantation, MACI = Matrix-carried autologous chondrocytes 
implantation, LFC = lateral femoral condyle, MFC = medial femoral condyle 
 
 
Table 5.13:  Continuous Variable Information 
  N  Minimum  Maximum  Mean  Std. 
Deviation 
  Latest MCS  73  10  100  49.2  26.8 
Covariate 
MCS      0  73  10  88  39.3  17.3 
Age  73  17  49  35.4  8.2 
  Duration symptoms 
(months) 
73  6  360  107  87 166 
 
 
Table 5.14: Results of the Generalised Linear Model 
Parameter  Magnitude 
of effect 
Std. Error  95% Confidence Interval  Hypothesis 
Test 
Lower  Upper  Sig. 
Type of surgery           
ACI  -1.1  4.4  -9.8  7.6  0.8 
MACI  0
a  .  .  .  . 
 
Presence of OA 
No OA 
 
 
6.1 
 
 
5.2 
 
 
-4 
 
 
16.3 
 
 
0.2 
OA  0
a  .  .  .  . 
 
Previous failed surgery 
No 
 
 
0.7 
 
 
5.9 
 
 
-12.2 
 
 
10.8 
 
 
0.9 
Yes  0
a  .  .  .  . 
 
Site of defect 
LFC/Trochlea 
 
 
11.9 
 
 
6.3 
 
 
-0.4 
 
 
24.2 
 
 
0.05 
Patella  1.6  5.1  -8.4  11.6  0.75 
MFC  0
a  .  .  .  . 
 
Continuous variables 
MCS0 
 
 
0.8 
 
 
0.15 
 
 
0.5 
 
 
1.1 
 
 
<0.001 
Age  -1.2  0.27  -1.8  -0.72  <0.001 
Duration of symptoms  -0.02  0.03  -0.07  0.04  0.5 
(months)          
Dependent Variable: Latest MCS 
LFC=lateral femoral condyle, MFC=medial femoral condyle, MCS 0 = pre-operative MCS 
0
a  represents the reference category for comparison of other categorical data within the group. 
 
 
 
Table 5.14 shows that the presence of OA has no significant effect on outcome when other 
variables were introduced into the model. In the first model, the presence of OA predicted an 
approximate 9 point decrease in the latest MCS. The number of patients with complete data 
set decreases as more variables are introduced. It may be that by introducing more variables 167 
 
into the GLM the power of the statistical model decreases and hence an increase in the 
chance of a type II statistical error. 
There was also no difference in outcome between ACI and MACI patients in this model. 
Interestingly, there was no difference in outcome in patients according to whether they had a 
failed previous procedure or not. Site was a significant factor. The MCS in patients that had 
trochlear or lateral femoral condyle lesions were on average nearly 12 points greater than in 
patients in which the lesions were in the medial femoral condyle. As predicted from previous 
models, MCS 0 was the strongest predictor of outcome, with a 1 point increase in MCS 0 
likely to predict a 0.8 increase in the latest MCS.  
Age was also a strong predictor; as the patients’ age increases by a year, the MCS was 
predicted to decrease by 1.2. 
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Inter-Observer Variation 
One hundred and fifteen radiographs were reviewed by two independent observers. The table 
below displays the results for each individual observation. 
The inter-observer variation using the Kellgren & Lawrence Grading system only resulted in 
a fair agreement (Kappa=0.31). However, when the Stanmore Grading System was used, 
there was substantial agreement (Kappa=0.72).  
 
Table 5.15: Inter-observer variation  
Patient 
number 
K&L Grade 
Observer 1 
 K&L 
Grade 
Observer 
2 
Stanmore Grade 
Observer 1 
Stanmore Grade 
Observer 2 
1  2  2  1  1 
2  0  0  0  0 
3  0  0  0  0 
4  3  2  2  2 
5  2  2  1  1 
6  2  2  1  1 
7  1  2  2  2 
8  0  0  0  0 
9  2  3  2  2 
10  0  0  0  0 
11  0  0  0  0 
12  0  0  0  0 
13  2  2  1  1 
14  0  0  0  0 
15  0  0  0  0 
16  0  1  0  1 
17  0  0  0  0 
18  0  0  0  0 
19  0  1  0  1 
20  0  0  0  0 
21  0  0  0  0 
22  0  2  0  1 
23  0  0  0  0 
24  0  0  0  0 
25  0  0  0  0 
26  1  1  1  0 
27  0  1  0  0 
28  0  2  0  1 169 
 
Table 5.15 continued 
Patient 
number 
K&L 
Grade 
Observer 
1 
 K&L 
Grade 
Observer 
2 
Stanmore Grade 
Observer 1 
Stanmore Grade 
Observer 2 
29  3  2  2  2 
30  0  0  0  0 
31  1  2  1  1 
32  0  0  0  0 
33  0  2  0  2 
34  0  1  0  0 
35  0  0  0  0 
36  0  0  0  0 
37  0  0  0  0 
38  3  3  3  3 
39  0  1  0  1 
40  2  3  3  3 
41  1  2  1  1 
42  1  1  0  0 
43  0  0  0  0 
44  2  3  2  2 
45  1  1  1  1 
46  0  1  0  0 
47  0  2  0  1 
48  2  3  3  3 
49  0  1  0  1 
50  1  0  1  1 
51  1  1  1  1 
52  1  2  2  2 
53  0  0  0  0 
54  0  0  0  0 
55  0  2  0  2 
56  2  1  1  1 
57  0  1  0  0 
58  0  1  0  0 
59  2  3  2  2 
60  0  0  0  0 
61  0  0  0  0 
62  2  3  3  3 
63  0  1  0  0 
64  0  1  0  0 
65  0  0  0  0 
66  0  0  0  0 
67  0  0  0  0 
68  0  0  0  0 
69  0  0  0  0 
70  0  0  0  0 
71  0  0  0  0 
72  0  2  0  1 
73  0  0  0  0 
74  0  1  0  0 170 
 
Table 5.15 continued 
Patient 
number 
K&L 
Grade 
Observer 
1 
 K&L 
Grade 
Observer 
2 
Stanmore Grade 
Observer 1 
Stanmore Grade 
Observer 2 
75  0  0  0  0 
76  0  0  0  0 
77  0  0  0  0 
78  1  0  0  0 
79  0  0  0  0 
80  0  0  0  0 
81  0  0  0  0 
82  0  0  0  0 
83  0  1  0  0 
84  1  2  1  1 
85  0  0  0  0 
86  3  2  2  2 
87  0  0  0  0 
88  2  2  1  1 
89  0  0  0  0 
90  0  0  0  0 
91  0  0  0  0 
92  0  2  0  1 
93  0  0  0  0 
94  0  0  0  0 
95  0  2  0  1 
96  0  0  0  0 
97  0  0  0  0 
98  0  0  0  0 
99  0  0  0  0 
100  0  0  0  0 
101  0  0  0  0 
102  0  0  0  0 
103  0  2  0  1 
104  0  0  0  0 
105  0  0  0  0 
106  1  2  2  2 
106  0  0  0  0 
108  0  2  0  1 
109  0  1  0  0 
110  0  0  0  0 
111  2  1  1  1 
112  0  0  0  0 
113  0  0  0  0 
114  0  0  0  0 
115        0  0 
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Discussion 
The initial results from this chapter suggest that Autologous Chondrocyte Implantation (ACI) 
is not as effective in patients with radiographic evidence of osteoarthritis (OA). The Modified 
Cincinnati Scores (MCS) were lower in the OA group at all time frames but the greatest 
discrepancy occurred at the longest interval following surgery (MCS Latest). Furthermore, 
when the paired data was analysed, although the OA group experienced an increase in MCS 
from their pre-operative status, this increase was statistically lower than the No OA group. 
Similarly, there was a greater proportion of good and excellent results at 1, 2 and latest follow 
up in the No OA group than the OA group.  
Using Minas et al classification (Minas et al 2009), simple isolated OCDs situated on the 
femoral condyles measuring less than 4cm
2 are termed simple lesions. Defects that are larger 
than 4cm
2 on the femoral condyles or any sized lesions in the patella, trochlea, or tibia are 
defined as complex. Kissing lesions and knees with evidence of early osteoarthritis are 
termed salvage. Niemeyer reported on the 2-year clinical results of a membrane seeded ACI 
in 59 patients with OCD in the knee (Niemeyer et al. 2010). They sub-divided their patients 
into three groups; isolated defects (group A), complex defects (group B), and salvage defects 
(group C – patients with signs of OA or kissing lesions). A significantly better IKDC score 
was reported in group A compared with group C patients. However, 11/15 patients in group 
C reported significant improvement (greater than 10 points) at 24 months following surgery. 
The overall failure rate (defined as improvement in IKDC score of < 10 points or worsening 
knee function) in this group was 17% though the failure rate was significantly lower in group 
A (5.9%) compared with groups B and C (40%). This group claim that although the ACI 
surgery is inferior in patients with OA compared to those patients with single defects, it 172 
 
should still be considered, especially in young patients in which arthroplasty surgery is the 
only other alternative. 
Minas et al. specifically analysed the minimum 2-year results of ACI in patients with 
radiographic evidence of OA. Their definition of early OA was peripheral intra-articular 
osteophyte formation and/or 0-50% joint space narrowing (Minas et al 2010). Clinically, 
patients were included in the study if they had normal radiographs but kissing lesions or 
generalised chondromalacia was present on arthroscopy. It was interesting to note that out of 
the 328 patients that had 2-year results, 153 had early OA as defined by their criteria. Paired 
t-test revealed statistically significant improvements in all 5 scoring systems at 2 years 
following surgery and a mean of 5 years after surgery. Furthermore, they reported 93% 
survivorship at 5 years with the end point being revision with arthroplasty. However, their re-
operation rate was considerably higher at 61%, mainly for the need to address graft 
hypertrophy, as they were still using autologous periosteum to contain the chondrocytes. The 
results seem very good in this study, in a cohort of patients that are similar to the ones in this 
chapter. However, this was a heterogeneous group of patients, as 103 patients had 
simultaneous procedures performed, including High Tibial Osteotomy (47) and Tibial 
Tubercle Osteotomy (44). Therefore one cannot state for certain whether the improvement in 
function was because of surgery to address the chondral defect or the simultaneous procedure 
performed to correct malalignment and other pathology.  
Kreuz et al. also stated that second-generation ACI techniques were efficacious in the 
treatment of focal degenerative cartilage defects. Nineteen patients with Kellgren and 
Lawrence grade II osteoarthritis in their pre-operative radiographs were followed up for 4 
years (Kreuz et al. 2009). There were statistically significant improvements in all three 
scoring systems used to assess knee function 6 months following surgery which was 173 
 
maintained at the time of the latest follow-up. However, 47% patients (9 out of 19) had to 
have a second operation (usually in the form of arthroscopic debridement for symptoms like 
grinding, pain and swelling). 21% of patients (4 out of 19) had to have revision surgery or 
knee arthroplasty. The overall re-operation rate seems particularly high given that periosteum 
grafts were not used, though the revision surgery rate is similar to results from this study in 
this difficult cohort of patients. 
Nehrer et al (2009) treated 53 patients with a hyaluronan-based scaffold seeded with 
autologous chondrocytes similar to MACI. These cohorts of patients’ knees were composed 
of 23 simple lesions, 22 complex and 8 salvage lesions. They further divided their patients 
into those with a primary indication for surgery (42 patients with stable, normally aligned 
knee, with single OCD and age under 55) and secondary indication (11 patients (including 7 
salvage cases) with more complex problems such as osteonecrosis following chemotherapy). 
They reported significant improvements in three scoring systems from pre-operative status in 
the primary indication group which was maintained at 7 years. The secondary indication 
group reported significant improvement at 2 years but the results declined to pre-operative 
status from 3 years onwards. The results from this chapter are similar. Graph 2 shows that 
there was significant increase in MCS at 2 years but at the time of latest follow-up, although 
there was still an increase it was not significant. Furthermore, Kaplan-Meier analysis of 
simple, complex and salvage cases revealed a 5 year survival of 95%, 75% and 12.5% 
respectively. Therefore the outcome in patients with early OA in terms of delaying 
arthroplasty is not good and the results from this chapter mirror this. Once again precaution 
needs to be taken when interpreting these results as a number of confounding variable were 
not addressed in this study. Patients with salvage procedure were older. Also, 11 patients had 
simultaneous procedures (such as HTO or ACL reconstruction) and it is not described how 174 
 
many of these procedures were performed in each group. Certainly the results from this 
chapter suggest that age is more of an important determinant than OA (Generalised Linear 
Model). Two studies have reported on the efficacy of ACI in patients older than 40 and 45 
years of age but with no evidence of OA (Kon et al. 2011, Rosenberger et al 2008). They 
concluded that although the patients’ satisfaction and function did improve at mean follow-up 
period of 4.7 years, the results were significantly inferior to younger patients that the authors’ 
had reported on previously. Once again, a number of confounding variables leads me to 
question the validity of their conclusions, namely the lack of younger patient cohort! 
 
Hollander et al performed histological analysis of 23 patients’ OCDs in the knee treated with 
Hyalograft C (a MACI type repair procedure) (Hollander et al 2006). Nine out of 14 patients 
had radiographic evidence of OA. Paradoxically, the repair tissue was mature hyaline 
cartilage in 36% of biopsies taken from non-arthritic joints and 67% of biopsies from arthritic 
knees. Even more surprising, was that in the 3 knees that were graded as severe OA 
radiographically, the repair tissue in 2 was hyaline. These initial results suggest that the 
presence of OA in the knee does not inhibit the maturation of implanted autologous 
chondrocytes. Furthermore, the type II collagen and proteoglycan content was significantly 
higher in biopsies from arthritic joints. These histological and biochemical analysis together 
imply that the presence of OA does not inhibit tissue regeneration but rather may improve it. 
Could it be that arthritic, degenerate tissue are primed for repair and require only appropriate 
cellular cues and the necessary substrate for regeneration? It was unfortunate that these 
histological and biochemical results were not correlated with the patients’ functional results. 
In addition, no functional studies were performed to determine the mechanical stability of the 
repair tissue. The key criticism in the data analysis of the patients in this chapter is the lack of 
histological information. This will be reviewed in the discussion chapter. 175 
 
Joint haemostasis and the composition of synovial fluid are of key importance in cartilage 
regeneration, particularly in the presence of osteoarthritis. Periosteum is known to drive 
chondrogenesis and in a goat model, better repair was seen in OCDs when the lesion was 
covered in periosteum compared to those that were not (Saris et al 2003). Similarly, synovial 
fluid improves chondrogenesis after chondrocytes implantation in a rabbit model (Neidel and 
Schulz 2000). In humans, synovial fluid from patients with acute traumatic OCDs have been 
shown to stimulate chondrogenesis, whereas, patients with chronic lesions inhibit cartilage 
proliferation (Rodrigo et al 1995). I suspect that the cytokine milieu in chronic traumatic 
lesions is considerably different to acute lesions and is one of the reasons why there is a 
discrepancy in results. The pro-inflammatory status of cytokines in the synovial fluid in 
patients with osteoarthritis is not beneficial for cartilage repair (Schlaak et al 1996, Scanzello 
et al 2009).  
 
Inter-observer variability 
Kellgren and Lawrence first described the radiological classification for osteoarthritis in the 
hand (Kellgren and Lawrence 1957). This was later adopted by the World Health 
Organisation in Rome as the standard for description of osteoarthritis in any joint. Several 
different versions of the original scoring system exist in the literature though none of them 
have been validated. The scoring system proposed by us seems logical as it corresponds to 
the pathological process occurring in the knee. This has not been published previously.  The 
substantial agreement using the Stanmore Grading system (k=0.7) suggests that this is easier 
to use than the Kellgren and Lawrence Scoring system which only had fair agreement 
(k=0.3).  176 
 
Conclusion 
The results from this chapter suggest that ACI is not as effective in treating OCDs in the 
knees of patients with early osteoarthritis as it is in patients without. The initial analysis 
revealed quite marked differences in results. Even the first GLM, adjusting for some of the 
confounding variables, patients without OA were predicted to have a MCS which is 8.8 
points better than patients with OA. When other confounders were included in the analysis, 
OA no longer became a significant predictor of outcome. Age was not a significant factor in 
Chapter 4 but was in Chapter 3. It may be that age in the presence of OA is significant but 
otherwise not. 
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Chapter 6:  
Smoking, Body Mass Index and Physical 
Activity 
 
Introduction  
 
The previous chapters have discussed factors that are not modifiable, such as the MCS before 
surgery or the size of the lesion. This chapter will investigate the effects of three factors 
which can be influenced before surgery to ascertain whether they have an effect on outcome 
following surgery; smoking, physical activity and weight of the patient (measured as the body 
mass index [BMI]).  
In a large Finnish prospective study, multivariate analysis revealed higher age, being 
overweight, smoking and previous knee injuries as significant predictors of incidental knee 
pain (Miranda et al 2002). Of the 2122 employees in a forestry company, 214 (10%) 
developed severe knee pain in one year. The odds ratio (OR) of developing knee pain if the 
BMI was greater than 29 (compared to BMI of 26 – 29.9) was 1.8 (p=0.02). The odds ratio 
was similar if the employees were smokers or ex-smokers compared to non-smokers 
(OR=1.6, p=0.01). In this model, previous knee injury was the greatest risk factor for 
developing knee pain (OR=2.4, p=0.0001). It was interesting to note that in this study, the 
amount of general physical exercise or the practise of different sports was not related to the 
one year incidence of knee pain or the persistence of knee pain. 
Another epidemiological study examined the relationship between knee osteoarthritis leading 
to arthroplasty and being overweight, smoking and hormone therapy (Sandmark et al 1999). 178 
 
Women with a high BMI at the age of 40 had a relative risk (RR) of 9.2 of developing knee 
arthrosis and men had a RR of 3.2. At the age of 50, the RR was 7.8 for women and 5.9 for 
men. Smokers were less likely to develop knee osteoarthritis (OA) leading to knee 
arthroplasty than non-smokers (RR=0.6, 95% confidence interval 0.4 to 1).  This effect 
appeared to be dose dependent as heavy smokers had a stronger inverse relation than light 
smokers (defined as less than 15 pack years). This ‘protective’ effect of smoking on knee OA 
has been described in earlier studies though the mechanisms by which this occurs is yet to be 
discovered (Felson et al 1989, Davis et al 1990, Hart and Spector 1993). Sandmark and 
colleagues also assessed the effects of physical work load and participation in sporting 
activities (divided into 3 classes) on the development of knee OA and found no effect 
(Sandmark et al. 1999). 
In a large epidemiological study of over 320,000 male construction workers in Sweden there 
was a doubling of the risk for having severe osteoarthritis of the knee with an increase of 
BMI of 5 Kg/m
2 (Jarvolm et al 2005). Similar to the findings of Sandmark et al., non-
smokers had a relative risk of 40% for OA of the hip though this effect was not evident in the 
development of knee OA.   
With these epidemiological studies in mind, the effects of these confounding variables on the 
outcome following orthopaedic surgery will be discussed in more detail. 
 179 
 
1. Smoking 
Smoking is a well-established risk factor for cardiovascular and respiratory disease. It also 
has deleterious effects on wound healing (Sorenson et al 2005, Manassa et al. 2003). More 
recently, cigarette smoking has been associated with musculoskeletal problems, such as 
progression of knee osteoarthritis, low-back pain and degenerative disc disease (Amin et al. 
2007, Goldberg et al. 2000, Deyo et al. 1989).  In orthopaedics, smoking is associated with 
worse clinic results following rotator cuff repair, ACL reconstruction, hind foot fusion, spinal 
fusion, hemicallotasis and hip and knee arthroplasty (Glassman et al. 2000, Moller et al. 
2003, Ishikawa 2002, W-Dahl et al. 2004, Karim et al. 2006, Mallon et al. 2004) 
Cigarette smoke has two phases: a volatile phase and a particulate phase. During the 
predominant volatile phase, nearly 500 different gases are released (which include nitrogen, 
carbon monoxide and hydrogen cyanide). In the particulate phase, nearly 3500 chemicals are 
released and as water is removed the particulate matter that remains, or ‘tar’, contains the 
majority of the carcinogens of cigarette smoke (Porter et al. 2001). Nicotine (the addictive 
component of cigarette smoke) has been implicated in the pathogenesis of a variety of 
diseases by increasing platelet aggregation, decrease microvascular prostacyclin levels, and, 
perhaps more importantly in surgery, inhibiting the function of fibroblasts, red blood cells 
and macrophages (Jorgensen et al 1998, Zevin et al 1998).  
Despite these associations, a comprehensive literature review failed to identify any 
publications on the effects of smoking on the outcome after ACI for the treatment of OCDs of 
the knee.  
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2. Body Mass Index 
Over the last two decades, the impact of certain risk factors such as ageing and BMI in OA 
has been actively studied.  The general consensus in the literature is that a high BMI raises 
the risk for the development of knee OA and the relative risk varies from 1.6 to 9.2 
(Holmberg et al. 2005, Anandacoomarasamy et al. 2009, Felson 1996, Manek et al. 2003, 
Manninen et al. 2004, Janssen & Mark 2006, Miranda et al. 2002, Sandmark et al. 1999, 
Gabay et al. 2008). A more recent study suggested that a high BMI was associated with 
accelerated rate of joint space narrowing, a radiographic indicator of severity of OA 
(Benichou et al. 2010).  
It is widely believed that obesity increases subchondral bone stiffness, hence transmitting 
more force to the articular cartilage, suggesting an injury mechanism with obesity as a risk 
factor (Dequeker et al. 1983, Felson et al. 1988). Ford et al. described a dose-response 
relationship between BMI and meniscal injury requiring surgery in middle-aged and older 
adults (Ford et al. 2005). With a reference category of a BMI of 20-22.49, the odds ratio of 
men sustaining a meniscal injury is 3 if the BMI is 27.5-29.99, 4.8 if the BMI is 30-32.49 and 
14.6 if the BMI is greater than 40. Similar results are seen in women with an odds ratio of 
24.3 if the BMI is greater than 40 (Ford et al 2005). Furthermore, obese patients (BMI greater 
than 30) were 2.5 times more likely to develop OA following menisectomy than case 
matched controls (Englund and Lohmander 2004).  
Several studies have indicated excessive weight as being a negative predictor of success of 
total knee arthroplasty whilst there are number of other studies which have reported no effect 
(Aglietti and Rinonapoli 1984, Ahlberg and Lunden 1981, Dannenmaier et al. 1985, Stern 
and Insall 1990, Griffin et al. 1998, Pritchett and Bortel 1991, Winiarsky et al. 1998, Bordinie 
et al. 2009, Jarvenpaa et al. 2010). Several other studies have reported lower functional scores 181 
 
in obese patients when compared to matched controls but the absolute improvement from 
pre-operative status was similar in both groups (Spicer et al. 2001, Foran et al. 2004, Amin et 
al. 2006, Jarvenpaa et al. 2010) 
The results following unicompartmental knee replacement (UKR) in obese patients are 
clearer. At an average follow up of 40.2 months, a BMI of greater than 32 did predict early 
failure in patients who had undergone UKR for medial compartment disease (Berend et al. 
2005).  
Similarly, the revision rate following patellofemoral replacement was significantly greater in 
obese patients compared to non-obese (van Wagenberg et al. 2009). 
To date, there are no studies in the literature assessing the effect of weight or BMI on 
cartilage repair when treating chondral defects in the knee. What is evident is that the obese 
patients are more likely to suffer from OA and also at an earlier age. This is postulated to be 
as a result of increased mechanical stresses the articular cartilage has to endure in weight 
bearing joints of such patients. Numerous in vitro studies have demonstrated that 
chondrocytes are sensitive to mechanical signals induced by loading and that moderate 
exercise is beneficial for cartilage constitution (Roos & Dahlberg 2005). However, excessive 
stresses or static stress disrupts the anabolic/catabolic balance in cartilage (Sharma et al. 
2007). It may be that obese patients experience more static stress when involved in physical 
activity and hence are more predisposed to OA and worse outcome after knee surgery. 
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3. Physical Activity  
The promotion of physical activity has been a recent world-wide public health initiative in 
developed countries. Increased physical activity is thought to protect against a number 
conditions such as cardiovascular disease, obesity and osteoporosis. There have been 
conflicting results from cross-sectional studies examining the effects of physical activity on 
knee health. Middle aged physical education teachers were reported to have less radiological 
evidence of OA than aged matched controls (White et al. 1993). Conversely, ex-elite female 
athletes had higher rates of radiographic OA than a control group (Spector et al. 1996). There 
are similar discrepancies in longitudinal radiographic studies. Results from the Framingham 
Heart Study showed that recreational exercise had no effect on the radiological status of older 
healthy adult knee joints (Felson et al. 2007). However, an Australian prospective study 
revealed that the average level of physical activity was independently associated with the 
development of radiographic knee OA (Szoeke et al. 2006). These inconsistent results are 
probably a result of the fact that the primary outcome measure is radiographic evidence of 
OA.  Whilst some studies have found an increased rate of osteophyte formation in exercising 
individuals (Spector et al. 1996), others have found no change in joint space (Felson et al. 
2007). Furthermore, it is well known that some people with radiographic evidence of OA 
have no symptoms, and others, with minimal or no OA visible have severe symptoms. 
The effect of physical activity on healthy adult cartilage (no previous injury or knee disease) 
has been assessed by cross-sectional studies utilising MRI (Hanna et al. 2007, Racunica et al. 
2007). Both studies indicate vigorous activity (i.e. activity leading to sweating, breathlessness 
or an increased pulse rate) was associated with increased tibial cartilage volume. 
Inactivity has been shown to be detrimental to articular cartilage health and development. 
Physically less active children have been shown to have less cartilage and gain less cartilage 183 
 
over 2 years than active children (Jones et al. 2003). This finding has important implications 
(particularly on the rehabilitation process following ACI), as the cartilage repair process 
following ACI is similar to cartilage development in children. Inactive adults (e.g. 
quadriplegics) have suffered from rapid cartilage loss within the initial 12 months of 
immobility (Vanwanseele et al. 2002).  Cartilage receives its nutrition from synovial fluid 
and movement of the joint is required in order for synovial fluid to move in and out of 
hyaline cartilage. Hence, the rehabilitation following ACI should take these observations into 
account (i.e. early range of motion exercises). 
Chondral and osteochondral lesions of the knee are especially common amongst those 
partaking in sporting activity (Smith et al. 1995). Up to a quarter of all knee injuries resulting 
in haemarthrosis are associated with cartilage damage (Curl et al. 1997). Participation in 
recreational and competitive sporting activities has been associated with increasing incidence 
of articular cartilage damage to the knee (Curl et al. 1997, Levy et al. 1996, Messner et al. 
1996, Piasecki et al. 2003). The chondral injuries in this cohort of patients often occur with 
other knee injuries, and have been described in up to 50% of athletes undergoing anterior 
cruciate ligament (ACL) reconstruction (Curl et al. 1997, Drongowski et al. 1994, Piasecki et 
al. 2003). Though athletes have been able to return to sporting activity after some form of 
cartilage repair, over time, knee function and athletic activity has declined (Messner et al. 
1996, Mithoefer et al. 2009). Furthermore, in high demanding athletes the risk of developing 
knee OA following injury can be as high as 12 fold (Drawer et al. 2001, Kujala et al. 1995). 
Articular cartilage repair in patients involved in regular sporting activities represents 
considerable challenge due to forceful, repetitive joint loading in impact sports. The repair 
tissue has to be able to withstand the significant mechanical joint stresses generated during 
such sporting activities. Microfracture, mosaicplasty and ACI have all been used in athletes 184 
 
with varying success (Gobbi et al. 2004, Gudas et al. 2005 & 2006, Kreuz et al. 2007, Kon et 
al. 2009). Functional scores are widely used to assess efficacy of various cartilage repair 
techniques, but only a few studies have assessed the ability to return to sporting activity. This 
is an important parameter of functional outcome in a subset of patients. 
With all of the above information in mind, the hypotheses, aims and objectives of this chapter 
are outlined below. 185 
 
Aims, Objectives, Hypotheses 
 
1)  To compare the efficacy of ACI in smokers and non-smokers 
Hypothesis:     
i)  smokers have worse outcome 
ii)  there is negative correlation between exposure of smoke and functional outcome 
following this procedure 
 
2)  To analyse the difference in outcome of ACI in patients with ideal BMI and those who 
are overweight or obese 
Hypothesis:  
i)  patients with ideal BMI have the best outcome 
ii)  there is a negative correlation between BMI and functional outcome after ACI 
 
3)  To determine if there was a difference in outcome in patients who regularly took part in 
sporting activities prior to their injury. A secondary aim in this cohort of patients was to 
determine the proportion of patients that returned to sporting to activities after ACI and to 
what level of sporting prowess they returned to 
Hypothesis: Those involved in sports prior to injury have a better outcome following 
ACI 
There will obviously be interplay with all the three factors listed above. For example, it 
stands to reason that those with a very high BMI are unlikely to be involved in many sporting 
activities. For this reason the Generalised Linear Model (GLM) was used to take into account 
this interplay and still provide information regarding statistical significance of the listed 
factors independent of each other. 186 
 
Patients and Methods 
 
In the first form (Form A see appendix) for all new patients entering the ACI vs. MACI trial, 
there are sections on smoking status as well as height and weight that needed to be 
documented. Unfortunately, this information was not recorded in a large proportion of 
patients and they certainly could not be used for statistical analysis. A detailed questionnaire 
concerning the patients’ weight, height and smoking status at the time of the surgery was 
constructed. The questionnaire (see appendix) also sought to delineate the physical activity 
profile of the patients prior to their injury and what level of sporting activity they were 
engaged in two years following surgery. The outcomes measures used to assess success of 
surgery were the Modified Cincinnati Score (MCS), and the Visual Analogue Score (VAS) 
before and after surgery. The functional scores were measured at 6, 12 and 24 months after 
surgery. 
The information provided by smokers also included the number of cigarettes smoked and the 
number of years the patient had smoked for. This enabled us to calculate the number of pack 
years (see formula below) which is an indication of the lifetime exposure of smoke. 
 
Pack years = no. of cigarettes smoked per day X no. of years smoked 
          20 
       
The patients’ height (in metres) and weight (in kilograms [Kg]) are used to calculate the body 
mass index (BMI). Patients with a BMI of 20 to 24.9 are categorised as ‘ideal body weight’. 
Those with a BMI of 25 to 30 are overweight and those with a BMI of greater than 30 are 
obese. 187 
 
BMI =       weight (kg) 
Height (metres)
2 
Patients who played a competitive sport at least once a month and train regularly were 
categorised as taking part in regular physical activity. This also included going to the gym 
and dancing. The physical activity profile was sub-divided into high, mid and low impact 
sports according to the type of activity performed: 
1.  High-impact sports: jumping, pivoting, cutting (basketball, netball, volleyball, 
soccer, gymnastics) 
2.  Mid-impact sports: running and turning (racquet sports, hockey, skiing) 
3.  Low-impact sports: running, cycling, swimming 
 
An earlier pilot study enabled us to perform sample size calculations. With α = 0.05 and β = 
0.2 (hence a power of 80%), a total of 90 patients would be required (with twice as many 
non-smokers as smokers) to detect a difference of 10 points in the Modified Cincinnati Score. 
Similarly, using the same parameters, 100 patients would be required to identify a difference 
between those patients who are overweight or obese and those who have an ideal BMI. The 
questionnaire was sent out to 150 patients who had traumatic osteochondral lesions in the 
knee treated with either ACI or MACI and the two year results (according to the MCS) were 
available with the hope that the response rate would be at least 75%. 122 patients responded 
(81%). 
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Results – Smokers 
 
The age, BMI, duration of symptoms, number of previous operations and size of lesions were 
all higher in the Ex-smokers group, though this was not statistically significant (Table 6.1).  
 
Table 6.1: Patient demographics 
  Smokers 
(n=48) 
Ex-smokers 
(n=15) 
Non-smokers 
(n=66) 
p-value 
Age 
 
33.4 +/- 1.2  36.4 +/- 1.9  33.7 +/- 1.1  0.5 
Body Mass Index 
 
26.4 +/- 0.6  27.5 +/- 1.4  26.3 +/- 0.5  0.6 
Duration of 
symptoms (months) 
102 +/- 10  137.1 +/- 28.6  113.3 +/-11.7  0.4 
No. of previous 
operations 
2.4 +/- 0.3  3.3 +/- 0.8  2.3 +/-0.2  0.2 
Size of lesion (cm) 
 
5.6 +/- 0.5  6.4 +/- 0.9  4.8 +/- 2.1  0.6 
Means displayed with standard error. p-values derived from one-way ANOVA 
 
Figure 6.1 shows the absolute values of the MCS at baseline and at 6, 12 and 24 months after 
surgery for descriptive purposes. Figure 6.2 shows the change in MCS from baseline to the 
aforementioned time frames. When directly comparing the graphs, a discrepancy is observed. 
For example, in figure 6.1 the change in the Modified Cincinnati Score 24 months after 
surgery in smokers (i.e. MCS 24 – MCS 0 = 5.1) does not match the change in MCS seen in 
figure 6.2 (change at 24 months = 9.3). This is because in figure 6.2, only the dataset in 
which patients who have scores pre-operatively and at 24 months after surgery are included 
in the analysis. The data analysis in figure 6.1 utilised all patients who had MCS at any of the 
time frames (so some patients may have had scores at 6, 12 and 24 months but not 
preoperatively and some may have scores pre-operatively but not at 24 months). It is 189 
 
therefore more useful to compare results in figure 6.2, even though number of patients is less 
and therefore the standard error is higher. ANOVA failed to identify a significant difference 
between the three groups in terms of change in MCS 24 months after surgery (p=0.2). When 
a direct comparison between smokers and non-smokers was analysed using the independent t-
test was performed, the p-value was lower but still not significant (p=0.09). 
 
 
Figure 6.1: Functional results with the Modified Cincinnati Score 
 
Graph displays mean values with standard error bars 
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Figure 6.2: Change in MCS in smokers, non-smokers and ex-smokers 
 
Graph displays mean change in Modified Cincinnati Score from preoperative score with standard 
error bars 191 
 
Table 6.2: Excellent and Good Results According to MCS 
Time  Outcome  Smokers  Non-smokers  p value 
 
 
6 months 
Excellent  2 (7%)  9 (20%)   
 
0.014 
Good  5 (19%)  17 (38%) 
Fair   16 (59%)  12 (27%) 
Poor  4 (15%)  7 (15%) 
Total  27  45 
 
 
1 year 
Excellent  5 (12.5%)  13 (23.5%)   
 
0.002 
 
Good  9 (22.5%)  25 (45.5%) 
Fair   15 (37.5%)  11 (20%) 
Poor  11 (27.5%)  6 (11%) 
Total  40  55 
 
 
2 years 
Excellent  3 (9.5%)  20 (40%)   
 
0.014 
 
Good  9 (28%)  13 (26%) 
Fair   11 (34.5%)  13 (26%) 
Poor  9 (28%)  4 (8%) 
Total  32  50 
 
The proportion of good and excellent results (according to MCS) was significantly better in 
non-smokers compared to smokers (see Table 6.2) at all time intervals after surgery. 
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Figure 6.3: Relationship between MCS at 24 months and pack years 
 
 
 
 
Linear regression analysis was performed to determine whether lifetime exposure to cigarette 
(pack years) had an effect on the change in MCS 24 months after surgery. Pack years is 
calculated by multiplying average number of cigarettes smoked per day by the number of 
years smoked during the patients’ life and dividing that by 20. Figure 6.4 shows that there 
was a significant negative correlation between the change in MCS 24 months and pack years 
(r = -0.3, p=0.01).  In these analyses, non-smokers were excluded from analysis (as they did 
not have pack years to speak of).  193 
 
Figure 6.4: Relationship between Change in MCS at 24 months and Pack Years 
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Generalised Linear Model (GLM) 
The GLM was used with the dependent variable being MCS 24 and the factors being 
analysed were the type of surgery, smoking status and MCS before surgery (MCS 0). This 
essentially serves as a baseline for future GLMs, in which we include other factors into the 
model. The results are shown below. Smoking did have a significant effect and smokers were 
predicted to have a MCS that was 13 points worse than non-smokers. The MCS before 
surgery was also a significant factor in the model. 
 
 
Table 6.3: Results of the Limited Generalised Linear Model 
Parameter  Magnitude 
of effect 
Std. Error  95% Confidence Interval 
Lower  Upper  Sig. 
Type of surgery           
ACI  0.26  4.5  -8.6  9.1  0.9 
MACI  0
a  .  .  .  . 
Smoking status           
Smoking  -13.3  5  -23.3  -3.4  0.009 
Ex-smoker  -14.5  7.7  -29.7  0.7  0.06 
Non-smokers  0
a  .  .  .  . 
MCS 0  0.6  0.13  0.3  0.85 
<0.001 
0
a  represents the reference category for comparison of other categorical data within the group. 
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Results – Body Mass Index 
 
Patients who were overweight or obese were older although this was not statistically 
significant (Table 6.4). Furthermore, these two groups of patients had experienced their 
symptoms for longer before undergoing the index procedure but this was also not significant. 
The number of previous operations and size of the lesion was similar in all three groups. The 
proportion of non-smokers in the three groups was slightly higher in patients with ideal BMI 
but this was also not statistically significant. 
 
Table 6.4: Patient and lesion characteristics according to BMI 
  Ideal Weight 
(n=53) 
Overweight 
(n=63) 
Obese 
(n=22) 
p-value 
Age 
 
32 +/- 1.2  35.2 +/- 1  35 +/- 1.7  0.1 
Body Mass Index 
 
23 +/- 0.3  27.1 +/- 0.2  33.4 +/- 0.7  <0.001 
Proportion of non-
smokers 
58%  47%  45%  0.5 
Duration of 
symptoms (months) 
90.9 +/- 11.8  116.6 +/- 10.7  129.8 +/- 20.9  0.2 
No. of previous 
operations 
2.2 +/- 0.2  2.4 +/- 0.2  2.5 +/- 0.4  0.7 
Size of lesion (cm) 
 
5.4 +/- 0.5  5.6 +/- 0.4  5.7 +/- 0.7  0.9 
Table displays mean value with standard error of mean 
 
The Modified Cincinnati Scores before and after surgery are shown in figure 6.4 below. Once 
again this is for descriptive purposes and allows comparison of scores with literature. Figure 
6.5 shows the change in MCS from baseline and judges the efficacy of surgery in these 
groups. 
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Figure 6.4: Functional scores before and after surgery according to BMI 
 
 
 
 
 
Figure 6.5: Change in Modified Cincinnati Score according to BMI 
 
Graph displays mean MCS with standard error bars 
 
Graph displays mean MCS with standard error bars 
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Non-smokers had the greatest improvement 24 months following surgery and analysis of 
variance (ANOVA) revealed this to be statistically significant (p=0.002). 
According to the Modified Cincinnati Score, the proportion of good and excellent outcome 
was higher in patients with ideal BMI than those who were overweight or obese (Table 6.4). 
This was the case at all time frames after surgery though was only statistically significant at 
one and two years following surgery. At the 24 month post-operative period, only one obese 
patient (5.5%) experienced a good or excellent outcome compared with 49% of overweight 
patients and 82% of patients with ideal BMI. This discrepancy was highly significant. An 
advantage of analysing results in this way is that it can enable us to compare these results 
with other studies which do not use the same scoring systems but do categorise results in a 
similar fashion. The disadvantage is that the effect of surgery is not being measured as we are 
not comparing pre- and post- operative scores. This will be discussed later in the chapter.198 
 
Table 6.5: Proportion of Good and Excellent Results According to the MCS  
Time  Outcome  Obese  Over-weight  Ideal 
Weight 
p-value 
 
 
6 months 
Excellent  2 (14%)  2 (6%)  6 (17%)   
 
0.08  Good  1 (7%)  11 (33%)  14 (39%) 
Fair  6 (43%)  13 (39%)  13 (36%) 
Poor  5 (36%)  7 (22%)  3 (8%) 
Total  14  33  36 
 
 
1 year 
Excellent  1 (6%)  8 (16%)  9 (22.5%)   
 
0.014 
 
Good  5 (28%)  18 (35%)  18 (45%) 
Fair  4 (22%)  18 (35%)  9 (22.5%) 
Poor  8 (44%)  7 (14%)  4 (10%) 
Total  18  51  40 
 
 
2 years 
Excellent  0  8 (18%)  17 (45%)   
 
<0.0001  Good  1 (5.5%)  14 (31%)  14 (37%) 
Fair  10 (55.5%)  17 (38%)  4 (10%) 
Poor  7 (39%)  6 (13%)  3 (8%) 
Total  18  45  38 
p-values derived from Chi-Square Test  
According to the paired t-test, patients with an ideal weight had a statistically significant 
improvement at the time of final follow-up of 2 years after surgery compared to baseline 
(p<0.0001). Overweight patients experienced similar improvements in the MCS 2 years after 
surgery, though the p value failed to reach statistical significance (p=0.07). ANOVA revealed 
that there was a statistically significant difference in the change in MCS 2 years after surgery 
between the three groups, with the greatest improvement occurring in the ideal weight group. 
(p=0.002). 199 
 
Figure 6.6: Relationship between BMI and MCS at 24 months 
 
 
 
 
Figure 6.6 displays a statistically significant negative relationship between the BMI and the 
MCS 24 months after surgery (r = -0.4, p=0.001). However such a relationship did not exist 
when linear regression was performed using the variables BMI and change in MCS at 24 
months. Figure 6.7 illustrates the relationship between BMI and the change in MCS 24 
months after surgery.  
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Figure 6.7: Relationship between BMI and change in MCS 24 months after surgery 
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Generalised Linear Model (GLM) 
The GLM was used with the dependent variable being MCS 24 and the factors being 
analysed were the type of surgery, BMI and MCS before surgery (MCS 0). This essentially 
serves as a baseline for future GLMs, in which other factors will be included in the model. 
The results are shown below. Once again MCS 0 was a strong predictor of the MCS 24 
months after surgery, as was BMI, which had a greater magnitude of effect. In this model if 
the BMI increased by 1, the MCS 24 was predicted to decrease by 1.5. 
 
Table 6.6: Results of the Limited GLM 
Parameter  Magnitude 
of effect 
Std. Error  95% Confidence Interval 
Lower  Upper  Sig. 
Type of surgery               
ACI  -0.8  4.2  -9.1  7.5  0.8 
MACI  0
a  .  .  .  . 
MCS0  0.6  0.1  0.3  0.8  <0.001 
BMI  -1.6  0.5  -2.6  -0.5  0.004 
               
0
a  represents the reference category for comparison of other categorical data within the group. 
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Results – Physical Activity 
 
ANOVA revealed a significant difference in the mean age between the four groups of 
patients. Patients involved in high impact sports had experienced their symptoms for shorter 
duration than the other groups, though this was not significant. All the other patient and 
lesion characteristics were similar (Table 6.6). There was a significant difference in the 
proportion of smokers and non-smokers between the four groups with the highest percentage 
of non-smokers belonging in the ‘Mid-impact’ and ‘High-impact’ groups. 
 
Table 6.7:   Patient and lesion characteristics in patients with varying degree of physical 
    activity pre-injury 
  No Sports 
(n=25) 
Low impact 
(n=21) 
Mid-impact 
(n=24) 
High Impact 
(n=49) 
p-value 
Age 
 
36.2 +/- 1.4  34.2 +/- 2.1  35.5 +/- 1.6  31 +/- 1.3  0.04 
Body Mass Index 
 
26.5 +/- 1  26.5 +/- 0.9  27.4 +/- 1  26 +/- 0.4  0.6 
Proportion of non-
smokers 
28%  29%  75%  61%  <0.001 
Duration of 
symptoms (months) 
117.8 +/- 10.8  134.6 +/- 23.6  129.1 +/- 23.5  92.3 +/- 10.4  0.2 
No. of previous 
operations 
2.4 +/- 0.2  2.2 +/- 0.3  2.1 +/- 0.2  2.3 +/- 0.2  0.9 
Size of lesion (cm) 
 
5.4 +/- 0.6  6.1 +/- 0.7  5.9 +/- 0.9  5.3 +/- 0.5  0.8 
Table displays mean value with standard error of mean 
 
The independent t-test revealed that patients partaking in high impact sports prior to their 
injury had statistically significantly higher pre-operative MCS (p<0.001) and at the final time 
point 24 months after surgery (p=0.001). When analysing the mean increase in MCS, there 
was not much difference between the four groups (especially at 1 year following surgery). 203 
 
Two years after surgery, the greatest increase in MCS occurred in the High Impact group, 
though this was not significant (p=0.1) (see figure 6.9). 
 
Figure 6.8:  Functional scores before and after surgery according to physical activity 
 
 
 
 
Figure 6.9: Change in Modified Cincinnati Scores according to physical activity 
 
Graph displays mean MCS with standard error bars 
 
Graph displays mean MCS with standard error bars 
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Of the 94 patients in participating in sports pre-injury, forty-five (47.9%) have returned to 
some form of sporting activity. This has mainly been in a low- to mid-impact kind of sporting 
activities (see figure 6.10).  Within the sporting group (n=94), if the patients had to wait for 5 
years or longer for surgery then they were less likely to return to sporting activity (26% 
versus 50%, p=0.025). 
Figure 6.10: Return to sporting activity 
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1) High-impact sports: jumping, pivoting, cutting (basketball, volleyball, soccer, gymnastics) 
2) Mid-impact sports: running and turning (racquet sports, hockey, skiing) 
3) Low-impact sports: running, cycling, swimming 
4) No sports, activities of daily life 205 
 
Generalised Linear Model  
The GLM was used with the dependent variable being MCS 24 and the factors being 
analysed were the type of surgery, MCS before surgery (MCS 0) and physical activity. This 
essentially serves as a baseline for future GLMs, in which other factors will be included in 
the model. The results are shown below. Once again MCS 0 was a strong predictor of the 
MCS 24 months after surgery. Patients partaking in high impact sports were predicted to have 
a MCS 24 score that was 13.3 points greater than patients that did not take part any sport. 
 
Table 6.8: Results of the limited GLM according to physical activity 
Parameter  Magnitude 
of effect 
Std. Error  95% Confidence 
Interval 
Lower  Upper  Sig. 
Type of surgery           
ACI  1.3  4.6  -7.7  10.3  0.84 
MACI  0
a  .  .  .  . 
Physical activity           
High impact  13.3  6.75  0.09  26.5  0.048 
Mid-impact  1.1  7.9  -14.4  16.6  0.9 
Low-impact 
No Sports 
-2.7 
0
a 
7.3 
. 
-17 
. 
11.6 
. 
0.7 
. 
 
MCS 0 
 
0.6 
 
0.14 
 
0.37 
 
0.9 
 
<0.001 
          
0
a  represents the reference category for comparison of other categorical data within the group. 
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Generalised Linear Model with all three variables 
There were 81 patients in total who had their BMI, smoking status and pre-operative physical 
activity profile recorded. The distribution of smokers and non-smokers as well as the physical 
activity profile can be seen in Table 6.8. Table 6.9 displays the mean for each of the 
continuous variables in this cohort of patients. 
 
Table 6.9: Categorical Variable Information 
 
  N  Percent 
 Smoker  Smoker  31  38.3% 
Ex-smoker  7  8.6% 
Non-smoker  43  53.1% 
Total  81  100.0% 
Sports Type Preop  High impact  34  42.0% 
Mid-impact  14  17.3% 
Low impact  18  22.2% 
No Sports  15  18.5% 
Total  81  100.0% 
 
 
Table 6.10: Continuous Variable Information 
 
 
  N  Minimum  Maximum  Mean  Std. Deviation 
Dependent Variable  MCS24  81  8  100  57.6  25.3 
Covariate  BMI  81  19  39.2  26.7  4.32 
MCS0  81  10  94  43.7  17.8 
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The smoking status, pre-operative physical activity profile, BMI and MCS 0 all had 
statistically significant effect on outcome 2 years following surgery (Table 12). The most 
significant variable was BMI and the magnitude of effect was such that each increase in pre-
operative BMI could predict a 2.1 points decrease in MCS 24. This effect was more powerful 
than MCS 0. Using this model, smokers could be predicted to have a MCS 24 that is 12.5 
points less than non-smokers. Similarly, those taking part in high impact sports could be 
predicted to have a MCS 24 that is nearly 12 points greater than those that do not take part in 
sports at all. 
 
Table 6.11: Results of Generalised Linear Model 
 
Parameter Estimates 
Parameter 
Magnitude 
of effect  Std. Error 
95% Confidence Interval 
Hypothesis 
Test 
Lower  Upper  Sig. 
           
 
Smoking Status  
Smoker 
 
 
-12.5 
 
 
4.8 
 
 
-21.9 
 
 
-3.0 
 
 
0.01 
Ex-smoker  -3.7  8.1  -19.5  12.1  0.65 
Non-smoker  0
a  .  .  .  . 
 
Physical activity 
High impact sports 
 
 
11.6 
 
 
6.1 
 
 
-0.5 
 
 
23.6 
 
 
0.06 
Mid-impact sports  -1.97  7.4  -16.5  12.5  0.8 
Low Impact Sports  -1.67  6.6  -14.6  11.2  0.8 
No Sports  0
a  .  .  .  . 
 
Continuous Variables 
BMI 
 
 
-2.1 
 
 
0.5 
 
 
-3.1 
 
 
-1.1 
 
 
p<0.001 
MCS0  0.4  0.1  0.1  0.6  0.004 
           
0
a is used as the reference category to compare other factors against 
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Generalised Linear Model – Further variables 
 
A generalised linear model incorporating more variables was utilised. These included number 
of previous operations, duration of symptoms, age of patient and size of lesion (Table 6.11). 
Only 66 patients included all of these variables. Table 6.12 displays the continuous variable 
information.  
 
Table 6.12: Further Categorical Variable Information 
 
 
  N  Percent 
 Smoking status  Smoker  26  39.4% 
Ex-smoker  5  7.6% 
Non-smoker  35  53.0% 
Total  66  100.0% 
No. previous ops   1  19  28.8% 
2  18  27.3% 
3  12  18.2% 
4 or more  17  25.8% 
Total  66  100.0% 
Physical activity profile  High impact  26  39.4% 
Low and Mid-impact  26  39.4% 
No Sports  14  21.2% 
Total  66  100.0% 
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Table 6.13: Further Continuous Variable Information  
 
 
N  Minimum  Maximum  Mean 
Std. 
Deviation 
Dependent Variable  MCS24  66  8  100  57.8  25.1 
Covariate  Age  66  18  50  33.5  8.5 
BMI  66  19  39.2  26.8  4.3 
Length of symptoms  66  3  300  106.4  77.9 
MCS0  66  10  94  44.4  17.3 
Size  66  1  15  5.6  3.2 
 
 
Including these variables in the model has altered the predictors of outcome significantly 
(Table 6.13). The most profound effect is that MCS 0 no longer predicts MCS 24 which does 
not seem logical as that is the one parameter which would seem the most likely to be related 
to functional scores following surgery. From the previous model, the results were similar in 
mid- and low impact sportsmen and therefore they were grouped together in this model. This 
still did not alter that fact that physical activity was still a statistically significant predictor of 
outcome (p=0.02). The duration of symptoms prior to the index procedure was a new found 
significant factor in determining MCS 24. Table 6.13 shows that for a further month that the 
patient has to wait for ACI, the MCS 24 is likely to be 0.07 less. This means that if a patient 
has to wait a year the MCS 24 is likely to be 1 point less. The strength of the relationship 
between BMI and MCS 24 as well as smoking status and MCS 24 has also strengthened 
when the interplay of all the above mentioned factors is taken into consideration. This is 
surprising since the number of patients in the model has decreased and the number of co-
variates and predictors has increased from the previous model. 
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Table 6.14: Results of the new generalised linear model 
 
Parameter Estimates 
Parameter 
Magnitude 
of effect 
Std. 
Error 
95% Wald Confidence Interval 
Hypothesi
s Test 
Lower  Upper  Sig. 
Type of surgery 
ACI 
MACI 
 
Smoking Status  
  
4.3 
0
a 
 
4.3 
. 
  
-4.1 
. 
  
12.6 
. 
  
0.3 
. 
Smoker  -15.1  4.9  -24.7  -5.5  0.002 
Ex-smoker  -8.7  8.8  -25.9  8.483  0.3 
Non-smoker 
 
Previous Operations  
0
a  .  .  .  . 
1  8.6  6.5  -4.1  21.4  0.2 
2  6.3  6.1  -5.7  18.227  0.3 
3  6  6.6  -6.9  18.933  0.4 
4 or more 
 
Physical Activity Profile  
0
a  .  .  .  . 
High Impact  11.4  6.5  -1.3  24  0.08 
Mid- and Low impact  -2.811  6  -14.6  9  0.6 
No Sports 
 
Continuous Variables 
0
a  .  .  .  . 
Age  -0.24  0.3  -0.8  0.3  0.4 
BMI  -2.4  0.5  -3.4  -1.3  <0.001 
Length of symptoms  -0.07  0.03  -0.1  -0.01  0.02 
MCS0  0.12  0.15  0.18  0.4  0.4 
Size  0.001  0.007  -0.01  0.015  0.9 
                
0
a  represents the reference category for comparison of other categorical data within the group. 
 
 
A possible explanation for the lack of effect of MCS 0 on MCS 24 is that there may be a 
relationship MCS 0 with one of the other continuous variables. If this is the case then two 211 
 
highly correlated variables in one model may both become insignificant. This is termed 
collinearity. Table 6.14 displays the results of these correlations. 
 
Table 6.15: Correlations between the continuous variables in the Generalised Linear Model 
 
Age  BMI 
Length of 
symptoms  MCS0  Size 
MCS0  Pearson Correlation  -0.1  -0.3
**  -0.21
*  1  0.05 
Sig. (2-tailed)  0.2  0.003  0.046    0.6 
N  134  135  122  135  117 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 As expected there was significant relationship between MCS 0 and BMI. There was also a 
significant negative relationship between MCS 0 and length of symptoms. However, in the 
Generalised Linear Model, Length of Symptoms is still significantly related to MCS 24 
whereas MCS 0 is not. This suggests that the strength of the relationship between MCS 24 
and Length of Symptoms is greater than that between MCS 0 and MCS 24.212 
 
Discussion  
 
The findings from this study suggest that smoking and having a high BMI prior to surgery 
can have a deleterious effect on outcome following ACI. Although smokers and obese 
patients’ pre-operative knee function is less (according to the MCS), the improvement after 
surgery is also lower. Patients involved in high impact physical activity are likely to do better 
than patients that are not involved in any sporting activity. The results from the Generalised 
Linear Model confirm that these factors have an effect on outcome independent of each other. 
The next section will discuss these factors in more detail. 
A number of different statistical tests have been used to address similar questions. It was 
necessary to present the results as seen in figures 6.1 (p.188), 6.4 (p.196) and 6.8 (p.203) as 
this represents the various groups we are interested in and the difference in their pre-operative 
and post-operative function (essentially a presentation of 3 different case-controlled studies). 
This allows a comparison of the results from this study with other studies that have utilised 
the Modified Cincinnati Score (MCS). For example it can be stated non-smokers have a MCS 
at 2 years that is comparable to the study in Gothenburg (Peterson et al. 2010) whereas 
smokers do not. However a number of other studies have not used the MCS and instead have 
grouped their results as Excellent/Good and Fair/Poor according to different scoring systems. 
Dividing patients into these 4 categories is a less efficient way of analysing the results but 
does enable comparison with a greater number of other studies. 
Figures 6.2, 6.5 and 6.9 give an idea of the effect the variables have on the response to 
surgery (i.e. the change in MCS from pre-operative status and how this varies between 
different groups). This is perhaps more important than the previous graphs as the data is 
paired and we can sequentially see the efficacy of ACI in different groups of patients (e.g. the 213 
 
change in MCS 2 years after surgery is almost non-existent in obese patients compared  to a 
22 point increase in ideal weighted patients). Perhaps the most efficient way of analysing all 
of these factors is with the use of a generalised linear model. This gives some indication of 
the magnitude of effect of each of the mentioned variables on outcome after surgery but this 
is not comparable to other studies and they have not utilised the same statistical model. 
However, it does allow us to determine whether the variables have a significant impact on 
outcome independent of each other which is important in any study assessing prognostic 
factors. 214 
 
1. Smoking 
 
To the best of our knowledge, this is the first study to assess the effect of smoking on 
outcome of ACI/MACI. The results suggest that patients who smoke have worse pre-
operative function. In addition, they do not experience as great a benefit from this procedure 
as non-smokers. It is unclear why smoking should affect outcome after ACI. Articular 
cartilage is avascular and does not rely on constituents in blood for repair. It receives its 
nutrition and oxygen supply by diffusion from the synovial fluid and subchondral bone 
(Hofstaetter et al 2005, Lane et al. 1977).  The partial pressure of oxygen in synovial fluid (50 
to 60 mmHg)
 (Lund-Olesen 1970) is approximately half than in arterial blood (80 to 100 
mmHg) and in osteoarthritic joints the oxygen tension is decreased further (Pfander et al. 
2005). In animal models, long term hypoxia down regulated gene expression levels of 
collagen and growth factors in knee articular cartilage (Hofstaetter et al 2005). Knee articular 
cartilage also expresses the hypoxia-inducible factor 1α, which helps tissue function at low 
oxygen tensions.  
Smoking has been shown to reduce its expression in other tissues (Michaud et al. 2003) and 
perhaps a similar mechanism is applicable in cartilage. Smoking has also been shown to 
delay chondrogenesis in a mouse model of tibial fracture healing. Mice exposed to smoke 
exhibited less type II collagen in the fracture callus with a delay in the chondrogenic phase of 
fracture healing (El-Zawawy et al. 2006). Tissue hypoxia may have been a major factor in the 
impaired production of cartilaginous callus in mice exposed to smoke. Perhaps, decreased or 
delayed type II collagen synthesis as a result of smoking as well as tissue hypoxia in the 
synovial joint lead to the deleterious effects of smoking on cartilage repair in our patients.  215 
 
Several reports have suggested that smokers experience more musculoskeletal pain than non-
smokers (Amin et al. 2007, Mallon et al. 2004, Anderson et al. 1998, Karim et al. 2006). In a 
longitudinal study assessing the degree of cartilage loss in male smokers and non-smokers 
according to MRI, men who smoked at the baseline of the study had statistically significant 
higher pain scores (according to the visual analogue score) than non-smokers (Amin et al. 
2006). They were also found to have an increased risk for cartilage loss at the medial 
tibiofemoral joint (odds ratio (OR) 2.3 with 95% confidence interval (CI) 1.0 to 5.4) and the 
patellofemoral joint (OR 2.5, 95% CI 1.1 to 5.7). Pain constitutes one fifth of the modified 
Cincinnati score, the other activities being assessed are walking, jumping, running, stairs, 
overall activity as well as symptoms of swelling and giving way. Therefore our cohort of 
smokers not only experience greater pain but also global restriction in function. Smokers 
were also found to have higher levels of pre-operative pain and lower levels of function prior 
to rotator cuff repair. In this study, smokers experienced less improvement following open 
rotator cuff repair than non-smokers (Mallon et al. 2004). 
Poorer outcomes were reported amongst smokers following anterior cruciate ligament 
reconstruction (Karim et al 2006). Though pain was not an issue in such cases, smokers were 
less likely to return to their original level of pre-injury sport and had worse functional knee 
scores than non-smokers. Animal studies suggest that decreased cellular density and type I 
collagen expression in injured ligament of mice exposed to smoke provides an explanation 
for poor healing of knee ligaments (Gill et al 2006).
 
 
ACI/MACI is not a universally successful procedure with reported rates of graft failures 
ranging from 7 to 25%, delamination from 8 to 22% and graft hypertrophy from 0 to 36% 
(Gikas 2009). An important study has shown several prognostic factors that may be 216 
 
associated with poor outcome following ACI. These include older patients, patients with 
lower pre-operative Cincinnati scores, longer duration of symptoms, multiple defects, and 
multiple procedures prior to the index procedure (Krishnan et al 2006). This case-controlled 
study has highlighted smoking as a possible cause of failure. Smoking has been shown to be 
the single most important risk factor for the development of complications after elective 
arthroplasty of the hip or knee (Moller et al. 2003). In addition wound complications have 
been shown to be related to smoking habits and smokers are more likely to need further 
surgery (Espehaug et al. 1997). Observational studies suggest that prolonged abstinence from 
smoking decreases the risk of many perioperative complications (Moller et al. 2003). Though 
the ex-smokers group did not experience as greater a benefit from ACI/MACI, the 
improvement following surgery was still better than the smoking group. 
 
Conclusion 
The counselling of patients undergoing ACI/MACI should include smoking not only as a 
general cardiopulmonary risk, but also that a poorer result can be expected following this 
procedure. Patients should be encouraged to enrol in smoking-cessation programme and at 
the very least stop smoking 6 to 8 weeks prior to surgery and during the period of 
rehabilitation as recommended in the literature (Moller et al 2003, Warner 2006). 217 
 
2. Body mass index (BMI) 
Following any kind of surgery, obese patients have a significantly higher risk of 
complications, including myocardial infarction, wound infection, nerve injury and urinary 
tract infection (Bamgbade et al. 2007). There is also a two fold increase in death rate 
following major surgery. Functional results following orthopaedic procedures are rather more 
unpredictable. Amin et al demonstrated no difference in Knee Society Scores in 300 
consecutive primary total knee replacements when comparing obese with non-obese patients 
(Amin et al 2006). Conversely, Berend et al reported that patients with a BMI greater than 
33.7 was associated with medial bone collapse following total knee arthroplasty (Berend et al 
2004) and a BMI greater than 32 predicted higher failure rates after unicompartmental knee 
arthroplasty (Berend et al 2005). More dramatic failure rates are seen in obese patients who 
underwent patellofemoral replacement (van Wagenberg et al. 2009). The failure to identify 
increased revision rates in obese patients who have undergone total knee or hip arthroplasty 
may be related to the fact that wear of the prosthesis is a function of use not time. McClung et 
al analysed the relationship between quantitative activity (measured with pedometer) and 
BMI and demonstrated in 209 individuals that had undergone total hip or knee arthroplasty 
that a higher BMI was associated with lower activity (McClung et al. 2000). 
Results from this study are unequivocal. This is the first study of its kind to analyse results 
following ACI in obese and non-obese patients. Indeed, a comprehensive literature review 
failed to identify clinical research on the effect of obesity on any cartilage repair techniques 
in the knee. However one small study in the German literature did show statistically inferior 
results in overweight compared with normal weight patients following microfracture for the 
treatment of OCDs in the talus (Becher et al 2008).  218 
 
The poor results following ACI in the knee can probably be explained by the increase in 
mechanical forces across the joint with an increase in patient weight. Several in vitro studies 
have shown that extracellular matrix (ECM) production by chondrocytes is highly sensitive to 
mechanical signals mediated by loading (Gabbay et al. 2008). Whilst moderate, regular 
exercise is beneficial for cartilage constitution (Roos & Dahlberg 2005), excessive stresses or 
static stress is harmful (Sharma & Chang 2007) and this is more likely to be present in obese 
patients. Static loading has also been shown to increase the synthesis of pro-inflammatory 
cytokines (Knobloch et al 2008, Sharma et al 2007). A case controlled study has shown a 
significant relationship between higher BMI and meniscal tears (Ford et al 2005) adding 
further weight to the argument that obese patients experience greater mechanical forces in the 
knee that is detrimental to knee function. 
The poor outcome in obese patients following ACI cannot be explained by mechanical stress 
alone. The established relationship between obesity and OA in non-weight bearing joints 
such as the hand (Attie & Scherer 2009) suggests that adipose tissue may have a role to play 
in this study also. Adipose tissue has been shown to secrete pro-inflammatory cytokines such 
as interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-A) and IL-1 (Trujillo et al 2006). 
A more recent study has confirmed that infrapatellar fat pad in obese women’s knees secreted 
greater concentrations of IL-6 than  subcutaneous adipose tissue (Distel et al 2009). There 
were also higher secretions of adiponectin and lower levels of leptin. Their results suggest 
that locally produced pro-inflammatory cytokines produced in the knee may contribute to 
cartilage damage in obese patients. Such an effect is not age related and may contribute to 
poor results seen in this study. 
A prospective, longitudinal observational study determined whether serum levels of IL-6, 
TNF-A, and CRP as well as BMI were associated with an increased prevalence of 219 
 
radiographic knee osteoarthritis (Livshits et al. 2009).  Using multiple logistic regression, 
they demonstrated that a high BMI (p=0.0003) and increased levels of IL-6 were independent 
predictors of the appearance of radiographic OA 5 years from the time these cytokines were 
measured. Their results further confirm the important role IL-6 may have in propagating OA 
and that this is independent of BMI. Could IL-6 represent a therapeutic target to prevent 
cartilage damage? 
As well as IL-6, adipose tissue also synthesizes and secretes over a hundred other proteins 
(such as hormones and growth factors) termed adipokines (Trujillo et al. 2006, Gabay et al 
2008). The main adipokine is Leptin, and since its discovery in 1994 (Zhang et al 1994), its 
role has been extensively studied. Adiponectin and resistin are two further adipokines that are 
associated with leptin in playing key roles in homeostatic mechanisms such as insulin 
regulation and inflammation as well as pathologic events. All three adipokines have been 
implicated in the pathogenesis of chronic inflammatory joint disease such as rheumatoid 
arthritis (Pottie et al 2006). Leptin has been shown to induce the expression of growth factors, 
stimulate proteoglycan and collagen synthesis, and increase the stimulatory effect of pro-
inflammatory cytokines on nitric oxide production in chondrocytes (Aspden et al 2001). 
Leptin also has an effect on bone tissue (Takeda et al 2003). Some of the most recent research 
has demonstrated that leptin behaves differently in lean and obese patients (Pallu et al 2010). 
Matrix metalloproteases (MMPs) and tissue inhibitors of metalloproteases (TIMPs) are 
physiologic degradative enzymes and their protein inhibitors respectively. Up regulation of 
TIMP-2 was markedly increased in leptin treated chondrocytes compared to control in normal 
and overweight patients only and decreased in obese patients (Pallu et al. 2010). Furthermore, 
the expression of MMP-13 was greatest from leptin treated chondrocytes from obese patients. 
These BMI-dependent effects of leptin may change the cartilage repair process following 220 
 
ACI. The leptin-induced TIMP-2 expression may delay cartilage destruction in non-obese 
patients whilst promoting cartilage damage in obese patients. The question that remains 
unanswered is if obese patients lose weight, will leptin behave differently, or have obese 
patients’ bodies adapted to permanently respond in a negative manner?  221 
 
3. Physical Activity 
 
This study reports significantly better results in patients actively involved in high impact 
sports prior to their injury than patients not involved in sports at all. The absolute MCS 2 
years following surgery was significantly better in the high impact sporting group as was the 
increase in MCS 2 years after surgery. The high impact group were the only group of patients 
to experience a statistically significant increase in MCS 6 months after surgery and the scores 
continued to improve 12 and 24 months after surgery. 
Kreuz et al. demonstrated better results of ACI in patients with higher sports activity levels 
from 6 months following surgery and this discrepancy in results was maintained at 18 and 36 
months after surgery (Kreuz et al 2007).  However, it was interesting to note that in their 
study there was no correlation between sports activity levels and pre-operative Cincinnati 
scores. In their cohort of patients, the 94% returned to some form of sporting activity (though 
the majority were at a lower level). 
In another study, only 15 out of 45 soccer players returned to playing this sport with 12 at the 
same pre-injury skill level (Mithoefer et al 2005). This was despite their cohort being 
younger, with a shorter duration of symptoms and less number of previous operations 
compared to the patients in this study. Furthermore, functional outcome, time to return and 
return to sports after ACI was related to level of participation in elite soccer players 
compared with recreational players (84% versus 16%). 
A systematic review analysed results from 12 studies assessing microfracture, 7 on ACI and 5 
on mosaicplasty all in athletes. Good and excellent results were observed in 67% in the 
microfracture group, 82% in the ACI group and 93% in mosaicplasty group. The rate to 
return to sporting activities  were 67% in ACI group, 66% in microfracture group and 91% in 222 
 
mosaicplasty group (Mithoefer et al 2009). However, over the longer-term, the best durability 
was reported after ACI (96% versus 52% for microfracture and mosaicplasty). 
Many animal studies have shown the positive effect of exercise on the healing of articular 
cartilage defects. Such defects in exercised horses and dogs resulted in greater concentration 
of endogenous proteoglycan as well as thicker and stiffer cartilage than non-exercised 
animals (Palmer et al 1995, Jurvelin et al. 1986, Kiviranta et al. 1988, Oettmeier 1992). 
Further evidence for the protective effects of exercise on articular cartilage has come from 
studying knockout mice with heterozygous inactivation of Col2a1-genecoding for type II 
procollagen, which makes cartilage more susceptible to osteoarthritis. In this experiment 
lifelong wheel running had a protective effect against experimental osteoarthritis 
(Lapvetelainen et al 2001). Translated clinically, studies have suggested that people who 
participate in regular physical activity enhance the metabolic activity of cartilage, which may 
equip articular cartilage with better self-repair mechanism that are otherwise absent in those 
who are sedentary (Urquhart et al 2007).  
Other studies have shown that ACI resulted in 96% of adolescent athletes being able to 
regularly participate in high-impact, pivoting sports at the recreational level or higher and 
60% returned to the same or higher level of athletic activity (Mithoefer & Minas et al. 2005). 
However, only a third of the patients were able to return to the same level of athletics if their 
pre-operative symptoms persisted for longer than 12 months. In this chapter, our patients’ 
mean duration of symptoms was 111.4 months and the modal average was 120 months. This 
discrepancy can be explained by current NICE guidelines which state that any form of 
cartilage transplant in the UK should not be used for routine primary treatment and all 
patients receiving such treatment should be enrolled in ongoing or new clinical studies  
(NICE Guidelines 2005). Consequently, the majority of patients enrolled in this study, have 223 
 
had several surgical procedures prior to cartilage transplant and have had symptoms for a 
considerable period of time. 
Other forms of surgical treatment for cartilage damage have reported better results in the 
short-term. Simple debridement and arthroscopic washout of cartilage defects resulted in all 
15 soccer players returning to physical activity at a mean of 10.8 weeks (Levy et al. 1996). 
However, in their cohort the mean defect size was 1.1cm
2 and 26% of patients required 
further surgical procedures. 2 years following microfracture for the treatment of OCDs in the 
knee, 44% of athletes were able to return to sporting activity. A younger age group with 
defect sizes less than 2cm
2 and shorter duration of symptoms (less than 12 months) were 
associated with a higher rate of return to sports (Mithofer et al. 2006). Good results were 
obtained with autologous osteochondral grafting, even at 7 years with 21 out of 30 patients 
returning to sporting activity (Marcacci et al. 2007). However, level I evidence suggests ACI 
is superior (Bentley et al. 2003), especially in the long term (Bentley et al 2012). 
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What can be done? 
Obesity is an established risk factor for the development and progression of knee 
osteoarthritis (Felson 1996, Jarvolm et al 2005) and knee pain (Jinks et al 2006). The 
Arthritis, Diet and Activity Promotion Trial (ADAPT trial) was designed to assess whether 
long term exercise and dietary weight loss (separately or together) were effective modes of 
improving knee pain, function and mobility (Messier et al 2004). 316 participants who were 
overweight(BMI > 28) and over 60 years of age with knee pain, radiographic evidence of 
OA, and self-reported physical disability were enrolled in the community based trial. Patients 
were grouped into 4 distinct 18 month interventions: exercise only, dietary weight loss only, 
dietary weight loss plus exercise, and usual healthy lifestyle (control). 80% completed the 
study. There were significant improvements in the diet plus exercise group in physical 
function, 6 minute walk distance, stair climb time and knee pain relative to control. In the 
exercise group there was a significant increase in the 6 minute walk distance only. The results 
of this study may not be directly related to the cohort of patients in this study, however the 
application of weight loss and exercise prior to surgical intervention in the form ACI does 
seem logical in order to improve outcome. A combination of dietary weight loss and 
quadriceps strengthening has been shown to significantly reduce knee pain and improve knee 
function in patients over the age of 45 with a BMI of greater than 28 (Jenkinson et al 2009). 
These findings were further substantiated in an overview of nine systematic reviews which 
concluded that exercise interventions for patients with knee OA reduce pain and improve 
physical function (Jamtvedt et al 2008). Another systematic review reported robust evidence 
that weight reduction improves self reported disability and reduces pain (Christensen et al 
2007). Furthermore, the onset of injury and pattern of injuries over time in overweight and 
obese patients has been shown to be attributed to BMI and weight reduction may be an 225 
 
avenue to reduce the risk of injury in sedentary overweight and obese patients (Janney and 
Jakicic 2010). 
 
Conclusion 
The results from this chapter unequivocally identify smoking, a high BMI and low levels of 
physical activity as risk factors for inferior results following autologous chondrocyte 
implantation. It was clearly demonstrated that although these factors were related to each 
other (e.g. there were a greater proportion of smokers in ‘non-athletes’), each of the 
aforementioned variables had an independent effect on outcome. It is difficult to advise 
patients to increase their activity level following injury. However, they should be advised to 
stay active and maintain their weight in order to improve outcome.  
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Chapter 7: 
Discussion 
 
Methodological Considerations 
 
Most if not all studies in the literature report their results in term of proportions (i.e. 
percentage of good and excellent results) regardless of the scoring system used to assess 
patient satisfaction and knee function. Although this allows comparison of results with other 
studies, there are two main problems with this approach. Firstly, by converting continuous 
data into binary data, valuable information is lost. Secondly, and more importantly, reporting 
outcome following surgery as percentage of good/excellent results does not take into account 
the patients’ baseline status (i.e. their knee function before surgery). It has been consistently 
reported in this thesis that the Modified Cincinnati Score pre-operatively (MCS 0) is the 
strongest predictor of the latest MCS after surgery, independent of any other variable. 
Therefore, if patients’ scores are high before surgery, the measured MCS after surgery at any 
time point is also likely to be high. The functional score after surgery is important, but what 
is more important is how effective the surgery is (i.e. the improvement or increase in MCS), 
as ultimately that is what we are striving to improve. 
In one study, it was reported that ACI patients with high MCS 0 were likely to have a high 
MCS post surgery (Krishnan et al 2006). It was also stated that patients with longer duration 
of symptoms had worse outcome and patients with more than 2 procedures prior to ACI did 
significantly worse than those that had 2 or less procedures. It stands to reason that patients 
waiting for a long period of time were likely to have had more operations, and also a low 227 
 
starting MCS. Since any one of these 3 variables could have influenced the final outcome 
performing simple linear regression without inclusion of said confounding variables is not 
appropriate. This statistical approach has been widely adopted throughout the Orthopaedic 
world and not just on reporting on outcome after ACI (Laxdal et al 2005, Gobbi & Francisco 
2006, Santaguida et al 2008, Mosely et al 2010, Welsch et al 2010, Dunbar et al 2012).  
 
Multiple linear regression was used by De Windt et al (2009) when assessing prognostic 
factors determining success of treatment for cartilage defects. Twenty-five patients had 
undergone ACI and 30 patients had received microfracture and knee function was assessed 
according to the Knee injury and Osteoarthritis Outcome Score (KOOS). When analysing 
their results, the continuous explanatory variables were dichotomised such as patient age (less 
than or greater than 30 years of age) and duration of symptoms (less than or greater than 24 
months). This approach has to be questioned as it leads to loss of valuable data and the model 
used is capable of handling continuous and categorical data. It was interesting to note that 
patient age showed a high correlation with defect location and was therefore excluded from 
the multiple linear regression model. Again this has to be questioned as one of the reasons for 
using this model is its ability to cope with collinearity. Whilst the authors’ must be applauded 
for anticipating the interplay between the prognostic factors, what they did not include was 
the surgical technique in their regression model. This is of significant importance as the two 
techniques are very different (microfracture versus ACI). In this thesis ACI and MACI 
patients were grouped together because fundamentally they are two types of the same 
technique. However, the surgical technique (i.e. whether the patient had received ACI or 
MACI) was included as an explanatory variable to see if it had an effect. 
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Limitations with the Generalised Linear Model 
When dealing with the analysis of data in a retrospective study (and especially when 
assessing prognostic factors in an outcome study), the GLM represents the best way of 
ensuring the correct results (and consequently conclusions) have been obtained. However, a 
RCT still remains the best way of answering a clinical research question due to the 
limitations of the GLM. The key limitation is the number of variables that can be analysed in 
the model which is dependent upon the sample size. To ensure accurate results, a rough ‘rule 
of thumb’ is that the number of variables that should be included in the analysis should not 
exceed the sample size divided by 10 (Petrie and Sabin 2006). Therefore, if there were 100 
patients in a study then the maximum number of explanatory variables that can be included in 
the analysis is 10. In each of the preceding chapters, the pre-operative variables were similar 
in the two groups being compared, however, this may not be true in other studies, and hence 
the analysis may not include all the confounding variables (particularly if there was a small 
number of patients in the study), leading to inaccurate conclusions being made.  
Secondly, there is the issue of collinearity. This is the term given when two explanatory 
variables in a GLM are highly correlated with each other. Under these circumstances, it is 
difficult to evaluate the individual effects of each of the explanatory variables and the 
problem manifests itself by neither explanatory variable having a significant effect on the 
dependent variable. The solution to this problem is to only include one of the variables. 
However, this may be difficult if the model includes several variables that are correlated. An 
example of collinearity occurred in chapter 5. When the GLM was performed and solely 
analysing the effects of smoking, BMI and physical activity MCS 0 was a strong predictor of 
MCS 24. When further variables were added to the model (such as duration of symptoms 
prior to ACI and size of lesion), MCS 0 ceased to be a significant predictor of MCS 24. A 
simple linear regression was performed to assess the relationship between MCS 0 and 229 
 
duration of symptoms and size of lesions and it became apparent that a relationship did exist 
between MCS 0 and duration of symptoms. 
Finally and perhaps most importantly, when using the GLM, we are assuming that we know 
all the possible confounding variables, and if the sample size is large enough are including all 
of them in the data analysis. This may not always be the case, as it is not always possible to 
be aware of every possible confounding variable. This is why a RCT is the most accurate 
method of determining superiority of one treatment over the other. In a well designed RCT, if 
the randomisation is performed correctly and if there is adequate blinding, then bias due to 
both known and unknown confounding variables is avoided in the study comparison and 
should be similar across the randomised treatment groups.  230 
 
Main Findings 
 
Prognostic factors that may affect outcome may be divided into modifiable and non-
modifiable. The randomised controlled trial (chapter 3) revealed no difference in outcome 
when patients were treated with ACI or MACI. However, when the outcome of ACI vs 
MACI was analysed in the patello-femoral joint (chapter 4), there appeared to be better 
outcome if MACI was used. In the PFJ chapter there was a statistically significant superior 
result when MACI was used in improving MCS 24 months after surgery (p=0.038). After 
taking all confounding variables into account in the GLM, ACI patients were predicted to 
have MCS that was 7 points less than MACI patients when treating lesions in the 
patellofemoral joint. The p value was no statistically significant (p=0.09).  The lack of 
significance may be due to lack of patient numbers in the GLM (i.e. the study is 
underpowered). Therefore it can be stated that with respect to the technique of chondrocyte 
transplantation, there is no statistically significant difference in the outcome when using ACI 
or MACI.  
Chapter 6 analysed other modifiable risk factors, namely BMI, smoking and physical activity. 
When analysing these factors independently, smoking and a BMI above 30 had a profound 
negative effect on the MCS 2 years after surgery. It stands to reason that there may be 
interplay between being overweight, smoking and lack of physical activity. However, when 
controlling for these variables in the GLM, the negative relationship persevered. It was 
interesting to note that the improvement in MCS in ex-smokers was similar to smokers 1 year 
following surgery but not at 2 years. However, the GLM (which is a more powerful form of 
analysis) revealed no statistically significant differences between non-smokers and ex-
smokers 2 years following surgery. There was negative relationship between BMI and MCS 2 231 
 
years after surgery. When the BMI was categorised into three groups (ideal weight, 
overweight and obese), patients with ideal weight experienced the maximum benefit 
following surgery whereas obese patients experienced no benefit. The results in overweight 
patients were intermediate. This relationship was confirmed in the GLM. After controlling for 
other confounding variables, a one point increase in BMI predicts a 2.1 point decrease in 
MCS 2 years after surgery. This relationship was even stronger than MCS 0!  
Participating in sports and physical activity is difficult to do prior to surgery as patients are 
often debilitated with pain. However, the GLM has demonstrated that patients taking part in 
high impact sports pre-injury experienced significantly better results than patients taking part 
in no sports, even after controlling for BMI, smoking and other confounding variables.  
A consistent finding in this thesis was that the outcome following surgery were significantly 
inferior in the patella, while the results in the trochlea were the best. This non-modifiable risk 
factor for poor results is well reported in the literature (Brittberg et al 1994, Minas et al 2005, 
Krishnan et al 2006, Niemeyer et al. 2008, Pascal-Garido et al 2009). Multiple defects were 
associated with even worse outcomes. Other non-modifiable factors included aetiology (i.e. 
patients with previous failed ACI or mosaicplasty had poorer results). Results from chapter 5 
identified another non-modifiable risk factor; the presence of early osteoarthritis. There was a 
significant difference in the absolute latest MCS between the two groups and there was also a 
significant difference in improvement in the MCS from baseline. Furthermore, the 
cumulative probability of survival (the endpoint being arthroplasty or osteotomy) at 5 years 
was 87% for patients with no radiographic evidence of OA compared with 52% for the OA 
group. 232 
 
Clinical consequences 
 
A number of factors have been identified that have a significant effect on outcome following 
ACI. However, the GLM identifies a relationship between a factor and outcome and a 
positive result does not necessarily mean a causative relationship. Therefore, modifying a 
factor in a patient may not necessarily improve their outcome. 
There does not appear to be a difference in outcome when performing ACI or MACI to treat 
osteochondral defects in the knee other than in the patella. The forces acting in the anterior 
knee compartment are different from those in the medial or lateral compartment and this 
partially explains the inferior results of all cartilage repair techniques (Bentley et al 2003, 
Hangody et al. 2003, Karataglis et al 2006, Kreuz & Steinwachs et al 2006, Kreuz & Erggelet 
et al 2006). MACI is technically easier to perform than ACI, especially in the patella, and 
therefore we should consider performing MACI when treating patella lesions. It was 
interesting to note that the results of treating trochlear lesions were significantly better than 
patella lesions, even though they articulate in the same joint. The reason for this is unclear. I 
can only speculate that the location of trochlear lesions as documented by the surgeons may 
be inaccurate (i.e. the lesion may be more distal and not actually be in contact with the patella 
or only a small proportion of the lesion be in contact with the patella in terminal extension). 
Obviously, there is no way of proving this unless all patients with trochlear lesions are re-
scoped. 
The question as to whether we should perform ACI in patients with mild OA (e.g. Kellgren 
and Lawrence grade 1 or 2) remains unanswered. Performing ACI to treat OCD in patients 
with generalised arthritic changes in the knee is not as efficacious as treating patients with an 
OCD and no radiographic evidence of OA, but nonetheless, is still shows significant benefit. 233 
 
As there was a dose dependent effect of smoking on outcome, patients should be encouraged 
to abstain prior to surgery. The only accurate method of determining whether abstaining from 
smoking prior to ACI will improve outcome would be to perform a RCT. Smokers could be 
randomised to either continue to smoke or to abstain smoking for a pre-determined period of 
time prior to undergoing ACI.  To investigate what is the ideal period of abstinence required, 
it may be prudent to have several different abstinence time frames. Similarly, when treating 
overweight and obese patients, patients should be encouraged to lose weight prior to surgery. 
However, from the results of this study it cannot be conclusively stated that losing weight 
prior to ACI will result in improved outcome. Once again, a randomised controlled trial could 
answer that question. What can definitely be stated is that obese patients should not undergo 
ACI as there is no benefit (as measured by the MCS) whatsoever. The results from this study 
do raise some questions. If ACI was not performed in obese patients then would their knee 
function deteriorate?  If this is the case, then is it acceptable to perform ACI to maintain the 
current level of function? Once again the only way to answer these questions would be to 
perform a randomised controlled trial in obese patients with two groups; group 1 would be 
composed of obese patients with OCD in the knee and no treatment and group 2 would have 
identical patients in which ACI is performed. Ethical issues regarding non-treatment of 
patients in pain may prevent a trial such as this from being instigated.  
After adjusting for variables such as BMI and smoking, it was shown that patients partaking 
in high impact physical activity pre-injury had significantly better results than those not 
taking part in sports at all. Obviously this is not a variable that can be modified but some 
form of exercise (e.g. simple static quadriceps contractions) would be useful to prevent 
muscle wasting prior to surgery to improve functional outcome post-operatively and patients 
should be encouraged to try and stay as active as possible whilst waiting for ACI. 234 
 
When trying to address the significantly inferior results in patients with known risk factors 
for adverse outcome, one needs to consider ways in which the surgical technique can be 
improved or in fact whether the right surgical technique is being used. 
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Limitations 
 
In each of the chapters a small pilot study was performed to determine the appropriate sample 
size. This allowed accurate statistical evaluation of each of the factors in the case-controlled 
studies as well as the randomised controlled trial. However, it became apparent that large 
sections of patient and lesion details were not being completed by the operating surgeons in 
the data capture sheets. This resulted in a smaller number of patients with complete dataset 
available for analysis in the Generalised Linear Model, hence the increased possibility of type 
II statistical errors in most of the chapters. For example, in chapter 3 (ACI vs MACI) after 
sample size calculations, an adequate number of patients were recruited to determine a 
difference between the two forms of treatment (126 patients had ACI and 121 had MACI). 
However, out of the 247 patients only 100 had a complete set of data recorded (e.g. size of 
lesion, duration of symptoms, number of previous procedures, etc.). This means that when 
multiple regression analysis is performed, the study may be underpowered. An attempt was 
made to retrieve the lost data by inspecting the patients’ notes but the missing information 
(e.g. duration of symptoms, number of prior procedures, size of lesion) was also not recorded 
there. In the future, all data capture forms should be heavily scrutinized. It was probably the 
case that such data at the time of collection was deemed unimportant and therefore not 
recorded. 
Another major problem in the randomised study was the high attrition rate. Only 122 patients 
(49%) attended their 2 year clinic appointment, leading to the risk of follow-up bias. 
However the fact that similar numbers of ACI and MACI patients were lost to follow up, 
makes it less likely that this would introduce bias in the comparison between the two types of 
surgery, even if a successful outcome following surgery influenced whether patients attended 
their clinic appointment.  The reasons for this have been discussed in the relevant chapter. 236 
 
The Royal National Orthopaedic Hospital is a tertiary referral centre, hence patients from all 
over the country have to be followed up. Therefore it makes it very difficult for patients to 
attend outpatient clinics, and the motivation to attend if they are doing well has to be 
questioned. Most of the missing data in this cohort of patients was retrieved via a postal 
questionnaire or by telephone. Ideally, the trial team needs to identify patients that have not 
attended their clinic appointment, and alert the investigator, so that patients’ knee status can 
be updated and attrition rates can be optimised. 
 
Chapter 6 assessed modifiable risk factors. In this cohort of patients, the Modified Cincinnati 
Score (MCS) was collected prospectively. However, the data regarding weight, smoking and 
physical activity was collected retrospectively. This therefore represents a source of recall 
bias. Whilst height will not fluctuate, weight can do. That is why patients were grouped into 
three groups (ideal weight, overweight and obese) as generally patients’ weight will not 
fluctuate beyond this particular range. Unfortunately the same thing cannot be applied when 
quantifying smoking. However, in the GLM, smoking status was ordinal (smoker, ex-smoker 
or non-smoker) and this is unlikely to undergo recall bias as patients can usually remember if 
they were smoking or not. Obviously it would have been more accurate to record the smoking 
status prospectively. Similarly, the physical activity profile is likely to suffer from recall bias 
as it may be harder for someone to remember how active they were two years ago than if they 
smoked or not. However the discrepancy in physical activity between high impact sports 
players and no sports being played is high and therefore recall bias between these two groups 
is going to be lower. 
 
The problems mentioned above highlight how difficult it is to ‘police’ a RCT, especially one 
that is a multicentre, multi-surgeon trial. As a research fellow, one can continue to write to 237 
 
surgeons that enrol patients to fill in the relevant details, but they may not write back with the 
necessary information. The solution is to use a Clinical Trials Unit (CTU). These specialist 
units’ main remit is to design, conduct, analyse and publish clinical trials as well as other 
studies and to ensure adequate research nurse support to improve complete data collection. 
Their capability to provide specialist expert statistical, epidemiological and methodological 
advice would have been invaluable, but the key activity lacking in this study is the co-
ordinated data collection from multiple centres and ensuring there is no loss to follow-up.  
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Future direction 
 More sophisticated outcome measures 
A very small minority of patients agreed to have the 1 year post-operative arthroscopy, and 
fewer still had biopsy of the repair tissue. A complete histological analysis would have been 
very useful as we could then determine factors that may influence hyaline cartilage formation 
and correlate that with clinical outcome. It was shown that with doubling of the time after 
implantation the likelihood of a favourable histological outcome was increased by more than 
fourfold up to a time point of 36 months (Gikas et al 2009). Any meaningful analysis of the 
available biopsy would not be possible as a significant proportion of patients had not 
undergone the biopsy procedure and therefore the potential for selection bias exists.  
 
Another potential medium for analysis that could have been performed is the synovial fluid, 
as well as biochemical markers in the patients’ blood and urine. Such markers could be 
correlated with patient and lesion characteristics before and after surgery, and then be used to 
predict outcome in future patients. Takahashi et al. had demonstrated that urinary 
pyridinoline had a significant correlation with joint space width and Kellgren and Lawrence 
(KL) grading on the antero-posterior radiographs of 71 females with knee OA (Takahashi et 
al 2004). Furthermore, tissue inhibitor of metalloproteinase (TIMP)-1 was the only blood 
biochemical marker (from three tested) to exhibit a significant relationship with radiographic 
severity of OA (as judged by KL grade). The main criticism of this paper is that none of the 
patients’ knee function was assessed, hence it could not be determined if there was a 
relationship between the biochemical markers in question and patients level of pain and knee 
function. Since we treat patients and their symptoms and not radiographs, the relevance of 
these findings are questionable.  239 
 
 
 Development of technique 
ACI has evolved considerably since its introduction in 1994. So-called ‘third generation’ 
techniques includes the potential for arthroscopic implantation (Feruzzi et al 2008) when 
treating lesions in the medial femoral condyle. The ultimate goal in treating OCD in the knee 
is to achieve high success rates in the long term with low complication and re-operation rates. 
This ultimate goal has 3 key requirements which are linked: 
 
 
 
 
 
The cells have to be responsive to their environment, and the environment has to optimal to 
allow chondrogenesis. The question then arises about the type of cells that can be used; both 
chondrocytes and mesenchymal stem cells (MSCs) possess these characteristics and MSCs 
will be discussed later. The cytokine milieu and oxygen tension may represent modifiable 
factors to promote growth once transplantation has occurred. Saris et al compared the results 
of ‘characterised’ chondrocytes implantation (CCI) versus microfracture in the treatment of 
OCD of the knee (Saris et al 2008). This group selected chondrocytes for expansion and 
transplantation on the basis of expressing a marker predictive of consistent production of 
hyaline cartilage. This marker profile has been previously described to preserve phenotypic 
characteristics and differentiation following cell expansion, thereby increasing the 
Cells 
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Factors  Scaffolds 240 
 
chondrogenic potency (Dell’Accio et al 2001). The results from randomised controlled trial 
proved that CCI was significantly better than microfracture for the treatment of OCDs of 
similar sizes (mean = 2.5cm
2). This is in contrast to other studies comparing standard ACI 
with  microfracture (Knutsen et al 2005, 2007, Kon et al 2009). The improved outcome in the 
study by Saris et al may be attributable to the use of characterised chondrocytes, but no study 
has compared characterised chondrocytes with chondrocytes prepared routinely. Moreover, 
the considerable increase in expense during cell selection and expansion prohibits its use, but 
certainly may represent an improvement in the cell therapy. 
The purpose of a scaffold in the context of ACI is to anchor, deliver and orientate cells post-
transplantation. There has been considerable evolution in the engineering of biodegradable 
scaffolds from the original use of the periosteal patch (Brittberg et al 1994). The use of a 
synthetic collagen membrane has reduced reoperation rates due to hypertrophy (Gooding et al 
2006, Gomoll et al 2009), the MACI technique can be performed more quickly (Bartlett et al 
2005) and currently the development of gel-like scaffold provides the potential for 
arthroscopic implantation, thereby further reducing surgical trauma (Selmi et al 2008). 
The potential exists to provide instructional cues to cells following transplantation with the 
use of bioactive factors or reagents. In vitro studies have demonstrated that chondrocytes 
cultured with TGF-β produce increased quantities of type II collagen (Goldberg et al 2005). 
Growth factors from the TGF-β super family, as well as Insulin Growth Factor (IGF) and 
Fibroblast growth factor (FGF) have been shown to have a positive effect on chondrogenesis 
(Skoog et al 1990, Matsumoto et al 1996, Chuang et al 2012), though as yet no work has been 
conducted on the enhancement of ACI with these factors. The question still remains whether 
we can enhance proteoglycan and type II collagen synthesis with use of growth factors. 
Conversely, inflammatory cytokines are present in the synovial fluid of patients with 241 
 
established osteoarthritis (Distel et al 2009) and are thought to play a role in paracrine 
inflammation and disease progression. Synovial fluid analysis has not been performed in 
patients with simple traumatic OCDs, though the presumption is that there may be 
inflammatory cytokines such as IL-6, IL-1 and TNF present. Targeting these cytokines with 
monoclonal antibodies may be another way to augment cell therapy by inhibiting matrix 
breakdown after cartilage injury. 
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The use of mesenchymal stem cells 
 
An open biopsy of articular cartilage is necessary in order to obtain the chondrocytes 
necessary for expansion and re-implantation. This exposes the patient to the morbidity of two 
surgical procedures. Stem cells are an ideal alternative to chondrocytes since they are easily 
accessible, expandable in culture and multipotent and can be inserted in a single stage. 
Mesenchymal stem cells (MSCs) have been isolated from many tissues including bone 
marrow (Pittenger et al. 1999), synovial membrane (De Bari et al. 2004), periosteum (De Bari 
et al. 2006) and articular cartilage (Douthawaite et al. 2004). 
There are two important studies concerning the use of MSCs to engineer cartilage. Caplan’s 
group developed an in vitro method of inducing both animal (Johnstone et al. 1998) and 
human MSCs (Yoo et al. 1998) into the chondrogenic pathway. The second important study 
was by Wakitani et al. (1994) in which rabbit MSCs were placed in full thickness OCDs in 
the medial condyle of young mature rabbits. Since then, considerable work has been 
performed on larger animal models (Liu et al. 2006, Wilke et al. 2007) but to date there are 
few studies in humans. 
Wakitini’s group advanced their studies by transplanting autologous culture-expanded bone 
marrow mesenchymal cells into nine full-thickness articular cartilage defects of the patello-
femoral joints (including two kissing lesions) in the knees of three patients.  Three weeks 
before transplantation, bone marrow blood was aspirated from the iliac crest. Adherent cells 
were cultured with media containing autologous serum. Six months after transplantation, the 
patients’ clinical symptoms had improved and the improvements have been maintained over 
the follow-up periods (17-27 months). Histology of the first patient 12 months after the 
transplantation revealed that the defect had been repaired with the fibrocartilaginous tissue. 243 
 
Magnetic resonance imaging of the second patient 1 year after transplantation revealed 
complete coverage of the defect, but they were unable to determine whether or not the 
material that covered the defects was hyaline cartilage. 
Haleem et al. used platelet-rich fibrin glue as a scaffold to deliver autologous culture-
expanded bone marrow MSCs for cartilage repair. All five patients had significantly 
improved clinical scores 1 year following surgery. Only two of the five patients had agreed to 
an arthroscopic assessment of their grafts one year following surgery and they had improved 
arthroscopic (ICRS) scores from 8/12 to 11/12 (Haleem et al. 2010). 
The source of stem cells is an important issue when considering cartilage repair. MSCs from 
bone marrow appear to have high propensity to cartilage hypertrophy and bone formation 
(Peltari et al. 2006) and hence may not be the ideal chondroprogenitors. MSCs from synovial 
membrane appear to have a greater propensity to form cartilage in vitro than MSCs from 
bone marrow and periosteum (Sakaguchi et al. 2005). 
Recent work by Bosetti et al. (2011) has identified several growth factors such as bone 
morphogenic proteins that can induce the differentiation of human bone marrow MSCs into 
mature chondrocytes, with the additional effect of increased expression of collagen type II 
and Sox9, the markers for chondrogenesis. However, the more recent discovery of its 
immunomodulation capacity is just as exciting. Several publications indicate that MSCs and 
their secretions affect dendritic cells, T-cells, B-cells and Natural Killer cells (Iyer et al., 
2008). Therefore the possibility exists of using MSCs to eliminate chronic inflammation from 
joints. 
There has been only one study in humans comparing MSCs and autologous chondrocytes 
when treating OCDs in the knee. Nejadnik et al. discovered superior scores in the SF-36 244 
 
physical role section with the use of bone marrow derived MSCs compared with ACI 
(Nejadnik et al 2010). Furthermore, the ACI group did significantly better if they were aged 
less than 45. This age-related effect was not seen with the MSC group. 
 
Conclusion 
Autologous chondrocytes implantation is still the technique most likely to produce hyaline-
like cartilage regenerate when treating osteochondral defects in the knee. When using the 
absolute Modified Cincinnati Scores, the results from this centre (now involving over 800 
patients) are inferior to other centres. This may be because of a challenging cohort of 
unselected patients who had a long history, had undergone several previous procedures and 
had a variety of defects. It certainly would be interesting to assess the efficacy of this 
procedure in patients who have not undergone any other surgical procedure and have had a 
relatively short duration of symptoms.  
The work in this thesis has identified adverse prognostic factors and possible methods to 
enhance results. Patients can now be adequately counselled regarding prognosis and the 
generalised linear model can be used to predict a more accurate outcome.  245 
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The Royal National Orthopaedic Hospital 
 
The UK Articular Cartilage Repair Study 
 
ACI –v- MACI 
 
 
FORM A – New Patient Form 
To be completed once for each new patient enrolled in the study 
FORM B – Surgery Form 
To be completed for each patient undergoing a cartilage repair procedure (must 
have had form A completed) 
FORM C (Part 1) – Follow Up Form  
@ 6 and 12, 24, 36 months post-op 
& 
FORM C (Part 2) – Follow Up Form 
@ 24 and 36 months post-op 
To be completed for each follow up arthroscopy procedure (must have had forms A 
and B completed) 
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PLEASE RETURN COMPLETED FORM TO: 
 
Prof George Bentley 
c/o Nerina Bee 
Teaching Centre 
RNOH NHS Trust 
Brockley Hill 
Stanmore 
Middlesex.  HA7 4LP 
UK Articular Cartilage Repair Study 274 
 
 
The Royal National Orthopaedic Hospital, Stanmore  
 
Surgeon Details 
 
Consultant:                                   Completed by:                                 Date: 
 
 
Patient Personal Details & Medical History 
 
Patient Name: ………………………………………………………………………..……….…  
 
Hospital Number:……..……………………………………………..……  Gender: ………. 
 
Patient Randomisation No………………………………….   ACI / MACI (please circle) 
 
Address: ………………………………………………………………………….……………... 
 
                ……………………………………………………………………….……………….. 
 
                ………………………………………………………………………………………… 
 
 
Date of Birth:  ……/……/…... 
 
Age at the time of MACI/ACI Surgery:  …………………………. 
 
FORM A 275 
 
Contact Phone Number:  ………………………………………….. 
 
 
Height: …………………(cm)      Weight:  ………………(kg) 
 
Occupation prior to injury:  ……………………  Occupation now: ……….…………… 
 
Smoker: Yes/No/Ex           Allergies:  Yes/No  If yes please state …………………. 
 
Alcohol:  Never       Occasionally       Units: < 14     15-21    > 21   
 
Opposite Knee:  Normal         Almost Normal       Not Normal   
 
Medication:      NSAIDS          Cortiscosteroids                Other   
 
Comorbidity: ……………………………………………………………………………………… 
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FORM A 276 
 
Surgical History 
 
Date of first stage (harvesting):           ….…./….…./….…. 
 
Date of Second Stage (implantation): ….…./.……./….…. 
 
Length of Symptoms: ………………… 
 
Aetiology of Cartilage defect:  Traumatic         OCD     Early OA    
 
       Chondromalacia Patellae         Other              
 
Side:  R       L                   Other Details:  ………………………………………… 
 
Previous Knee Surgery:   Arthroscopy and Removal of Loose Bodies        
                 Drilling/microfracture         Debridement    
  Diagnostic Arthroscopy   Mosaicplasty   
   
  MSP Graft            ACI       Other       
 
            
No. of previous surgeries on the Index (affected) Knee:  ………………………… 
 
 
Other Details:   Lateral Release          Patellectomy          277 
 
 
 Tibial Tubercle Transfer:   Med        Lat        Prox        Dist           
Ant     
 
                                              ACL Recon          PCL Recon          
 
Menisectomy:              M               L     
 
Meniscal Repair:         M                L     
 
Osteotomy:         Tibial   Femoral        
 
Other Surgery to same Limb       Describe:  ………………………………………. 
 
Indications for Surgery:     Pain with Cartilage Defect           Locking          
                                             Giving Way         Other          
 
 
 
                                                                                                                                                           
                                                                                          
UK Articular Cartilage Repair Study 
The Royal National Orthopaedic Hospital, Stanmore  
 
Examination Findings & Scoring System (for scoring system please see 
overleaf) 
FORM A 278 
 
Wasting (6cm above patella)   Nil        <2cm      >2cm  
 
Alignment:    Normal       Valgus        Varus     
 
Effusion:               Nil            Mild          Mod        Sev     
 
Range of Movement (degrees)   Flexion: ………….   Extension:  ………… 
 
    Fixed flexion deformity: ……….. Ext Lag:  ……. 
 
Crepitus:              Nil            Mild          Mod         Sev     
 
Joint Tenderness: Nil     Lateral       Medial        PFJ     
 
Patella Tracking             Stable       Unstable         J Sign     
 
Ability to Squat:    Normal       Difficult       Unable    
 
Anterior Draw:   0      1     2       3      MCL instability:  0        1     2  
     3  
 
Lachman Test:   0      1      2       3      LCL instability:   0        1     2  
     3    
 
Posterior Sag:    0      1      2       3        Pivot Shift:    Pos   Neg  279 
 
 
 
Visual Analogue Score (0-10):     ……….   
 
Bentley Functional Rating Score (0-4)  ………. 
 
Modified Cincinatti Score (1-100)     ………. 
 
Other Comments: 
…………………………………………………………………………………… 
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Investigations 
 
FORM A 280 
 
Xray Findings         Valgus Angle …………….   Sulcus Angle ………… (tangential view) 
(AP Standing) 
 
Patella:     Baja        Alta      Tracking:     Normal     Abnormal   
 
Defect:      Visible   Yes         No        Depth ………. (mm) 
 
MRI Scan      Defect size (mm)      Width ……….  Depth ………. 
 
Defect:  Visible   Yes         No       Depth   ………. (mm) 
 
Site:  MFC        LFC       Pat      Troch   
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FORM B 282 
 
ACI 
Site Size and Depth of 
Lesion 
 
 
Type 
 
ACI        
MACI     
Other    ……… 
 
 
Harvest 
Site(s) 
  
 
 
 
 
 
Type of Cover 
 
Perisoteum           
 
Type I-III collagen 
membrane           
 
Other                  
 
APPROX NO. OF CELLS 
USED 
 
 
Patient Name …………………………………………………………….. 
 
Surgeon ………………………………  Randomisation No……….... 
 
Hospital No. …………………………………   D.O.B ………………… 
 
Intention to Treat:   Yes         No     
(i.e. is the patient being treated as randomised) 
 
If No, reason:   Difficult Access       Combined Procedure      
 
 
Please draw the defects on the above diagram 
 
Defect 1 
Location -  Medial Femoral Condyle         Trochlear        
                    Patella – Single Facet            Patella – Multi Facets     
                    Lateral Femoral Condyle       Lateral Tibial Condyle    
 
ICRS Grade of defect (see over) :1  2   3  4  A   B  C  D  
 
Outerbridge Grade of defect  :     1   2   3   4  
 
Size of defect pre-debridement (mm) -  Height …..….  Width …..…. 
 
Size of defect post-debridement (mm)  Height  …..….  Width …….. 
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Other Structures 
 
 
 
 
 
 
 
Defect 2 
Location -  Medial Femoral Condyle        Trochlear        
                    Patella – Single Facet           Patella – Multi Facets    
                    Lateral Femoral Condyle       Lateral Tibial Condyle   
 
ICRS Grade of defect (see over) : 1  2   3   4   A   B   C   D  
Outerbridge Grade of defect  : 1   2   3   4  
Size of defect pre debridement (mm)   Height  ……….  Width ….. ….  
5 million                
10 million              
15 million              
More                      
 
 
Notes : 
 
 
 
 
                                                                    Depth  ……… 
 
FORM B 284 
 
 
 
 
 
 
 
Size of defect post debridement (mm) Height  ……….  Width ….. …. 
                                                                    Depth  ……… 
Medial Meniscus  Intact    Degenerative    Degenerative tear     
 
              Traumatic tear                       Absent   
 
Lateral Meniscus  Intact    Degenerative    Degenerative tear      
 
            Traumatic Tear                         Absent   
 
 
Anterior Cruciate 
Ligament 
 
 
Intact     Chronic tear                  Acute tear     Lax   
 
Posterior Cruciate 
Ligament 
 
 
Intact    Chronic tear                  Acute tear     Lax   
 
Loose Bodies     1   2    3    > 3     
 
Plica 
 
Medial    Lateral    Suprapatellar     
Combined 
Procedures 
ACI and Osteotomy     
ACI and ACL Reconstruction     
ACI and Lateral Release   
 
Other …………………………………………………… 285 
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Patient Name   ……………………………………………………………… 
 
Hospital Number:……..……………………………Gender: …………… 
 
Height (cm)………………………   Age at time of 2
nd operation………. 
 
Weight (at time of surgery)…………… Weight (now)…………….. 
 
Do you have any other medical problems?……………………………. 
What mediations do you take?............................................................. 
 
How did you injure yourself…………………………………………………… 
 
Smoker?  Y / N / Ex (If ex: when did you stop…………………) 
If yes/Ex, What do you/did you smoke…………………………………….. 
 
o  How long did you smoke for………………………………………… 
 
o  How many do you smoke a day…………………………………… 
 
o  Did you smoke before your surgery?……………………………… 
 
o  Did anyone tell you to stop smoking prior to surgery?………… 
 
o  If you did stop, how long before the surgery did you stop?…… 
 
Form for BMI, 
Occupation & Smoking 289 
 
o  Did you start smoking after surgery & if so how long after?…… 
Alcohol:  Never    Occasionally    Units: < 14     15-21   >21  
 
How long were you in hospital for after 2
nd stage operation?............ 
 
Were there any problems with your wound after the operation?…….. 
 
If so what?……………………….Did you require antibiotics?…………….. 
 
Symptoms Prior To Cartilage Operation (please circle): 
Pain        Swelling 
Stiffness      Giving way 
Locking      Grating 
Other (please specify)……………………….............................. 
 
 
Occupation 
 
Occupation prior to injury…………………………………………………… 
Occupation prior to operation……………………………………………… 
Occupation now………………………………………………………………….. 
Estimated time off work due to symptoms (prior to cartilage 
operation)…………………………………………………………………………. 
Estimated time off work due to Cartilage operation…………………… 
Did you go to 6
th form college?......................................................... 
 
After cartilage surgery has there been a modification in your work (if so 
what?)……………………………………………………………..……….. 
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Occupational Activity (in an average working day) 
 
  Before Cartilage 
Operation 
After Cartilage 
Operation 
Sitting for > 2 hours in 
total 
   
Standing/walking for  
> 2 hours (total) 
   
Kneeling for > 1 hour 
(total) 
   
Squatting for > 1 hour 
(total) 
   
Getting up from 
kneeling or squatting > 
30 times 
   
Driving for 4 hours in 
total 
   
Walking for > 2 miles in 
total 
   
Climbing > 30 flights of 
stairs 
   
Lifting/moving weights 
of +10Kg by hand 
   
Lifting/moving weights 
of +25Kg by hand 
   
 
 291 
 
Occupational & Psychological Factors 
 
  Before Cartilage 
Operation 
After Cartilage 
Operation 
Better/Worse/Same 
Annual Income       
Work Stress:       
o  Often       
o  Sometimes       
o  Seldom       
o  Never       
Job Satisfaction       
o  Not satisfied       
o  Somewhat       
o  Mostly       
o  Totally       
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Physical Activity 
 
Which sports did you play at least 5 times a year (prior to injury)….. 
 
………………………………………………………………………………………… 
 
At what age did you begin playing these sports…………………………. 
 
At what age did you stop………………………………………………………… 
 
Have you returned to playing these sports………………………………… 
 
How many months after the cartilage operation were you able to return to the 
following: 
 
o  Walking (for exercise)………………………………………………….... 
 
o  Swimming………………………………………………………………….... 
 
o  Cycling…………………………………………………………………......... 
 
o  Gym work…………………………………………………………………………… 
 
o  Running…………………………………………………………………….... 
 
 